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Embryonic stem (ES) cells are derived from the inner cell mass of the blastocyst 
stage embryo.  They exhibit unlimited proliferation in culture and have the ability to 
differentiate into all three germ layers of the developing organism, a property 
defined as pluripotency. Previously it was reported that growth factor-bound protein 
2 (Grb2) is required for differentiation of the epiblast, the embryonic tissue that 
harbours the pluripotent founder cells of the foetus. 
GRB2 is an adapter protein involved in the activation of the mitogen-activated 
protein kinase (MAPK) pathway in response to extracellular signals.  It has also 
been implicated in the activation of the phosphoinositol-3-kinase (PI3K) pathway in 
response to fibroblast growth factor (FGF) signaling. 
The work presented in this thesis examines the role of Grb2 in ES cells and 
describes previously unreported contributions of this adaptor protein in regulating 
ES cell growth and differentiation.  
It has been previously been shown by others that Grb2 deficient (Grb2-/-) cells grow 
relatively normally in ES growth medium containing serum. However, in serum free 
conditions (N2B27 medium) in this project, proliferation of Grb2-/- cells is reduced 
compared with wild type and “restored” Grb2-/- cells stably expressing a Grb2 cDNA 
mini gene.  
Under serum free conditions, Grb2-/- cells grow in tight, refractive colonies.  Nanog 
expression was uniformly upregulated, in contrast to the heterogeneous pattern 
reported in serum-based medium.  Colony expansion on the substratum appears to 
be compromised, although there is no apparent   defect in the initial attachment of 
Grb2-/- cells.  Cell cycle analysis indicates that the slower growth of Grb2-/- cells in 
serum free medium could be due to lengthening of the G1 phase of the ES cell 
cycle.  
In an attempt to identify the signalling deficiency responsible for the growth defect of 
Grb2-/- cells, MAPK activation was restored by two methods, PMA a ligand that 
bypasses the requirement for Grb2, and Raf-ER, a conditionally regulated 
component of the MAPK pathway that acts downstream of Grb2 in the MAPK 
pathway. Although both approaches increased MAPK signalling they were unable to 
rescue the growth defect.  This suggests that MAPK is not required or alone is not 
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sufficient.  Inhibition of Glycogen synthase kinase 3 ! (GSK3!) is known to augment 
growth of ES cells under MAPK inhibition.  Surprisingly, GSK3! inhibition did not 
enhance Grb2-/- cell growth.  Under GSK3! inhibition, Grb2-/- ES cells fail to thrive.  
It is hypothesised that under these conditions cells undergo hyper-self-renewal at 
the cost of growth.  
Grb2-/- ES cells are reported to exhibit limited differentiation potential. To examine 
the potency of Grb2-/- cells, these cells were subjected to embryoid body (EB) and 
monolayer differentiation. Analysis of EBs showed a loss of Gata4, Gata6 and 
endoderm marker gene expression. However, markers of ectoderm (Sox1, Pax6, 
MAP2), the late epiblast/nascent mesoderm (Brachyury) and markers associated 
with gastrulation (Twist and Snail) were expressed. Outgrowths of morphologically 
and immunohistochemically identifiable neuronal cells confirmed differentiation of 
ectodermal cell types, indicating Grb2 is not required for neuronal differentiation. 
However, beating cardiomyocytes could not be identified in Grb2-/- EBs, though 
readily found in restored Grb2-/- cells expressing the Grb2 cDNA.  This suggests that 
there is an essential role for Grb2 in the mesoderm/cardiomyocyte differentiation 
pathway. This may be due to a defect in GATA factor expression since these factors 
are essential for cardiogenesis. 
In serum-free monolayer differentiation, Grb2-/- cells formed neuronal cells. 
Additional inhibition of the MAPK pathway using a small chemical inhibitor failed to 
prevent this differentiation. However, biochemical analysis of the cells indicates that 
this occurs when ERK activation is very low, indicating differentiation was not 
MAPK-independent. 
Grb2 mediates FGF-MAPK induced exit from the naïve ground state. These data 
suggest a Grb2-independent pathway can also facilitate this transition. Grb2 is 
dispensable for differentiation in to some lineages. However as differentiation of 
Grb2-/- ES cells is restricted, this indicates Grb2 is required for true pluripotency. 
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1.1 Pluripotent Embryonic Cells 
Pluripotency is a property that is defined as the potential of a cell to develop into 
the differentiated cell types that make up the tissues of an organism.  There are 
many types of pluripotent cell that share specific characteristics.  These include 
the ability to expand indefinitely in culture, maintenance of self-renewal and the 
capacity to differentiate into more specialised cell types.  A discussion of 
different types of pluripotent cell follows. 
1.1.1 Embryonic Carcinoma Cells 
Murine embryos can form teratocarcinomas when injected subcutaneously 
(Solter et al., 1970). A teratoma is a tumour mass constituted of a random 
assortment of differentiated cell types, encompassing all three germ layers; 
ectoderm, mesoderm and endoderm.  A teratocarcinoma is a malignant form of 
teratoma derived from pluripotent germ cells.  Ectopic transplantation of 
embryos at embryonic stage E7.0 (Figure 1.1) results in the formation of 
teratocarcinomas at low frequency (Solter et al., 1970).  Later, Diwan and 
Stevens (1976) refined this research to show the origin of these tumours was 
the epiblast.  The undifferentiated cells present in these tumours can also be 
expanded in culture to create cell lines (Finch and Ephrussi, 1967).  Martin and 
Evans (1975) demonstrated that a fibroblast feeder layer aided maintenance 
and expansion of these cells and named them embryonal carcinoma (EC) cells.  
EC cells retain an ability to differentiate upon transplantation into a syngeneic 
murine host (Damjanov et al, 1982) and injection into blastocyst embryos results 
in contribution to many lineages of the embryo, excluding the germ line (Brinster 
1974; Rappolee et al., 1994).  The inability of these cells to form germ cells may 
be explained by the typically abnormal karyotype exhibited by EC cells and the 
consequent termination of meiosis (Bradley et al., 1984). This early research led 









   
 
Figure 1.1 Early mouse development.  Figure directly copied from Beddington and Robertson 




1.1.2 Embryonic Stem Cells 
Embryonic stem (ES) cells are derived from pre-implantation embryos.  Upon 
plating the inner cell mass (ICM) of an embryonic stage E3.5 blastocyst onto a 
fibroblast feeder layer in the presence of foetal calf serum, a pluripotent cell 
population can be expanded (Evans and Kaufman, 1981; Martin, 1981).  Like 
EC cells, ES cells proliferate indefinitely and differentiate into all three germ 
layers. ES cells have the greatest potency of all embryonic cell types and 
represent a transient population of cells that appear in the inner cell mass of the 
pre-implantation blastocyst. 
Injection of ES cells into pre-implantation blastocysts show their capacity to 
contribute to chimeric mice is greater than that of EC cells and without tissue 
bias (Brinster et al, 1974).  As their karyotype is diploid and stable, ES cells are 
also able to contribute to the germ line (Bradley et al., 1984) and pass the most 
stringent test of pluripotency: tetraploid complementation (Nagy et al., 1993).  In 
this technique, tetraploid embryos are created upon fusion of late two-cell-stage 
embryos to one-cell-stage embryos.  These embryos develop into blastocysts, 
albeit lacking an ICM.  ES cells are injected into the blastocoel and, providing 
they are of sufficient quality, go on to form every tissue of the developing foetus. 
The ability of ES cells to contribute to the germ line coupled with their 
amenability to genetic manipulation has enabled research into the role of genes 
both in development and the adult organism. 
The availability of ES cells presents an opportunity to access some of the 
earliest events of embryo development and cell fate decisions.  Their potential 
for creating disease models, cell therapy and drug screening has generated 
intense interest from both scientists and the media. 
ES cells have the ability to generate fully functional terminally differentiated cell 
types in vitro.  The clinical relevance of this was demonstrated by the 
remyelination of axons by ES cell-derived ogliodendrocytes in a myelin-deficient 
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mouse (Liu et al., 2000).  This research has implications in the treatment of 
chronic diseases such as multiple sclerosis; a progressive condition in which 
demyelination of axons occurs. 
The propagation of ES cells is a relatively recent development (Evans and 
Kaufman, 1981; Martin, 1981).  Understanding the molecular mechanisms that 
regulate fundamental ES cell biology will enable efficient culture and expansion 
of this cell type and uniform differentiation and tissue generation in a controlled 
manner. 
1.1.3 Epiblast Stem Cells 
Pluripotent stem cells have also been isolated from the post-implantation 
embryo (Brons et al., 2007).  When the epiblast of E5.5-6.5 mouse embryos is 
cultured in media containing FGF2, a pluripotent population of cells termed 
epiblast stem cells (EpiSCs) is expanded.  EpiSCs have a capacity to 
differentiate into many cell types in vitro and form teratomas exhibiting multi-
lineage differentiation upon injection under the kidney capsule of severe 
combined immunodeficient (SCID) mice.  In comparison to ES cells, EpiSCs 
exhibit reduced clonogenicity, a limited differentiation capacity and are unable to 
contribute to chimeras.   
The significance of EpiSCs is their role in redefining the relationship between 
mouse and human ES cells (hES cells).  
Despite their similar terminology, hES cells and mouse ES cells are distinct with 
regards to their morphology, marker expression and growth requirements.  hES 
cells typically grow as a colony whilst mouse ES cells grow as a monolayer 
(Evans and Kaufman, 1981; Martin, 1981; Thomson et al., 1998). hES cells 
express markers SSEA3 and SSEA4 and lack SSEA1 (Thomson et al., 1998) 
but conversely, mouse ES cells exhibit a SSEA1 positive, SSEA3 and SSEA4 
negative marker profile. However, there are some similarities in marker 
expression, for example Oct4, Nanog and Sox2 (discussed later). 
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hES cells are typically cultured with a layer of irradiated embryonic fibroblasts 
known as feeders, which secrete a poorly defined mixture of signalling 
molecules sufficient to prevent differentiation (Thomson et al., 1998).  Medium 
conditioned by these cells can also be utilised.  Fibroblast growth factor 2 
(FGF2) and Nodal were elucidated to be key factors in maintaining the hES cell 
population. (Vallier et al., 2005) 
Xu et al. (2005) reported hES cells cultured in unconditioned medium showed 
increased BMP signalling when compared to cells cultured in feeder-conditioned 
medium. Differentiation was significantly repressed in the presence of FGF2 and 
this inhibition was enhanced with the addition of BMP antagonist Noggin.  These 
data are supported by Dvorak et al. (2005), who also reported that inhibition of 
the FGF receptor (FGFR) causes rapid differentiation. 
A study by Vallier et al. (2005) developed these findings, showing that TGF! 
family member Nodal is necessary to maintain pluripotency. Inhibition of 
Activin/Nodal signalling not only induces differentiation but also blocks the action 
of FGF2, suggesting an essential interaction of Activin/Nodal and FGF signalling 
occurs. 
In summary, the growth requirements of mouse and human ES cells are distinct. 
Mouse ES cell cultures are supported by LIF and BMP4 stimulation and hES 
cells require FGF2 signalling coupled with BMP antagonisation for long-term 
culture.  
hES cells are derived from blastocyst embryos at a similar developmental stage 
as mouse ES cells (Thomson et al., 1998), however, mouse EpiSCs are 
maintained by the same factors required for the maintenance of hES cells. Both 
mouse and human ES cells express a similar profile of core ES cell transcription 
factors but surface markers such as the SSEA antigens, morphology and 
signalling response of the cells are dissimilar.  Furthermore, the pattern of gene 
expression of hES cells is closer to that of EpiSCs (Tesar et al., 2007).  This 
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may indicate that human ES cells represent a later stage of development than 
previously considered.  
1.1.4 Induced Pluripotent Stem Cells 
A long-term goal of many researchers is to convert somatic cells to a pluripotent 
state.  This would permit the generation of patient-specific tissues to be used in 
cell therapy, drug screening and disease modelling.  
Reprogramming has been achieved via the transfer of the nucleus of a somatic 
cell into an enucleated egg in a technique known as somatic cell nuclear transfer 
(SCNT) (Wilmut et al., 1997; Wakayama et al., 1997) and also through the 
fusion of somatic cells with pluripotent cells (Cowan et al., 2005; Do and 
Scholer, 2004).  However, SCNT is inefficient and requires the use of oocytes 
and cell fusion produces tetraploid cells, which are unsuitable for medical 
applications.  Despite their limitations, these techniques proved the principle that 
somatic cells can be converted to a pluripotent state. 
Recent advances in this field showed somatic cell reprogramming is possible via 
direct ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and c-
myc) in murine fibroblasts (Takahashi and Yamanaka, 2006).  These cells were 
termed induced pluripotent (iPS) cells.   
iPS cells have the ability to form a range of differentiated tissues including the 
germ line (Okita et al., 2007) and tetraploid complementation has been achieved 
(Kang et al., 2009).  The technique has been applied successfully to mouse, rat 
and human somatic cells and is currently being applied to an increasing number 
of species. 
The first generation of iPS cells were isolated upon selection for Fbx15 
expressing cells (Takahashi and Yamanaka, 2006).  Fbx15 is a marker of ES 
cells.  This proved an unsuitable method of selection as gene expression and 
DNA methylation patterns differed significantly from that of ES cells and, 
importantly, these cells failed to produce adult chimaeras.  The utilization of 
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fibroblasts containing a Nanog-GFP reporter overcame these issues (Okita et 
al., 2007).  Another group reported an alternative set of genes, namely Oct4, 
Sox2, Nanog and Lin28, also induced pluripotency in somatic cells (Yu et al., 
2007). 
One study demonstrated the medical potential of iPS cells.  Human fibroblasts 
from five patients with idiopathic Parkinson’s disease were reprogrammed and 
differentiated into dopaminergic neurons (Soldner et al., 2009).  An earlier study 
showed neurons differentiated from rat iPS cells can integrate into the brain and 
improve symptoms of rats with Parkinson's disease (Wernig et al., 2008).   
Although the potential benefits of iPS cell technology are clear, it is not yet fully 
understood. While progress is being made to increase efficiency, it is not clear 
why reprogramming is a rare event.  Viral transduction of the 4 genes ensures 
maximum exposure of cells to the reprogramming factors, but integration of 
genetic material into the host cells is unsafe for medical applications.  While 
silencing of the ectopic genes occurs upon complete reprogramming, these 
genes may be reactivated upon differentiation. This is supported by an 
observation by Okita et al. (2007), which described the development of tumours 
in mice created using iPS cells.  This has been circumvented via the use of 
episomal vectors (Okita et al., 2008) or the use of recombinant proteins (Zhou et 
al., 2009), but the use of Klf4 and c-myc is unlikely to be regarded as safe for 
medical application due to their oncogenic nature. 
ES cells remain the archetypical pluripotent cell type which iPS cells are 
intended to mimic.  Research into both cell types will be complementary to 









1.2  Regulation of Embryonic Stem Cells 
  
1.2.1 Intrinsic factors 
Three transcription factors play critical roles in the regulation of the 
transcriptional network that defines ES cell self-renewal and pluripotency; Oct4, 
Sox2 and Nanog.   
1.2.1.1 Oct4 
Oct4 is a POU class transcription factor often described as the master regulator 
of ES cell fate.  Oct4 expression is detectable in oocytes, blastomeres, the ICM 
and germ line cells.  The importance of this was demonstrated upon the 
generation of Oct4 null blastocysts. The ICM of an Oct4 deficient blastocyst 
develops into extraembryonic trophoblast rather than a pluripotent population 
(Nichols et al., 1998), demonstrating the importance of this transcription factor in 
establishing the ES cell identity.  A study by Niwa et al. (2000) showed the level 
of Oct4 expression determines whether the cells adopt one of three fates.  A 
normal level of Oct4 in the cell maintains the pluripotent ES cell population; 
upregulation causes endoderm and mesoderm differentiation and 
downregulation of Oct4 results in differentiation into trophectoderm. This 
suggested that transcriptional control by Oct4 is not an ‘on or off’ system of 
regulation. 
Oct4 and the trophoblast regulator Cdx2 exhibit mutual repression.  Cdx2 is a 
homeobox transcription factor and marker of trophoblast (Niwa et al., 2005).  
Oct4 represses the expression and activity of Cdx2, which in turn inhibits Oct4 
auto-regulation.  These data demonstrate the importance of Oct4 in establishing 
and maintaining a pluripotent population.  
1.2.1.2 Sox2 
Sex determining region Y-box 2 (Sox2) is defined as a key regulator of ES cells 
(Masui et al., 2007).  Sox2 null embryos develop to stage E6.5 but derivation of 
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Sox2 null ES cells has not been achieved (Avilion et al., 2003).  Conditional 
expression of Sox2 in ES cells results in trophoectoderm-like differentiation 
when Sox2 is switched off and ectopic expression of Oct4 rescues the Sox2 null 
phenotype (Masui et al., 2007).  As observed with Oct4, overexpression of Sox2 
does not enforce ES cell self-renewal but rather enhances neural differentiation 
(Zhao et al., 2004). Sox2 regulates the expression of transcription factors 
affecting Oct4 expression and with Oct4, co-ordinately regulates Oct4/Sox2 
binding sites enabling regulation of target genes (Yuan et al., 1995). 
1.2.1.3 Nanog 
Nanog is a divergent homedomain transcription factor related to the Nkx family 
of homeodomain proteins (Chambers et al., 2003; Mitsui et al., 2003).  
Expression initially occurs in the morula with high levels in the early blastocyst 
and downregulation following implantation.  In ES cells, Nanog expression 
oscillates in cultures maintained by Leukaemia inhibitory factor (LIF) and 
serum/Bone morphogenetic protein 4 (BMP4) (Chambers et al., 2007).  This is 
in contrast to Oct4 and Sox2 expression, which is uniform in an undifferentiated 
ES cell population.  It is hypothesised that this expression pattern signifies 
Nanog-facilitated control of the propensity of cells to undergo differentiation 
(Chambers et al., 2007; Glauche et al., 2010). 
Deletion of Nanog results in primitive endoderm differentiation (Matsui et al., 
2003); a fate similar to that of ES cells overexpressing GATA6.  It has been 
suggested that Nanog may inhibit the endodermal fate via GATA6 repression.  
Overexpression of Nanog enables factor-independent self-renewal of ES cells 
(Chambers et al., 2003), but efficiency is further enhanced in the presence of 
LIF.  
Approaching embryonic stage E5.5, Nanog deficient embryos degenerate into 
extraembryonic tissue with a loss of normal patterning.  One early study 
reported Nanog deficient ES cells exhibited an endodermal morphology and 
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markers (Mitsui et al., 2003).  These cells maintained the expression of Oct4 
and Rex1 in a feeder co-culture system but this was lost without feeder support. 
Another study generated an ES cell line genetically manipulated to express a 
tamoxifen-inducible cre recombinase and a loxP flanked Nanog transgene.  
These cells undergo deletion of Nanog upon addition of tamoxifen, resulting in 
Nanog deficient cells (Chambers et al., 2007). The cells were cultured 
extensively in the absence of Nanog and remained pluripotent with low levels of 
differentiation.  Chimeras were successfully generated but germ cells failed to 
mature upon reaching the genital ridge.  This suggests Nanog is dispensable for 
the maintenance of pluripotency but is required for the formation of germ cells. 
The function of Nanog was further explored with regard to recent advances in 
cellular reprogramming.  A somatic cell can become pluripotent upon fusion to 
an ES cell (Do and Scholer, 2004) and Nanog is absolutely required for the 
successful completion of reprogramming (Silva et al., 2009).  Furthermore, 
reprogramming of neural stem cells via ectopic expression of Oct4, Klf4 and c-
myc is reliant on intact Nanog expression in order to complete the transition to 
an ES-cell-like state. 
These data imply Nanog is required for establishing rather than maintaining the 
state of pluripotency, and support the idea that Nanog is the ‘guardian’ of 
pluripotency. 
1.2.1.4 Transcription Factor Network 
Targets of Oct4, Sox2 and Nanog were investigated by chromatin 
immunoprecipitation (ChIP) analysis.  A large number of targets were identified 
and many of these were found to interact with all three transcription factors, 
indicating cooperative regulation (Boyer et al., 2005; Loh et al., 2006).  Genes 
known to be active in ES cells are regulated by these transcription factors, as 
are genes known to be inactive (Boyer et al., 2005).  This suggests Oct4, Sox2 
and Nanog are positive and negative regulators of gene expression.  They were 
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also shown to promote their own expression and the expression of the other two 
transcription factors.  Together these data imply these three transcription factors 
constitute a self-regulating network that establishes and maintains the 
pluripotent state. 
1.2.2 Signals Regulating ES cell Self-Renewal 
ES cells were originally derived on a fibroblast feeder layer in the presence of 
serum (Evans and Kaufman, 1981; Martin, 1981).  It was observed that media 
conditioned by Buffalo rat liver (BRL) cells supported ES cell self-renewal (Smith 
and Hooper, 1987) and subsequent fractionation of this media revealed 
leukaemia inhibitory factor (LIF) as the component inhibiting differentiation 
(Smith et al., 1988; Williams et al., 1988).  
1.2.2.1 LIF/STAT3 
LIF is a protein belonging to the inter-leukin 6 (IL-6) family of cytokines.  It was 
first described in a study demonstrating its pro-differentiative effect on M1 
leukaemia cells (Tomida et al., 1994; Gearing et al., 1994).  LIF binds to the LIF 
receptor (LIFR) and dimerises with the GP130 receptor, which increases binding 
affinity (Zhang et al., 1997). 
Deletion of LIF, LIFR or GP130 does not affect normal embryonic development 
(Yoshida et al., 1996 Stewart et al., 1992; Ware et al., 1995) but GP130 is 
required for blastocyst development during diapause (Nichols et al., 1996).  
Downstream of the LIFR-GP130 heterodimer, Janus kinases (JAK) 
phosphorylate cytoplasmic domains of GP130 upon LIF induction.  These 
phosphotyrosine residues prompt binding of SH2 domain proteins which are 
also phosphorylated by JAK. 
The two major pathways associated with the activation of the LIFR-GP130 
cascade are signal transducers and activators of transcription (STATs) (Stahl et 
al., 1995; Luttickan et al., 1994) and the mitogen-activated protein kinase 
pathway (MAPK-discussed later) (Boulton et al., 1994; Yin and Yang, 1994). 
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Phosphorylation of STAT3 by JAKs induces dimerisation and translocation to 
the nucleus where it functions as a transcription factor (Ihle et al., 1996).  
Activation of STAT3 signalling has been shown to activate Krüppel-like factor 4 
(Klf4), which in turn promotes Sox2 (Niwa et al., 2009).  Another downstream 
target of STATs is suppressor of cytokine signalling 3 (SOCS3). Induction of 
SOCS3 by STATs initiates a negative feedback loop wherein SOCS3 represses 
STAT activity (Auernhammer et al., 1998).  
STAT3 is required for efficient self-renewal of ES cells (Niwa et al., 1998) and 
active STAT3 enables LIF-independent self-renewal in serum-based ES cell 
cultures (Matsuda et al., 1999). 
In the absence of serum, LIF induces neural differentiation (Ying et al., 2003), 
indicating LIF-mediated self-renewal is serum-dependent.  This implies one or 
more components of serum are also required for ES cell self-renewal.  Ying et 
al. (2003) revealed this factor to be bone morphogenetic protein 4 (BMP4). 
1.2.2.2 BMP4 
BMP4 is a member of the transforming growth factor-! (TGF!) superfamily (Shi 
and Massague, 2003), originally isolated from bone protein extracts and named 
after its ability to direct bone and cartilage formation.  BMP4 signals through 
type I and II receptors, resulting in Smad phosphorylation.  Smads are 
transcription factors that mediate signalling by members of the TGF! 
superfamily from the extracellular environment to the nucleus. 
BMP4 activates Smads1, 5 and 8, resulting in transcription of the Id genes.  This 
may inhibit neural differentiation of ES cells through repression of mammalian 
achate schute homolog 1 (Mash1) (Ying et al., 2003). Overexpression of Id 
genes 1, 2 or 3 replaces the requirement for BMP4 in ES cell culture, suggesting 
these genes play a role in BMP4-mediated self-renewal. 
BMP4 has been shown to play a role in both the maintenance of ES cell self-
renewal and induction of differentiation.  In serum-free culture, BMP4 is 
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sufficient to replace serum in supporting self-renewal (Ying et al., 2003).  
However, BMP4 induces non-neural differentiation in the absence of LIF.  The 
identity of the large, flat, non-neural cells produced upon exposure to the BMP4 
signal is currently unclear, although Harvey et al. (2010) recently reported the 
expression of early epidermal precursor markers by these cells.  Interestingly, 
the ability of BMP4 to induce a non-neural fate is dependent on functional FGF 
signalling (Kunath et al., 2007), supporting previous studies in chick and 
Xenopus models (Stern, 2005).   
1.2.2.3 PI3K/AKT  
Insulin and insulin-like growth factors (IGFs) are present in serum (Breitman et 
al., 1980) and at high concentration in defined media such as N2B27-based 
media (Cold Spring Harbor Protocols, 2006).  The phosphoinositol-3-kinase 
(PI3K) pathway is a key downstream effector of these signals and is reported to 
play a role in both ES proliferation and self-renewal. 
PI3Ks are a family of lipid kinases known to phosphorylate position 3 hydroxyl 
group of the inositol ring of phosphatidylinositol (PtdIns), located at the cellular 
membrane.  
PI3K generates phosphotidylinositol-3-phosphate (PIP3) through the 
phosphorylation of phosphotidylinositol-2-phosphate (PIP2) (fig1.2).  PIP3 is a 
secondary messenger that binds to proteins bearing a pleckstrin homology (PH) 
domain, acting as a signal for PH domain proteins to translocate to the 
membrane.  Two of the best-studied PH domain-containing proteins are kinases 




Fig1.2:  Direct activation of PI3 kinase.   A) Ligand is presented to receptor, B) Upon binding of the ligand, 
the receptor’s intracellular domain autophosphorylates, presenting a phosphotyrosine residue.  The 
regulatory subunit (here p85) of PI3K binds to the receptor as it contains SH2 domains specific to this 
residue (Kazlauskas, 1994; Pawson, 1995). C) The catalytic subunit (e.g. p110) is recruited to the 
membrane by the regulatory subunit. D) The catalytic subunit is now in close proximity to its substrate, 
PIP2, which is phosphorylated to form PIP3 (Reif et al., 1996). 
 
PI3K activity enables translocation of AKT and PDK1 to the membrane where 
PDK1 phosphorylates and activates AKT (Alessi et al., 1997).  Once activated, 
AKT is known to regulate multiple downstream effectors including glycogen 
synthase kinase ! (GSK3!) (Cross et al., 1995), BAD (del Peso et al., 1997) and 
forkhead transcription factors (Brunet et al., 1999). 
There are three forms of AKT; AKT1, AKT2 and AKT3.  AKT1 knockout mice 
suffer compromised growth and a reduced lifespan without any effect on 
metabolism (Chen et al., 2001) whereas AKT2 knockout mice exhibit insulin 
insensitivity developing into a diabetic state (Cho et al., 2001).  A human family 
presenting a similar pattern of insulin resistance and diabetes have also been 
diagnosed with genetically harbouring a faulty AKT2 gene (George et al., 2004).  
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AKT1 and 2 are expressed in many tissues though overexpression of one 
cannot compensate for the loss of another (Bae et al., 2003). AKT3 is 
predominantly expressed in nervous tissue and testes and is essential to the 
development of the brain rather than metabolism (Tschopp et al., 2005). 
Inhibition of PI3K signalling occurs through dephosphorylation of PtdIns3,4,5 by 
phosphatase/tensin homologue (PTEN) (Maehama and Dixon, 1998) and SH2-
containing inositol 5’-phosphatase-2 (SHIP2) (Backers et al., 2003).  
PI3K plays an integral role in ES cell growth and differentiation.  Inhibition of 
PI3K via expression of a dominant negative form of regulatory subunit p85a and 
also small molecule inhibitor LY294002 results in ES cell differentiation (Paling 
et al., 2004).  This could be mediated by enhanced ERK phosphorylation in 
response to LIF or downregulation of Nanog (Storm et al., 2007), although 
MAPK activation has previously been linked to Nanog repression (Hamazaki et 
al., 2006).  Watanabe et al., (2006) demonstrated a expression of a 
myristoylated form of AKT conferred constitutive activation of this pathway and 
enabled factor-independent ES cell self renewal. 
Two signals may contribute to the constitutive activation of PI3K signalling in ES 
cells, T cell lymphoma protein 1 (Tcl1) and Eras.  Tcl1 was discovered through 
global expression profiling combined with ChIP analysis of Oct4 targets (Matoba 
et al., 2006).  Oct4 directly targets the Tcl1 promoter region and enhances its 
transcription.  Overexpression of Tcl1 increases ES cell proliferation whilst 
suppression causes reduced proliferation.  Suppression of Tcl1 is accompanied 
by reduced phosphorylation of AKT1 and it is suggested that this is how Tcl1 
contributes to ES cell growth. 
PI3K activity is also constitutively activated by the expression of an ES cell-
specific homolog of Ras, Eras, which binds directly to and activates the catalytic 
subunit of PI3K (Takahashi et al., 2003).  ERas exists in a constitutively active 
state as it is not affected by GTP-GDP exchange factors or GTPase-activating 
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proteins (Takahashi et al., 2005).  It was suggested that a motif of three amino 
acids that is common to oncogenic forms of Ras and Eras is responsible for this 
lack of downregulation.  These data lead to the suggestion that PI3K activity is 
largely regulated cell-autonomously rather than via extracellular signals. 
 
1.2.3 Signals Regulating Differentiation 
 
1.2.3.1 FGF4 
Fibroblast growth factor 4 (FGF4) mediates its response through binding and 
activation of one of the four isoforms of the FGF receptor in conjunction with 
heparin or heparan sulphate proteoglycans (HSPG) (Rapraeger et al., 1991; 
Yayon et al., 1991; Ornitz et al., 1992).  FGFs and HSPG enable dimerisation of 
the receptor tyrosine kinase FGFR, which autophosphorylates and recruits 
scaffold protein FRS (FGF receptor substrate).  The active FRS presents 
multiple phosphotyrosine residues enabling signal amplification and activation of 
many downstream pathways including MAPK and PI3K (Böttcher and Niehrs, 
2005) 
FGF4 is critical for early development.  Expression can be detected as early as 
the 4-cell-stage embryo (Rappolee et al., 1994) and FGF4 null embryos die 
shortly after implantation (Feldman et al., 1995).  ES cells secrete FGF4 into the 
culture media and promote differentiation.  FGF4 null ES cells have an 
attenuated differentiation capacity under defined conditions (Kunath et al., 2007) 
and this can be rescued by supplementing FGF4 to the culture media.   
1.2.3.2 MAPK 
Small molecule inhibition of the FGF-receptor (FGFR) by PD173074 reduces 
neural differentiation in mouse ES cells (Stavridis et al., 2007).  The mitogen-
activated protein kinase (MAPK) pathway was identified as the downstream 
effector of the FGF signal as inhibition of MAPK components has a similar effect 
on ES cells as FGFR inhibition.  Inhibition of MAP/ERK Kinase (MEK) using 
PD184352 and overexpression of MAPK phosphatase 3 (MKP3), a negative 
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regulator of extracellular-related kinase (ERK) activity, results in a reduction in 
differentiation.  Interestingly, these findings were transferrable to early neural 
specification in the chick (Stavridis et al., 2007). 
The MAPK pathway is activated by receptor tyrosine kinases (RTKs) including 
FGF, LIF and Insulin/IGFs.  Phosphotyrosine residues presented by activated 
RTKs can initiate binding of growth receptor-bound protein 2 (GRB2) (Fig1.3) 
and binding partner son of sevenless (SOS), a guanine exchange factor (GEF). 
GRB2 brings SOS into close proximity with Ras GTPase at the membrane.  Ras 
undergoes exchange of GDP for GTP, which facilitates binding and activation of 
the serine/threonine kinase Raf1.  This initiates a cascade of kinase activation: 
activated Raf1 phosphorylates MEK, which in turn phosphorylates ERK.  
Activated ERK dimerises and translocates to the nucleus to phosphorylate 
transcription factors such as Elk-1, STAT3 and myc, activating gene expression. 
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Fig1.3:  The MAP-kinase pathway. Receptor tyrosine kinases or scaffold proteins present phosphotyrosine 
residues upon activation (Cobb et al., 1989).  The SH2 domain of adaptor protein GRB2 enables binding to 
the P-tyr (Kessels et al., 2002).  GRB2 also binds to son of sevenless through a SH3 domain (Simon and 
Schreiber, 1995).  As the GRB2/SOS complex is brought to the membrane P-tyr interaction, SOS is 
activated and can carry out its function as a guanine exchange factor of Ras, a small GTP binding protein 
(Egan et al., 1993).  SOS exchanges GDP for GTP and Ras is able to activate Raf, a kinase of MEK 
(MAPK/ERK kinase), which in turn is a kinase of ERK (extracellular signal-regulated kinase).  Once 
activated, an ERK dimer regulates cytosolic targets, cytoskeletal proteins and can also enter the nucleus to 





Furthermore, while plating ES cells under MEK inhibition prevented 
differentiation, addition of PD184352 17-24 hours post plating failed to do so, 
indicating a temporal role for ERK signalling in differentiation.  Stavridis et al. 
(2007) also revealed that induction of ERK activity for just one hour was 
sufficient to permit neural differentiation.     
ERK isoforms 1 and 2 play a parallel role in FGF signalling but ERK2 is 
expressed more highly in ES cells. Erk2-/- embryos develop normally until after 
implantation when defects in mesoderm (Yao et al., 2003) and trophoblast 
(Saba-el-Leil et al., 2003) generation become apparent.  Erk2-/- ES cells are 
viable, proliferate normally and express markers of pluripotency (Kunath et al., 
2007), although their morphology is larger and flatter than wild type.   
In serum-free conditions and in the absence of LIF, Erk2-/- ES cells express 
Oct4, Nanog and Rex1, indicating their resistance to differentiate.  Fgf5, a 
marker of early differentiation, is also expressed but this is reversed upon 
addition of LIF, suggesting Fgf5 expression does not signify commitment to 
differentiation in vitro. Erk2-/- ES cells form EBs poorly and fail to differentiate 
into mesoderm when prompted (Kunath et al., 2007).  
Together these findings reveal ERK signalling is required for commitment to 
differentiation.  ERK activation initiates a reversible state in which naïve ES cells 
become receptive to extracellular signals that promote differentiation (Fig 1.4).  
This naïve state has been proposed as the ‘Ground State’ model of ES cell 















Figure 1.4.  Model of ES cell commitment to differentiation.  ERK activation induces a reversible 
‘primed’ state in which ES cells are sensitive to differentiative signals (Kunath et al., 2007). 
 
Serum response factor (SRF) is a cytoplasmic target of ERK known to regulate 
somatic proliferation in response to serum.  SRF controls expression of growth 
promoting transcription factors such as c-fos and EGFR1.  SRF null ES cells 
proliferate normally despite impaired serum-dependent c-fos and EGFR1 
expression, indicating SRF is dispensable in ES cells (Weinhold et al., 2000).  
However, SRF null ES cells have a limited capacity to differentiate.  This 











1.3  ES cell growth 
 
1.3.1 Cell cycle regulation 
The cell cycle is a controlled sequence of events resulting in cellular division and 
replication.  The cell cycle is composed of four phases: G1, M, G2 an S phases 
(Fig 1.5a) (Reviewed in Sherr, 1993).  During G1 and G2 gap phases, cells 
increase in size.  The S phase denotes a period of synthesis in which cells 
replicate the genome.  In M (mitotic) phase, cells cease growing and undergo 








Figure 1.5 Cell cycle of a) the somatic cell and b) the ES cell.  Suppression of p53 activity and 
the constitutive expression of cyclinE contribute to the short G1 phase exhibited by ES cells, 
resulting in rapid progression through the cell cycle. 
 
The cell cycle is regulated by cyclins and cyclin-dependent kinases (CDKs) 
(Reviewed in Sherr, 1993 and 1994).  Cyclins are non-catalytic regulatory 
proteins and their expression oscillates throughout the cell cycle.  In contrast, 
CDKs are constitutively expressed binding partners of cyclins.  Upon formation 
of a cyclin-CDK heterodimer, CDKs become catalytically active. 
In the mammalian cell cycle, cyclinD binds to CDK4 and this heterodimer 
phosphorylates the retinoblastoma protein (Rb) (Connell-Crowley et al., 1997). 
Activation of Rb disrupts an inhibitory complex of the E2F genes, which results 
a) b) 
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in expression of cyclinE, cyclinA and genes required for DNA synthesis (Arroyo 
et al., 1992; Dowdy et al., 1993), cyclinE binds CDK2 and this complex initiates 
the transition from G1 to S phase (Duronio et al., 1996).  A similar sequence of 
events occurs near the end of G2 phase, where cyclinB forms a complex with 
CDK1 to initiate the G2/M transition (Reviewed in Nigg, 1995). 
During the somatic cell cycle, p21 induces the formation of the cyclinD-CDK4 
complex (Cheng et al., 1999).  At higher concentrations, p21 is released by the 
cyclinD/CDK4 complex and inhibits cyclinE/CDK2, preventing progression to S 
phase (Sherr & Roberts, 1999). 
ES cells exhibit an unusual cell cycle in comparison to somatic cells.  A rapid 
progression through the cell cycle is accompanied by constitutive expression of 
cyclin E, rather than the oscillating levels seen in somatic cells (Savatier et al., 
1996).  ES cells may lack a G1 checkpoint due to cytoplasmic sequestration of 
p53 (Aladjem et al., 1998), a checkpoint protein involved in Chk2 and p21 
induction.  Chk2 is a checkpoint kinase responsible for Cdc25 phosphorylation 
and consequent inhibition of cyclinE-CDK2 upon DNA damage while p21 is a 
potent cyclin-independent kinase inhibitor.  p21 is undetectable in ES cells 
(Stead et al., 2002).  Thus, ES cells have a short G1 phase (Fig1.5b) and 
express low levels of cyclinD, a regulator of the G1-S transition (Jirmanova et 
al., 2002). 
In ES cells, PI3K rather than MAPK signalling regulates the transcription of 
cyclin D1 in contrast to somatic cells (Jirmanova et al., 2002). This ERK 
independence supports a lack of Rb control of G1 phase (Savatier et al., 1994). 
Evidence supporting the role of PI3K in ES cell cycle regulation includes the 
phenotype exhibited by phosphatase and tensin homolog (PTEN) null lines.  
PTEN is a negative regulator of PI3K signalling and ablation of the Pten results 
in a 5-10% faster progression through the cell cycle (Sun et al., 1999).  Also, 
deletion of Eras decreases proliferation and is restored upon expression of 
 23 
constitutively active PI3K catalytic subunit p110a (Takahashi et al., 2003).  
Furthermore, inhibition of PI3K activity through the addition of small molecule 
inhibitor LY294002 reduces proliferation with an accumulation of cells in G1 
(Sun et al., 1999).  Downstream of PI3K, genetic ablation or rapamycin-
mediated inhibition of mammalian target of rapamycin (mTOR) or results in 
reduced proliferation (Murakami et al., 2004; Takahashi et al., 2005).  
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1.4 ES Cell Differentiation 
ES cells differentiate to produce cells belonging to the three germ layers known 
as endoderm, mesoderm and ectoderm.  They can also form extraembryonic 
cell types although differentiation into the trophoblast lineage is rare (Dyce et al., 
1987; Fleming et al., 1987). 
When cultured in suspension, ES cells form aggregates termed embryoid 
bodies.  A variety of tissues can be generated using this method.  However, ES 
cells can differentiate in a monolayer culture.  This method is thought to confer a 
more homogeneous environment as cells are equally exposed to extracellular 
signals.  This tighter control over the signals received by the cells from the 
culture media can augment a more uniform differentiation of cells into specified 
lineages. 
1.4.1 Endoderm 
There are two major categories of endoderm; primitive and definitive endoderm.  
As early as stage E3.5, the ICM consists of two cell populations, identified by 
mutually exclusive expression of Nanog or Gata6 (Chazaud et al., 2006).  
Nanog expressing cells are fated to become the epiblast that forms foetal 
tissues whereas GATA6 positive cells go on to form primitive endoderm; a 
precursor of the extraembryonic endodermal lineage. Extraembryonic endoderm 
forms parietal endoderm (PE) and visceral endoderm (VE).  PE migrates to form 
a layer inside the trophectoderm-lined cavity of the embryo and secretes 
extracellular matrix components of Reichert’s membrane and also contributes to 
the parietal yolk sac.  VE covers the epiblast in an epithelial layer and 
contributes to the visceral yolk sac.  The extraembryonic lineages are vital to the 
survival of the developing embryo as a source of nutrition. 
Extraembryonic endoderm (XEN) cell lines derived from blastocyst stage 
embryos proliferate indefinitely and retain their function upon injection back into 
the developing embryo (Kunath et al., 2005).  ES cells have been induced to 
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form primitive endoderm-like cells upon withdrawal of LIF (Smith et al., 1988), 
overexpression of Oct4 (Niwa et al., 2000) and forced expression of Gata4 or 
Gata6 (Fujikura et al., 2002); indicating ES cells retain the ability to form 
extraembryonic tissue.   
The definitive endodermal lineage first arises from the mesendodermal cells of 
the anterior primitive streak in the developing embryo.  This tissue goes on to 
produce the gastrointestinal tract and accessory digestive and respiratory 
organs including lung, liver, pancreas, thyroid and thymus.   
Differentiation of ES cells into endodermal lineages has been developed using 
increasingly specific markers.  Previous methods of endoderm induction failed to 
consider that the position of endodermal cells in the developing embryo is a key 
factor in their specification.  Recent studies have refined ES cell differentiation 
protocols to recapitulate conditions similar to those experienced in vivo, utilising 
highly specific markers to verify efficient differentiation of biologically relevant 
tissues (Morrison et al., 2008). 
The anterior definitive endoderm (ADE) forms the ventral foregut and multipotent 
pancreatic and hepatic precursors.  In this regard, understanding the 
mechanisms regulating efficient differentiation of ES cells into this lineage has 
implications for the generation of these tissues for clinical applications.  ADE 
was formed upon exposure of an ES cell monolayer to Activin A and BMP4 for 
two days followed by Activin A, EGF and FGF4 for 7 days in defined media.  
After this time, 90% of cells were positive for Hex and Crxr4 markers, showing 
the majority of cells had adopted an ADE fate.  
Activin A and BMP4 increased survival and proliferation of the ADE population.  
Inclusion of FGF4 or FGF2 increased the number of ADE cells present at day 7.  
It remains unclear whether FGF signalling promotes induction, survival or 
proliferation of ADE cells, but FGFR1 null embryos fail to produce endoderm 
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(Deng et al., 1994; Yamaguchi et al., 1994) therefore, this signal is critical to the 
endodermal specification.  
1.4.2 Mesoderm 
A variety of mesodermal cell types can be derived upon plating ES cells on type 
IV collagen in the presence of serum (Nishikawa et al., 1998).  In order to 
increase the specificity of mesendodermal differentiation, Bakre et al. (2007) 
derived mesendoderm progenitor cells (MPCs).  Using sustained Wnt3a or 
GSK3! inhibition, ES cells differentiated into a mesendodermal lineage 
precursor cell line which can be maintained with a stable phenotype for over one 
year.  MPC aggregation and suspension culture results in beating 
cardiomyocytes in up to 70% of the aggregates, while ES cell aggregates 
produced beating cells in 15% of embryoid bodies (EBs).  Osteogenic 
differentiation was also possible after 3 weeks culture in high glucose media 
supplemented with serum, steroid dexamethasone, vitamin C derivatives and a 
phosphatase inhibitor.  ES cells did not survive in this media, inferring all viable 
cells cultured in this medium must undergo differentiation.  This study suggests 
derivation of precursor cell lines from ES cells may increase the uniformity of 
directed differentiation by ‘capturing’ cells that are undergoing differentiation at a 
precursor stage. 
1.4.3 Ectoderm 
Neural differentiation is the best-characterised form of ectodermal specification.  
Two models of vertebrate neuroectodermal differentiation have been put 
forward.  One states differentiation into the neural lineage is an instructive 
process, wherein Wnt and FGF are involved in the specification of the neural 
fate.  Another model suggests neural differentiation is a default process. 
Induction of neural differentiation of ES cells was originally achieved through the 
exposure of embryoid bodies (EBs) to serum and retinoic acid (RA) (Bain et al., 
1995).  Recently, RA was shown to drive ES cell differentiation through the initial 
promotion of FGF signalling followed by FGF repression (Stavridis et al., 2010).  
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Enhanced FGF signalling increases the propensity of ES cells to leave the 
naïve, undifferentiated state.  However, upon initiation of the differentiation 
process, FGF signalling is prohibitive to its progression.  This is demonstrated 
by the culture conditions defined for EpiSCs.  These cells are isolated later in 
development compared to ES cells and require FGF signalling to promote self-
renewal (Brons et al., 2007).  RA was demonstrated to play an analogous role in 
chick development, suggesting this mechanism of differentiation is conserved 
across species. 
Co-culture of ES cells with PA6 stromal cells also has neural-inducing effects 
(Kawasaki et al., 2000).  It was shown that BMP antagonists cannot substitute 
for these feeder cells but the factor or factors contributing to differentiation 
remain undefined. 
Ying et al., (2003) have established a defined, monolayer system for efficient 
neural differentiation.  In serum-free media containing N2 and B27 supplements, 
ES cells undergo differentiation.  After four days 60% of cells express Sex 
determining region Y-box 1 (Sox1), the earliest known neuroectodermal marker 
(Wood and Episkopou, 1999). After 6-8 days culture, transferring cells to 
fibronectin-coated plates results in GABAergic neurons.  Alternatively, addition 
of FGF8 and Sonic Hedgehog (SHH) yields dopaminergic neurons, 
demonstrating the potential for the directed differentiation of neuronal subtypes.  
As the number of Oct4 positive cells decreases, the number of Sox1 expressing 
cells increases, but the process remains asynchronous across the ES cell 
population.  Up to 15% of the population retains Oct4 expression despite 
demonstrating full differentiation capacity upon extraction from the culture 
environment.  Thus, the protocol does not yield a pure population of 
differentiated cells without sorting by FACS or drug selection.   
However, the defined system described by Ying et al. (2003) facilitates 
investigation into the effect of distinct signals on neural differentiation.  BMP4 
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inhibits neural induction in favour of undefined non-neural flat cells (Ying and 
Smith, 2003).  However, addition of BMP antagonist Noggin does not disrupt 
neural differentiation in this system, despite promoting neural development in 
Xenopus laevis (Munoz-Sanjuan and Brivanlou, 2002).  One explanation for this 
was the expression of noggin and follistatin by the cell population, which may act 
as autocrine inhibitors of BMP signalling.  
To investigate the role of FGF signalling in neural differentiation, cells were 
plated at low density to reduce autocrine signalling.  Addition of FGF4, but not 
FGF2, increased the number of Sox1 positive, neural precursor cells by day 4 
and inhibition of FGFR signalling using small molecule inhibitor SU5402 
decreased this population.  Also, expression of a dominant-negative FGFR 
reduced neural differentiation without affecting proliferation or viability, indicating 
a role for FGF signalling in neural differentiation. 
Generation of robust and defined methods of differentiation is essential to the 
future of ES cells as a reliable source of tissue for clinical applications and aids 
the elucidation of early developmental processes.  Removing the requirement 
for co-culture, conditioned media and cell aggregation is enabling clearer 
deduction of the factors required for synchronous, directed differentiation.    
Understanding the complex effects of autocrine signalling and direct cell-cell 
interactions within the cell population is one of the greatest challenges of 
controlled differentiation.  Measures can be taken to reduce the influence of 
these factors, such as starting with a pure population of ground state ES cells or 
homogeneous precursors that are plated at low density, but it is unlikely that it 




1.5.1 Structure and function 
GRB2 is a small protein consisting of 217 amino acids resulting in a protein of 
25kDa molecular weight.  GRB2 is a ubiquitously expressed adapter protein 
containing two SH3 (src homology 3) domains flanking a SH2 (src homology 2) 
domain (Lowenstein et al., 1992).  The SH3 domains bind poly-proline type II 
helices while the SH2 domain binds to phosphotyrosine motifs.  This structure 
reflects the function of GRB2 as a non-enzymatic protein that brings together 
molecules bearing phosphotyrosine residues with molecules containing proline-
rich motifs.  
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1.5.2 Upstream signals 
The GRB2 SH2 domain is known to link GRB2 with many receptor tyrosine 
kinases, docking proteins and phosphotyrosine phosphatases bearing a pYXNX 












Figure 1.6 Signals upstream of GRB2. 
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GRB2 binds directly to phosphotyrosine residues presented by activated 
receptor tyrosine kinases (RTKs).  Consequently, GRB2 mediates a vast 
number of signalling responses.  GRB2 also facilitates signalling via non-
receptor tyrosine kinases such as the scaffold proteins insulin receptor substrate 
(IRS) (Tobe et al., 1993) and FGF receptor substrate (FRS) (Kanai et al., 1997).  
These signalling components amplify upstream signals through the presentation 
of multiple phosphotyrosine residues upon recruitment to a corresponding 
receptor. 
Phosphotyrosine phosphatase SHP2 binds directly to GRB2 via tyrosine residue 
584 (Vogel and Ullrich, 1996).  Shp2-mutant ES cells retain some capacity to 
differentiate but also maintain self-renewal upon a 4-fold reduction of LIF levels, 
suggesting they have increased sensitivity to the LIF signal (Qu and Feng, 
1998). This is explained by the observation that Shp2-mutant ES cells exhibit 
increased levels of STAT3 activity in response to LIF and decreased ERK 
signalling (Chan et al., 2003), indicating SHP2 regulates both ERK and STAT3 
signalling in a positive and negative fashion, respectively. 
1.5.3 Downstream targets 
The N-terminal SH3 domain of GRB2 binds SOS, Cbl, sprouty and dynamin via 
a P-x-x-P-x-R motif (Reviewed in Sparks et al., 1996).  The C-terminal SH3 
domain of Grb2 binds to several signalling proteins containing the motif P-x-x-x-
R-x-x-K-P (Lewitzky et al., 2001).  These include GAB1 (Lock et al., 2000), N-
WASP (Carlier et al., 2000), CD28 (Kim et al., 1998; Okkenhaug and Rottapel, 







Figure 1.7 Downstream targets of GRB2 
Once activated, GAB1 is phosphorylated at specific tyrosine residues and 
downstream effector proteins are associated via SH2 domains.  Two key 
effectors of GAB are SHP2 and PI3K regulatory subunit p85, (discussed later). 
Another downstream effector of Grb2 is SH2–containing inositol-5-phosphatase 
(SHIP).  SHIP is a member of the inositol polyphosphate-5-phosphatase 
(INPP5) family and contains an N-terminal SH2 domain, an inositol phosphatase 
domain, and two C-terminal protein interaction domains.  SHIP removes 
phosphorylation from PIP3 and acts as a negative feedback mechanism for 
PI3K signalling.  
ES cells and haematopoietic stem cells express an isoform of SHIP (s-SHIP) 
lacking the SH2 domain, which is found constitutively at the membrane and 
interacts directly with GRB2 via the SH3 domain (Tu et al., 2001).  s-SHIP 
retains phosphatase activity but responds to different signals mediated by 
GRB2.  For example, s-SHIP co-immunoprecipitates with the activated gp130 
receptor (Desponts et al., 2006), likely through its association with GRB2.  s-










1.5.4 Biological Relevance 
 
1.5.4.1 GRB2 in Cancer 
Misregulation of GRB2 has been reported in many human tumours.  For 
example, GRB2 directly interacts with Bcr-Abl, an oncogenic tyrosine kinase 
associated with leukemias such as chronic myeloid leukemia (Pendergast et al., 
1993).  GRB2 expression is also upregulated in breast (Verbeek et al., 1997), 
bladder (Watanabe et al., 2000) and prostate (Misra et al., 2004) cancer cell 
lines.   
Due to its role in mediating multiple oncogenic signalling pathways, GRB2 has 
been designated a valuable target for anti-cancer therapy (Dharmawardana et 
al., 2006).  Knockdown of GRB2 via RNA interference (Tari et al., 1999) or 
GRB2-SH2 domain-blocking peptides (Chen et al., 2010) have proved effective 
anti-cancer agents in vitro.  Both methods report decreased proliferation of 
breast cancer cell lines upon downregulation of GRB2 signalling.  
GRB2 has also been associated with metastasis; the process by which 
cancerous cells leave the primary tumour to enter the blood or lymph system 
and establish secondary tumours in other tissues (Steeg, 2006).  Metastasis is 
regarded as the primary cause of death for most cancer patients and GRB2 is 
considered of interest as a target for inhibiting this process.  Addition of GRB2 
inhibitor C90 blocked Grb2/c-Met and Grb2/FAK binding, resulting in disrupted 
focal adhesion formation and reduced N cadherin expression and subsequently 
reduced solid tumour metastasis in two in vivo models (Giubellino et al., 2007). 
1.5.4.2 GRB2 in Cardiac Hypertrophy 
Under cardiac stress, Grb2+/- mice fail to activate p38 MAP kinase and Jun N-
terminal kinase (JNK), resulting in inhibition of cardiac hypertrophy and fibrosis 
as observed in wild-type mice (Zhang et al., 2003).  Mice expressing a 
dominant-negative form of p38! and p38" developed cardiac hypertrophy 
without cardiac fibrosis upon exposure to cardiac stress. This suggests a role for 
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Grb2 activity in cardiac hypertrophy and fibrosis and that separate signalling 
pathways downstream of Grb2 regulate each of these processes. 
1.5.4.3 GRB2 in Development  
Grb2 is a key regulator of the MAPK pathway, which is involved in the very early 
stages of development.  The importance of MAPK signalling to development is 
demonstrated in the ground state hypothesis of ES cell biology.  The ground 
state is a hypothetical state in which an ES cell is unaffected by any process of 
differentiation.  It is believed that ground state ES cell cultures can be achieved 
under defined conditions with the addition of small molecule inhibitors of GSK3! 
and MEK (Ying et al., 2008). 
Many publications have indicated that activation of the MAPK pathway causes 
ES cells to leave the naïve ground state and become receptive to differentiation 
signals (Burdon et al., 1999; Kunath et al., 2007; Stavridis et al., 2007).  As Grb2 
is a key mediator of MAPK signalling, it is possible that in its absence, ES cells 
have a limited capacity for differentiation due to their resistance to leave the 
ground state.   
Deletion of Grb2 results in embryonic lethality at approximately E4.5 when the 
ICM begins differentiation into endoderm in wild type embryos (Cheng et al., 
1998). 
As the formation of the ICM is not affected in Grb2 deficient embryos, Grb2-/- ES 
cells can be derived.  Cheng et al. (1998) reported Grb2-/- ES cells grow at a 
comparable rate to wild-type, although they show a capacity for differentiation 
limited to trophoblast cells.  It was demonstrated that this restricted 
differentiation is caused by insufficient activation of SOS and therefore Ras in 
the MAPK pathway. 
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To investigate the role of Grb2 later in development, mice were generated with 
one null Grb2 allele and a hypomorphic Grb2 allele containing a E89K 
substitution resulting in weakened SH2 binding (Saxton et al., 2001).  These 
mice did not expire at stage E4.5 but developed abnormally with defects in many 
tissues including impaired survival of some branchial arch-forming neural crest 
cells and defective heart development.  The heterozygous embryos were non-
viable by E11.5 due to irregular placental tissue.  Homozygous E89K Grb2 
embryos survived albeit at a reduced birth weight attributed to poor placental 




1.6 Project Aims 
Embryonic stem cells represent a transient population of pluripotent cells in the 
epiblast.  They offer access to some of the earliest molecular events of 
development.  Since the derivation of ES cells, great progress has been made in 
delineating the mechanisms of self-renewal and differentiation.  However, the 
molecular basis of these processes is not fully understood. 
Grb2 is involved in many of the key signals associated with growth and 
differentiation.  This study aims to expand on the findings presented by Cheng et 
al. (1998) and Saxton et al. (2001).  Both of these studies utilise serum-based 
media, which may mask subtle phenotypic effects of the Grb2 deletion in ES 
cells.  An examination of the role of Grb2 in ES cell growth under defined 
conditions has not yet been described in the literature and it is important to bring 
previous research up to date with a more recent culture system. 
The role of Grb2 in ES cell differentiation has been described in a number of 
publications, but with a focus on its essential role in endodermal differentiation 
(Cheng et al. 1998; Saxton et al. 2001).  This study aims to test the 
differentiation capacity of ES cells in the absence of Grb2, examining a wider 
range of lineages and differentiation markers than has previously been 
described. 
In summary, the aims for this thesis are as follows: 
• Characterise growth of Grb2-/- ES cells under serum-free conditions. 
• Elucidate signals required for growth under serum-free conditions. 
• Investigate the differentiation capacity of Grb2-/- ES cells. 
 
The following hypotheses will be tested: 
• Grb2 signalling is required for ES cell growth under serum-free 
conditions. 
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• Grb2 is dispensable for differentiation into some lineages. 
Together, these experiments should expand on the current knowledge of signals 
that regulate ES cell biology. 
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CHAPTER 2 
Materials and Methods 
 
2.1 Cell Culture, Manipulation and Assays 
 
2.1.1 Media, Supplements and Reagents 
2.1.1.1 Media 
GMEM Complete ES Cell Media   
Glasgow Minimal Medium (GMEM) (Sigma, G5154) 
Foetal Calf Serum (10%) 
Non-essential amino acids (Gibco 11140-035) 
L-Glutamine, 2mM (Gibco, 25030-024) 
Sodium Pyruvate, 1mM (Gibco, 11360-039) 
2-Mercaptoethanol 
LIF-enriched supernatant equivalent to 100u/ml EScGro LIF (see below) 
 
GMEM LIF-Free Media  
As GMEM Complete ES Cell Media, omitting LIF. 
 
Starvation Media 
As GMEM Complete ES Cell Media, omitting LIF and serum. 
 
N2B27 Complete ES Cell Media 
1:1 DMEM:F12 (Gibco, 42430:21765) 
5ml “B27+N2” supplement  
6ml Non-essential amino acids (Gibco 11140-035) 
500µl 2-Mercaptoethanol 
LIF-enriched supernatant equivalent to 100u/ml EScGro LIF (see above) 
BMP4 10ng/ml (R&D Systems, 314-BP-010) 
 
(NB: N2 Supplement consists of: 50!g/ml BSA, 50!g/ml insulin, 6ng/ml 
progesterone, 16!g/ml putrescine, 30nM selenium, 100!g/ml transferrin. 
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“B27+N2” supplement combined these ingredients with Stem Cell Sciences 
B27 recipe, which is protected by CDA.) 
 
2.1.1.2 Cytokines and Growth Factors 
LIF-enriched Supernatant 
Cos7 cells were transfected with a mouse LIF-encoding plasmid and 
supernatant was collected after 4 days.  The LIF activity of the supernatant 
was determined by titration in comparison to EScGro (Millipore, ESG1106) 
recombinant LIF.  ES cells were cultured for 5 days in varying amounts of LIF 
supernatant. Relative level of self-renewal attained was determined by 
staining for alkaline phosphatase activity. Quantity of supernatant used was 
equivalent to 100u/ml EScGro LIF.  
 
Leukaemia Inhibitory Factor (LIF): (Millipore, ESG1107) 
Bone Morphogenetic Protein 4 (BMP4): (R&D Systems, 314-BP-010) 
Fibroblast Growth Factor 2 (FGF2): (Peprotech, 100-15) 
Insulin-like Growth Factor (IGF1): (BA Chem, H5555) 
 
2.1.1.3 Inhibitors and Small Molecules 
ROCK inhibitor Y-27632 (Sigma, Y0503) (Li et al., 2009) 
GSK3! inhibitor CHIR99021 (Signalling Technologies, University of Dundee) 
(Ying et al., 2008) 
MEK inhibitor PD0325901 (Signalling Technologies, University of Dundee) 
(Ying et al., 2008) 
PKC activator Phorbol 12-myristate 13-acetate (PMA): (Sigma, P8139) (Verin 
et al., 2000) 
 
2.1.1.4 Other Tissue Culture Reagents 
Phosphate Buffered Saline (PBS) (Oxoid, BR0014G)  





Puromycin (Sigma, P9620): 1.5µg/ml 




0.25% Trypsin (Gibco, 15090-046) 
1.3mM EDTA (Sigma, E5134) 
0.1% Chicken serum (Invitrogen, 16110-033) 
 
TryplE Express (Invitrogen, 12604) 
 
2X Freezing Mix  
Serum + 20% DMSO 
 
2.1.2 Cell lines 
Grb2-/- 
R1 ES cell line carrying targeted knockout of both Grb2 alleles (Created and 




Enhanced Cyan Fluorescent Protein (eCFP) expressing R1 cell line (Created 
and used by Hadjantonakis et al., 2002).  Developmental potential of the cells 
was verified through injection into tetraploid ICR blastocysts. Obtained from 
Dr. Andras Nagy’s lab (Toronto) (MMRRC: 011984-MU). 
 
Fgf4+/- 
R1 ES cell line carrying targeted knockout of one Fgf4 allele. Clone 342. 




2.1.3 Tissue Culture Common Practice 
All cell lines maintained in humidified incubators at 37oC, 5% CO2 
 
2.1.3.1 Murine Embryonic Stem Cell Culture 
mES cells were routinely maintained on gelatine-coated  tissue culture 
plastics in GMEM ES cell media.  Serum-free cultures were maintained on 
identical gelatin-coated tissue culture plastics in N2B27 complete ES cell 




Cells were washed once in PBS and incubated with TVP (serum cultures) or 
TryplE Express (serum-free cultures) for approximately 3 minutes at 37oC.  
Detached cells were quenched using 5ml of appropriate media, pelleted by 
centrifugation at 1000rpm for 3 minutes and plated at the required density. 
 
2.1.3.2 Cos7 Cell Culture 
Immortalised African green monkey kidney cell line.  These cells have been 
transformed by introduction of the SV40 genome resulting in the production 
of large T antigen.  Cos7 cells were cultured as ES cells omitting the LIF 




For routine ES cell maintenance, tissue culture plastics were coated with 




Laminin (Sigma, L2020) 
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Diluted to a final concentration of 1-2µg/cm2 in PBS.  Culture surface coated 
with a minimal volume and incubated at 37°C OVERNIGHT.  Prior to plating 
cells, surfaces were washed 3 times with PBS. 
 
Fibronectin (Calbiochem, 341668) 
Diluted to a final concentration of 5µg/cm2 in serum-free medium at 37oC. 
Culture surface coated with a minimal volume and incubated at 37°C 
OVERNIGHT.  Prior to plating cells, surfaces were thoroughly aspirated. 
 
Collagen I (Sigma, C3867) 
Diluted to a final concentration of 8µg/cm2 in H2O.  Culture surface coated 
with a minimal volume and incubated at 4oC OVERNIGHT.  Excess fluid was 
removed and surfaces dried overnight. Prior to plating cells, surfaces were 
washed 3 times with PBS. 
 
Foetal Calf Serum (FCS) (Biowhittaker, DE14-802F, lot 8SB013) 
Culture surface coated with a minimal volume of undiluted foetal calf serum 
and incubated at 37°C overnight.  Prior to plating cells, surfaces were 
washed 3 times with PBS. 
 
Gelatin 0.1% 
Diluted to a final concentration of 0.1% in H2O.  Culture surface coated with 
a minimal volume and incubated at 37°C overnight.  Prior to plating cells, 
surfaces were thoroughly aspirated. 
 
2.1.5 Freezing cells 
A confluent T75 flask of cells was trypsinised, pelleted and resuspended in 
2ml GMEM complete ES cell media.  2ml of chilled freezing mix was added 
and 1 ml of this mix was aliquotted into 4 cryovials.  Vials were immediately 




2.1.6 Thawing cells 
Cryovials were thawed at 37oC.  Under sterile conditions, cells were 
transferred to a sterile falcon with 5ml warm ES cell medium.  Cells were 
pelleted by centrifugation for 3 minutes at 1000rpm and the supernatant 
aspirated.  Cells were resuspended in fresh ES cell medium and transferred 
to a gelatinised T25 flask. 
 
2.1.7 Genetic Manipulation 
2.1.7.1 Transfection – Transient expression 
Transient expression of genes was achieved through lipofection.  5x105 ES 
cells (2.5x105 cos7 cells) were plated per well of a 6-well plate overnight.  
Transfection mixes were prepared with a 2:5 DNA:Lipofectamine ratio. 5µl 
Lipofectamine 2000 (Invitrogen, 11668-019) was mixed with 125µl Opti-mem 
(Invitrogen, 11058-021) and incubated at RT for 5 minutes.  2µg of plasmid 
DNA and 125µl Opti-mem was mixed with 125µl of the diluted lipofectamine 
and incubated for 30 minutes at RT.  After this time 250µl of the 
DNA/lipofectamine mix was added to the well of cells.  Cells were incubated 
at 37oC overnight (up to 16 hours) before the medium was changed. 
 
2.1.7.2 Transfection – Stable clones 
Stable integration of transgenes was achieved using the above lipofection 
protocol, albeit using linearised plasmid vectors.  After removal of 
lipofectamine-containing media, cells were cultured for another 2-3 hours in 
fresh media and then replated into two 10cm dishes, one containing a quarter 
of the cells and the other containing the remaining three quarters.  24 hours 
after this replating, fresh media was added containing the appropriate 
selective antibiotic, (Puromycin – 1.5µg/ml; Hygromycin B – 200µg/ml). 
 
Selective media was replaced every 2-3 days for up to 10 days.  Colonies 
were ‘picked’ when large enough using a pipette tip and disaggregated in 
TVP for 2 minutes.  The dissociated cells were replated in a well of a 24-well 
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plate and cultured until near confluency.  These wells were expanded into a 
6-well plate and frozen down upon expanding to fill the well. 
 
2.1.8 Differentiation Protocols 
2.1.8.1 Monolayer differentiation 
Cells were plated at low density (2.5x104 per well 6 well plate) in LIF-free 
media.  Cells were analysed after 5 days culture. 
 
2.1.8.2 Embryoid Bodies 
Formation of Embryoid Bodies 
2x106 ES cells were plated in 10cm bacteriological (low attachment) petri 
dishes in 10ml of LIF-free media.  Media was changed every 2-3 days.  
Embryoid bodies (EBs) were collected and left to settle in a 50ml falcon.  Old 
media was aspirated and EBs resuspended in 10ml fresh media and fresh 
petri dishes.  Care was taken not to break up or damage the EBs. 
 
Plating EBs 
After 4 or 7 days, 10-20 EBs were plated in gelatine-coated 6 well plates and 
media changed every 2-3 days.  
 
2.1.8.3 Neural differentiation 
Cells were cultured in N2B27 Complete ES Cell Media for one passage 
before being plated at low density (5x103 per well 4 well plate) in LIF and 
BMP4-free N2B27 media.  Media were changed every 2-3 days and cells 
were assayed at day 7. 
 
2.1.8.4 Laminin Differentiation 
Cells were cultured in the presence of PD0325901 (1!M) and Chiron (3!M) 
for two passages before being plated at low density (5x103 per well 4 well 
plate) on laminin-coated plastics.  Media were changed every 2-3 days.  At 
day 7, cells were harvested using TryplE Express and replated at 1x104 cells 
per well of laminin-coated 4 well plates.  Cells were assayed at day 14. 
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2.1.9 Proliferation assays 
2.1.9.1 Cell counting 
Cells were plated at 8x105 per well of a 6 well plate and passaged every two 
days.  The total number of cells harvested was recorded and 8x105 cells 
replated.  This process was repeated up to 7 passages.  Cumulative 
population doublings were calculated using the following formula: PDL = 
3.32(log (total cells at harvest/total cells at seed)). 
 
2.1.9.2 MTT assay 
Kit: Vybrant® MTT Cell Proliferation Assay Kit (Invitrogen, V13154) 
The MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) 
assay utilises the reduction of yellow tetrazolium MTT into a purple formazan 
to estimate cell numbers.   
 
8x102 cells were plated per well 96 well plate including blank wells for 
background subtraction.  Plates were replicated for each time point to be 
assayed.  To assay, 1ml of MTT at 12mM in PBS was added to 10ml phenol 
red-free GMEM LIF-Free Media.  Media was aspirated from cells to be 
assayed and 100!l of diluted MTT added to each well.  After 1hr incubation 
at 37oC the wells were lysed and solublised through the addition of 100!l 
10% SDS in 0.01M HCl and incubation at 37oC overnight.  The optical 
densities of samples were measured at 570nm by a Multiskan Ascent plate 
reader (Thermo Electron Corporation). 
 
2.1.9.3 CyQuant Direct Assay (Invitrogen, C35011) 
The CyQuant Direct assay utilises a fluorescent, live cell-permeable nucleic 
acid dye and a suppression dye, which is impermeable to live cells.  The 
latter dye suppresses fluorescence in all but live, intact cells.  Together, 
these dyes label the nuclei of live cells. 
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4x102 cells were plated in 100!l of appropriate media per well 96 well plate 
including blank wells for background subtraction.  Plates were replicated for 
each time point to be assayed.  To assay the DNA content of cultures, 48!l 
CyQuant® Direct nucleic acid stain and 240!l CyQuant® Direct background 
suppressor I were mixed in 11.7ml PBS.  100µl of this combined stain was 
added on top of cells in culture and incubated at 37oC for 1hr.  Fluorescence 
intensity was measured using a 488/520nm filter on a Victor2 1420 Multilabel 
Counter (Wallac). 
 
2.1.10 Adhesion assay 
0.8x106 cells were plated per well of a gelatine-coated 6 well plate.  At set 
time points media was removed, cells carefully washed once with PBS and 
the remaining, adherent cells were harvested and counted. 
 
2.1.11 Annexin V: FITC Apoptosis Detection Kit II (BD Biosciences, 
556570) 
At the onset of apoptosis, phosphatidyl serine residues are exposed on the 
outer leaflet of the cell.  This change can be detected using Annexin V 
(Vermes et al., 1995).  Annexin V is a calcium-dependent phospholipid-
binding protein with a high affinity for phosphatidyl serines.   Conjugated with 
a fluorochrome such as FITC, it can be used to label cells with exposed 
phosphatidyl serines.  Loss of membrane integrity is a later event in 
apoptosis and necrosis (Kerr et al., 1972) and can be measured using a live 
cell-impermeable nucleic acid stain such as propidium iodide stain. 
 
Reagents 
10X binding buffer (0.1M Hepes/NaOH (pH 7.4), 1.4M NaCl, 25mM CaCl2) 
diluted 1:10 with dH2O 




Triplicate wells were passaged three times in N2B27 Complete ES Cell 
Media with parallel GMEM Complete ES Cell Media cultures.  Cells were 
carefully harvested and 4x106 cells resuspended in 1ml X1 Binding Buffer. 
100!l samples were taken and cells were incubated with/without 10!l FITC-
conjugated annexin V solution at RT for 15 minutes in the dark.  After this 
incubation, 300!l 1X Binding Buffer was added to each sample.  5!l 
propidium iodide solution was added immediately before analysis by flow 
cytometry. 
 
2.1.12 PI cell cycle analysis 
Fixation 
Cells were harvested to a single cell suspension.  1x106 cells were 
resuspended in 50!l PBS and fixed in 1ml ice cold 80% ethanol.  Samples 
were stored at 4°C for at least 24 hours prior to staining 
 
Staining  
Samples were pelleted, ethanol aspirated and washed in 1ml PBS. 
 
Staining solution 
 69µM propidium iodide 
 500!g/ml RNase A 
 38µM trisodium citrate solution 
 0.5% NP-40 
 
Washed cells pelleted again and resuspended in 500!l staining solution. 
Samples incubate at RT in dark for 15 minutes.  Samples vortexed 
immediately prior to flow cytometry analysis. 
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2.1.13 Staining protocols 
2.1.13.1 Leukocyte Alkaline Phosphatase Kit (Sigma, 86R) 
Alkaline phosphatase is a hydrolytic enzyme and a marker of pluripotent ES 
cells.  Although other somatic cell types also express alkaline phopshatase, 
loss of alkaline phosphatase activity is associated with loss of pluripotency 
during early differentiation.  The kit identifies cells exhibiting alkaline 
phosphatase activity through incubation in a mixture of naphthol AS-BI 
alkaline solution with fast red violet LB. The resulting insoluble diffuse, red 
dye deposit indicates sites of alkaline phosphatase activity. 
 
Fixation 




Media was removed from cells in culture.  Cells were washed once with PBS 
and fixed for 45 seconds.  Fixed cells were washed with ddH2O. 
 
Staining 
0.2ml FRV alkaline solution 
0.2ml Na Nitrite solution 
9ml ddH2O 
0.2ml Napthol solution 
  
FRV and Na Nitrite solutions were mixed and incubated at RT for 2 minutes.  
ddH2O was added and then Napthol solution.  Complete stain was kept in 
dark.  Fixed cells were aspirated and incubated with stain for 15 minutes at 
RT in the dark.  Stain was rinsed with two ddH2O washes and brightfield 








PBST: 1XPBS + 0.3% Triton X-100 
Blocking solution: 10% goat serum + 1% BSA in PBST 
 
Cells were washed once with PBS and fixed with 4% PFA for 10 minutes.  
Fixed cells were washed twice with PBS briefly and four times with PBST for 
5 minutes.  Cells were incubated for 2 hours in blocking solution and probed 
overnight at 4oC with primary antibodies diluted in fresh blocking solution.   
See table 2.1 for antibody dilutions. 
 
Cells were washed four times with PBST for at least 5 minutes and incubated 
for 2 hours at RT in the dark with appropriate secondary antibodies diluted 
1:1000 in fresh blocking solution.  Cells were washed four times with PBST 
for at least 5 minutes and stained with 1ng/ml DAPI (Invitrogen, D1306) in 
PBS for 10 minutes at RT in dark.  DAPI was rinsed with PBS and stained 
cells were stored in dark at 4oC before images were taken.  
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Table 2.1 Antibodies 
Antigen Source Class Company Cat No Dilution 
!actin Mouse IgG1 Santa Cruz sc-47778 1:2000 
pERK1/2 Rabbit IgG Cell Signaling 9101 1:1000 
ERK2 Mouse IgG BD Transduction 610104 1:2000 
pAKT Rabbit IgG R&D Systems AF887 1:1000 
AKT Rabbit IgG Cell Signaling 9272 1:1000 
GRB2 Rabbit IgG Santa Cruz sc-255 1:2000 
pGSK3! Rabbit IgG Cell Signaling 9336 1:1000 
GSK3! Rabbit IgG Cell Signaling 9315 1:1000 
pSTAT3 Rabbit IgG Cell Signaling 9131 1:1000 
STAT3 Rabbit IgG Santa Cruz sc-482 1:1000 
Oct4 Mouse IgG2b Santa Cruz sc-5279 1:200 
! Tubullin III Mouse IgG2a Covance MMS-435P 1:200 
Nestin Mouse IgG1 DSHB Rat401 1:20 
Nanog Rabbit IgG1 Abcam ab80892 1:200 
Anti Rabbit IgG HRP Goat IgG Cell Signaling 7074 1:5000 
Anti Mouse IgG HRP Goat IgG Cell Signaling 7076 1:5000 
AlexaFluor Secondary 
Antibodies Goat Various Invitrogen   1:1000 
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2.2 Molecular Biology 
2.2.1.1 Biochemical induction 
Cells were plated 1x106 per well of a 6 well plate and incubated overnight at 
37oC. Cells were washed once with PBS and incubated in 1ml starvation 
media for 3hrs.  If an inhibitor was used, cells were treated for one hour after 
starvation.  Cells were induced with chemical or cytokine and immediately 
harvested for protein. 
 




62.5mM Tris HCl pH6.8 
0.005% Bromophenol Blue 
3% 2-Mercaptoethanol  
 
Cells were washed once with PBS and immediately placed on ice.  100!l 1X 
SDS buffer was used to cover entire surface and lysates were scraped and 
transferred to 1.5ml eppendorf tube.  Samples were sonicated for 8 minutes 
in an XL2020 Ultra Sonic Processor (Misonix Inc) and stored at -20oC. 
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2.2.1.3 Western Blotting  
Table 2.2 Buffers and Reagents 
 
10% Resolving gel  10% Stacking gel 
6ml d H2O  3.3ml d H2O 
5ml 40% acrylamide - Fisher #BP14021  625µl 40% acrylamide 
3.2ml 2% Bis solution - BioRad #161-
0142  400µl 2% Bis solution 
5ml 1.5M tris pH 8.8   650µl 1M Tris pH 6.8 
200µl 10% SDS  50µl 10% SDS 
200µl 10% Ammonium persulphate  50µl 10% Ammonium persulphate 
12µl Temed - Sigma #T9281-50ml  5µl Temed 
   
5X Running buffer  1X Running buffer 
30g Tris  200ml 5X Running buffer 
188g glycine  upto 1L d H2O 
10g SDS   
upto 2L H2O   
   
10X Transfer buffer  1X Transfer buffer 
29.3g Glycine  100ml 10X Transfer buffer 
58g Tris  200ml ethanol 
18.8ml 20% SDS  upto 1L d H2O 
upto 1L H2O   
   
Block  Primary antibody dilutant 
5% Marvel milk in TBST  5% BSA (Sigma, A9647) in TBST 
   
25X TBS  1X TBST (Wash buffer) 
125g Tris  80ml TBS 
400g NaCl  2ml Tween 20 (Sigma, P7949) 
upto 2L H2O  upto 2L d H2O 
pH7.6   
   
Secondary antibody dilutant   
10% Blocking Solution in TBST   
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2.2.1.3.1 SDS PAGE Gel Preparation 
The resolving gel was mixed and poured immediately into cassette (Biorad, 
345-9903) and sealed with a layer of isopropanol.  Once set, the isopropanol 
was removed and stacking gel was mixed and poured on top.  A comb was 
inserted and the gel was left to set.  Wells were syringed prior to loading 
samples. 
 
2.2.1.3.2 Sample Preparation 
Prior to loading, samples were thawed at 37oC and boiled at 95oC for 5 
minutes.  
 
2.2.1.3.3 Loading/Running gel 
8!l of sample or molecular weight marker was loaded per well. Empty wells 
were filled with 1X SDS buffer.  Gels were ran at 50V until molecular weight 
markers began to resolve at which point the voltage was increased to 100V.   
The gel finished running when the bromophenol blue band ran off the bottom. 
 
2.2.1.3.4 Wet Transfer 
Membrane soaked in dH2O on rocker 10 minutes, then transferred to chilled 
1X transfer buffer for 10 minutes.  Gel and membrane were sandwiched in a 
transfer cassette between two fibre pads and two pieces of chromatography 
paper.  Once inserted into transfer tank in the correct orientation, the tank 
was filled with chilled 1X transfer buffer, placed in a bucket of ice and ran at a 
constant voltage of 95V for 75 minutes. 
 
2.2.1.3.5 Blocking 
The membrane was washed in PBS for 2 minutes and transferred to blocking 






2.2.1.3.6 Primary antibody  
The membrane was rinsed in TBST to removed excess block.  Primary 
antibody was diluted as described in table 2.1 and membrane probed for 1hr 
or overnight. 
 
2.2.1.3.7 Primary wash 




2.2.1.3.8 Secondary antibody  
Appropriate, HRP-conjugated secondary antibody diluted 1:5000 and 
membrane probed for 1hr 
 
2.2.1.3.9 Secondary Wash 




Membrane was treated with Amersham ECL Western Blotting 
Detection Reagents (GE Healthcare, RPN2109) for 1min and signal captured 
using Amersham Hyperfilm (GE Healthcare, 28-9068) using exposures 
ranging from 10 seconds to overnight. 
 
2.2.1.3.11 Stripping  
Membrane was rinsed in TBST for 5 minutes and stripped with Restore 
stripping buffer (Thermo Scientific, 21059) for 15 minutes at RT.  Membrane 






2.2.2 RNA Methods  
2.2.2.1 RNA Extraction 
RNA was extracted using Qiagen RNeasy Mini Kit (Qiagen, 74104) and 
QIAshredder Homogenization columns (Qiagen, 79654) following 
manufacturer’s instructions.  Samples were eluted in RNAse-free water. 
 
2.2.2.2 Quantification 
RNA was quantified using a Nanodrop 1000 and accompanying software 
(Thermo Scientific). 
 
2.2.2.3 cDNA synthesis from RNA 
cDNA was synthesised from RNA using Superscript First Strand Synthesis 
System (Invitrogen, 11904-018) using oligo-dT primers following 
manufacturer’s instructions. 
RNA      – 8µl (5ng-5µg) 
10mM dNTP mix    – 1µl 
0.5µg/µl Oligo(dT)12-18 primer  – 1µl 
 
The above mix was incubated at 65oC 5 minutes then on ice 1min. 
In a new tube (per reaction): 
(in order) 
10X RT buffer  – 2µl 
25mM MgCl2  – 4µl 
0.14M DTT   – 2µl 
RNaseOUT   – 1µl 
 
9µl of above reaction mix was added to the RNA:primer mix, mixed gently 
and incubated at 42oC 2 minutes.  1µl SS II RT (or 1µl DEPC-treated H2O for 
no RT control) was added to each tube and incubated at 42oC 50 minutes 
then the reaction was heat killed at 70oC 15 minutes.  Reactions were sat on 
ice, 1µl RNase H added and incubated at 37oC 20 minutes.  cDNA samples 
were stored at -20oC. 
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2.2.3 DNA methods 
2.2.3.1 Polymerase Chain Reaction (PCR) 
PCR Reaction Mix 
Reagents were mixed on ice (in order): 
upto 50µl  Nuclease-free H2O 
5µl   X10 buffer (Invitrogen, 10342-020) 
1.5µl   50mM MgCl2 
0.8µl   25mM dNTPs 
1µl   10µM Oligo Fwd 
1µl   10µM Oligo Rev 
2µl   cDNA (200ng/µl) 
0.5µl   Taq polymerase (Invitrogen, 10342-020) 
 
Samples were amplified using the DNA Engine Dyad Peltier Thermal Cycler 





























































































2.2.3.3 Restriction digest 
DNA was digested using enzymes and appropriate buffers (New England 
Biolabs/Roche) for one hour (analytical) or two hours (preparative). 
 
2.2.3.4 Agarose gel electrophoresis 
Analytical gels were prepared and run using 1X TBE buffer (Ambion, 
AM9865) whilst preparative gels were made and run with TAE (40mM Tris-
acetate, 2mM EDTA).  Buffers were mixed with the appropriated amount of 
agarose (Invitrogen, 15510-027) and heated in a microwave until the agarose 
was completely dissolved.  Once set in a casting tray, gels were transferred 
to an electrophoresis tank containing buffer, loaded and ran at 50V to resolve 
bands. 
 
2.2.3.5 DNA visualisation 
Gels were bathed in dilute ethidium bromide for 10 minutes prior to 
visualisation. Images of gels were taken using a Gel Logic 200 system 
(Kodak). Preparative gels were visualised using a shortwave UV 
transilluminator to minimise UV exposure. 
 
2.2.3.6 Gel extraction  
DNA bands were excised from preparative gels using a clean scalpel blade 
and extracted using the Gene Clean II (MP Biomedicals, 1001-400) 
according to manufacturer’s instructions.  DNA was eluted in ddH2O.  Water 
was chosen to elute the DNA as it does not contain salts that may affect 
applications such as ligation and sequencing. 
 
2.2.3.7 Chloroform extraction 
100µl chloroform was added to 100!l DNA and vortexed. The solution was 
spun at 13000rpm in a standard benchtop micro centrifuge for 2 minutes.  
The DNA-containing supernatant was transferred to a fresh Eppendorf tube 
and the protocol repeated.  This procedure was immediately followed by an 
ethanol precipitation. 
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2.2.3.8 Ethanol precipitation 
200µl absolute ethanol and 10!l Na Acetate pH5.2 was added to 100!l DNA 
and mixed by inversion.  The stringy DNA precipitate was pelleted at 13.2rpm 
in a standard benchtop micro centrifuge for 10 minutes.  After two washes in 
80% ethanol the pellet was air dried for 10 minutes and resuspended in an 
appropriate volume of RNase-free H2O. 
 
2.2.3.9 Quantification 




Ligation reactions were set up using 400units T4 DNA ligase (NEB, M0202), 
following manufacturer’s instructions.  A molar ratio of 1:3, insert:vector DNA 
was used with 100ng vector DNA.  Ligation mixes, including a vector only 
control, were incubated at 16oC overnight. 
 
2.2.3.11 Transformation 
Competent cells, Subcloning Efficiency DH5! Competent Cells (Invitrogen, 
18265-017), were thawed on ice.  50!l of cell suspension was mixed with 5!l 
DNA, including a pUC19 plasmid positive control, and incubated on ice for 30 
minutes.  Cells and DNA were heat shocked at 42oC for 45 seconds and then 
incubated on ice for another 2 minutes.  950!l warm SOB (Super Optimal 
Broth, 2% w/v bacto-tryptone, 0.5% w/v bacto-yeast extract, 8.56mM NaCl, 
2.5mM KCl, 10mM MgCl2 in ddH2O) was added and cells incubated at 37
oC, 
225rpm for 1hr.  The cells were spun briefly in a benchtop centrifuge and 
excess supernatant poured off.  Cells were resuspended in residual media 
and spread onto warm LB agar plates (1.5% agar in LB (Lysogeny Broth, 
1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride)) containing 




2.2.3.12 Plasmid DNA propagation and purification 
2.2.3.12.1 DNA Miniprep 
Miniprep cultures were cultivated from one colony picked into 4ml LB plus 
100!g/ml ampicillin (Sigma, A9393) and incubated at 37oC, 225rpm 
overnight.  Cultures were spun down and DNA purified using Wizard Plus SV 
Miniprep kit (Promega, A1460), following manufacturer’s instructions.  DNA 
was eluted in nuclease-free H2O. 
 
2.2.3.12.2 DNA Maxiprep 
Maxiprep cultures were cultivated from one colony picked into 250ml LB plus 
100!g/ml ampicillin and incubated at 37oC, 225rpm overnight.  Cultures were 
spun down and DNA purified using Purelink HiPure Plasmid Filter Maxiprep 
kit (Invitrogen, K2100-17), following manufacturer’s instructions. DNA was 





Grb2-/- ES cells Do Not Grow Efficiently in N2B27-LB 
Medium.    
 
3.1 Introduction 
3.1.1 Defined/Undefined Culture Conditions and their Effects on ES cell 
Identity 
Embryonic stem cells are derived from the inner cell mass of the blastocyst 
embryo (Evans and Kaufman, 1981).  They represent a population of cells in 
the embryo that go on to form the tissues of the foetus.  ES cells are defined 
by two characteristics; the capacity to expand in culture indefinitely and the 
ability to differentiate into the three germ layers of the developing embryo, a 
property known as pluripotency. 
 
Three transcription factors play a critical role in the regulation of ES cells; 
Oct4, Sox2 and Nanog.  Oct4 and Sox2 exhibit uniform expression across a 
self-renewing ES cell population (Scholer et al., 1989; Yuan et al., 1995).  
However, the level of Nanog expression oscillates in each cell (Chambers et 
al., 2007).  Two additional ES cell markers; Rex1 and Stella, also exhibit 
variable levels of expression across the population (Toyooka et al., 2008; 
Hayashi et al., 2008).  Rex1 or Stella negative ES cells can resume 
expression of Rex1 or Stella without becoming fully committed to 
differentiation.  These data demonstrate the inherent heterogeneity of ES cell 
populations. 
Since their first derivation, significant progress has been made in 
understanding and controlling the identity of the ES cell through modifications 
to their culture conditions. 
ES cells were originally derived, expanded and maintained in serum-based 
media in co-culture with murine embryonic fibroblasts (MEFs) (Evans and 
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Kaufman, 1981).  The mechanism by which MEFs and serum supported ES 
cell self-renewal and proliferation was unclear.  Smith et al. (1988) reported 
the first feeder-free ES cell cultures.  These were established using a defined 
substrate coating, gelatin, and LIF. 
Further research identified targets of LIF activation.  LIF induces activation of 
two major pathways; Stat3 and MAPK.  Stat3 is a key signal for the 
promotion of ES cell self-renewal (Niwa et al., 1998).  In contrast, MAPK 
signalling via LIF is dispensable for this process (Burdon et al., 1999). 
For many years, LIF and serum-based media have been used for the 
propagation of ES cells.  Serum is a complex media component derived from 
the non-cellular fraction of coagulated blood.  The use of serum is regarded 
as a source of complexity and inconsistency in ES cell culture.  Recent 
advances identified BMP4 as a suitable substitute for serum (Ying et al. 
2003).  BMP4 was shown to promote the transcription of Inhibitor of 
differentiation (Id) genes. 
Utilising specific factors in place of serum reduces the potential of exposing 
ES cells to pro-differentiative signals that may promote heterogeneity within 
the ES cell population.  Using a combination of LIF, BMP4 and N2 and B27 
supplements, Ying et al. (2003) established a fully defined, robust system for 
the propagation of ES cells. 
Interestingly, the mechanism by which LIF and BMP4 support the culture of 
ES cells is to block differentiation rather than promote self-renewal.  In the 
absence of BMP4, LIF is incapable of blocking neural differentiation (Ying et 
al., 2003) whilst BMP4 promotes non-neural differentiation (Ying et al., 2003; 
Zhang et al., 2010).  Together, LIF and BMP4 inhibit the progression of 
differentiation into all lineages, resulting in the maintenance of self-renewal. 
Nonetheless, even under these fully defined conditions, the ES cell 
population remains heterogeneous.  This may be due to the effect of 
autocrine signalling via FGF4.  FGF4 signalling is known to inhibit Nanog 
 63 
expression (Hamazaki et al., 2006) and promote differentiation (Kunath et al., 
2007; Stavridis et al., 2007).   
These data culminated in a new strategy for the expansion and maintenance 
of the ES cell population.  Ying et al. (2008) utilised small molecule inhibitors 
of specific signals in order to prevent differentiation of ES cells.  Addition of 
inhibitors of the FGF receptor (SU5402) and MEK (PD184352), a component 
of the FGF-MAPK pathway, to N2B27-based media resulted in the expansion 
of undifferentiated cells for multiple passages.  This suggests inhibition of 
pro-differentiative signalling by FGF and MAPK is sufficient to promote self-
renewal.  However, cells failed to thrive under these conditions, particularly at 
low density.  This was overcome by the addition of an inhibitor of GSK3! 
(CHIR99021).  When combined with FGF receptor and MEK inhibition, this 
inhibitor mimicked the effects of both AKT and Wnt signalling to promote ES 
cell growth.  
ES cells under FGF receptor inhibition by SU5402 exhibit homogeneous 
expression of Nanog (Hamazaki et al., 2006).   This supports in vivo data 
demonstrating that FGF receptor and MEK inhibition results in homogeneous 
expression of Nanog throughout the blastocyst-stage epiblast (Nichols et al., 
2009).  It is reported that inhibition of FGF signalling increases the 
homogeneity of an ES cell population (Lanner et al., 2010).  The identity of 
the cells under 3i culture has been described as ‘naïve’.  This suggests the 
cells are in a state of self-replication that is unaffected by any process 
associated with the progression of differentiation.  This homogeneous status 
reported in ES cells and their in vivo equivalents has been termed the 
‘Ground State’ (Ying et al., 2008).  
3.1.2 ES Cell Growth  
Self-renewal encompasses both the inhibition of differentiation and the 
promotion of ES cell proliferation.  The Ground State hypothesis claims ES 
cells employ an intrinsic mechanism of growth wherein extracellular signals 
are not required (Ying et al., 2008). 
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PI3K is a major pathway involved in the regulation of growth in many cell 
types. Two signals may contribute to the constitutive activation of PI3K 
signalling in ES cells, T cell lymphoma protein 1 (Tcl1) and Eras.  Tcl1 was 
discovered through global expression profiling combined with ChIP analysis 
of Oct4 targets (Matoba et al., 2006).  Oct4 directly targets the Tcl1 promoter 
region and enhances its transcription.  Overexpression of Tcl1 increases ES 
cell proliferation whilst suppression causes reduced proliferation.  
Suppression of Tcl1 is accompanied by reduced phosphorylation of AKT1 
and it is suggested that this is how Tcl1 contributes to ES cell growth. 
PI3K activity is also constitutively activated by the expression of an ES cell-
specific homolog of Ras, termed Eras, which binds directly to and activates 
the catalytic subunit of PI3K (Takahashi et al., 2003).  Eras exists in a 
constitutively active state as it is not affected by GTP-GDP exchange factors 
or GTPase-activating proteins (Takahashi et al., 2005).  It was suggested 
that a motif of three amino acids that is common to oncogenic forms of Ras 
and Eras is responsible for this lack of downregulation.  These data lead to 
the suggestion that PI3K activity in ES cells is largely regulated cell-
autonomously rather than via extracellular signals. 
3.1.3 Grb2 
GRB2 consists of a SH2 binding domain flanked by two SH3 domains.  The 
SH2 domain associates with phosphotyrosines presented by activated 
receptor tyrosine kinases (RTKs) and docking proteins such as the insulin 
receptor substrate (IRS) and the FGF receptor substrate FRS.  The two key 
pathways mediated by GRB2 are MAPK and PI3K/AKT. 
Upon binding to a phosphotyrosine residue, GRB2 binds to a SH3 domain-
containing protein, Son of sevenless (SOS), recruiting it to the membrane.  
Here SOS is activated and carries out its function as a guanine exchange 
factor of Ras, a small GTP binding protein.  SOS exchanges GDP for GTP, 
thus activating Ras.  Active Ras induces a cascade of phosphorylation in the 
MAPK pathway, including Raf, MEK and ERK kinases. 
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GRB2 can also activate PI3K/AKT through the recruitment of SH3 domain-
containing GRB2-associated binding protein (Gab).  This docking protein 
directly recruits PI3K to the membrane resulting in the activation of the PI3K 
pathway. 
3.1.4 Grb2 Regulates Growth 
Grb2 has been implicated in the regulation of growth in various systems.   
Grb2 is directly recruited by activated of Vascular endothelial growth factor 
receptor-3 (VEGFR3) in Human Umbilical Vein Endothelial Cells (HUVECs) 
(Salameh et al., 2005) resulting in the promotion of proliferation through 
activation of ERK1/2 and AKT signalling pathways.  Grb2 also promotes 
proliferation via heregulin-ErbB2 signalling in human breast cancer cell lines 
(Tari et al., 1999; Lim et al., 2000).  AKT, rather than MAPK/ERK was shown 
to be the key downstream signal in these cell types. 
A study into cultured smooth muscle cells derived from Grb2+/- and Grb2+/+ 
mice showed Grb2+/- cells were resistant to neointima development in 
response to vascular injury (Zhang et al., 2003).  Neointima is a term used to 
describe new vascular tissue generated in response to injury or the presence 
of aprosthesis.  Generation of this tissue requires the migration and 
proliferation of smooth muscle cells.  The role of Grb2 in proliferation of aortic 
smooth muscle was confirmed upon knockdown of the Grb2 mRNA 
transcript.  Grb2 was targeted through the introduction of morpholino 
oligonucleotides into primary rat aortic smooth muscle cells (RAOSMCs).  A 
reduction in GRB2 protein levels was observed, with reduced proliferation 
and MAPK signalling. 
3.1.5 The Grb2-/- ES Cell Phenotype 
Deletion of Grb2 results in embryonic lethality at approximately E4.5 when 
the ICM begins differentiation into endoderm in wild type embryos (Cheng et 
al., 1998). From these embryos, a Grb2 deficient (Grb2-/-) ES cell line was 
derived.  While Grb2-/- ES cells grow at a rate comparable to wild type, they 
exhibit a limited capacity for differentiation. 
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As the formation of the ICM is not affected in Grb2 deficient embryos, a  
Grb2-/- ES cell line was derived.  Cheng et al. (1998) reported Grb2-/- ES cells 
grow at a comparable rate to wild type cells and exhibit a restricted capacity 
for differentiation which is limited to trophoblast cells.  It was demonstrated 
that this restricted differentiation is caused by insufficient activation of SOS 
and therefore Ras in the MAPK pathway. 
These findings were expanded upon with the report that the ICM of Grb2-/- 
embryos consist of a population of cells exhibiting uniform expression of 
Nanog as opposed to a mixture of Gata6 and Nanog positive cells (Chazaud 
et al., 2006).  Grb2-/- ES cells are also resistant to sodium vanadate-mediated 
Nanog repression (Hamazaki et al., 2006). 
3.1.6 Aim 
No defect in proliferation is observed in Grb2-/- ES cells (Cheng et al., 1998).  
However, the behaviour of Grb2-/- ES cells in defined media has not been 
reported.  The aim of this chapter is to investigate the role of Grb2 in ES cell 




3.2.1 Grb2 ES Cells Grow Poorly in N2B27 
To begin investigating the requirement of Grb2 in ES cells, wild type and 
Grb2-/- ES cells were cultured in serum-based GMEM Complete ES Cell 
Medium (GMEM+FCS) and serum-free N2B27 Complete ES Cell Medium 
(N2B27-LB).  No difference was observed upon plating wild type or Grb2-/- 
lines in GMEM+FCS or N2B27-LB during the first passage.  However, 
differences between the lines emerged at the second passage in N2B27-LB.  
In N2B27-LB, wild type ES cells appeared normal (fig 3.1).  In contrast, Grb2-
/- cells grew in tight, refractive colonies with indistinguishable cell boundaries 




 ES cell exhibit an unusual morphology when cultured in N2B27-LB.  Cells 
grow in tight, refractive colonies in which individual cells are difficult to distinguish.  Scale bar 
– 100µm. 
 






















N2B27-based media were originally developed in order to cultivate neuronal 
cells (Bottenstein et al., 1979; Brewer et al., 1993) and upon withdrawal of 
LIF and BMP4, ES cells can differentiate into neural lineages (Ying et al., 
2003).  Although Grb2-/- ES cells are reputed to be unable to differentiate, 
their behaviour under defined conditions is yet to be reported.  It was, 
therefore, important to investigate whether cells retained expression of stem 
cell markers.  The status of the cells was confirmed through 
immunohistochemical staining for two key ES cell markers; transcription 
factors Oct4 and Nanog.   
These proteins were located in the nuclei of the majority of cells (fig3.2), 
consistent with established expression pattern of ES cells. In GMEM+FCS 
medium, wild type and Grb2-/- cells exhibited differing levels of Nanog 
expression across the ES cell population.  However, Grb2-/- ES cells stained 
very highly and uniformly for Nanog in N2B27-LB, whilst wild type ES cells 


























































Figure 3.2  Grb2
-/-
 ES cells stain intensely for ES cell markers Oct4 and Nanog.  Scale bar – 
25µm. 
 
The change in morphology of Grb2-/- cells switched to N2B27-LB suggested 
that there might be a defect in growth related to Grb2 deficiency in this 
medium. To establish whether there was a defect in growth, a cell counting 
assay was performed.  0.8x106 wild type or Grb2-/- ES cells were plated per 6 
well plate in GMEM+FCS or N2B27-LB media and cultured for 2 days.  After 
2 days, the number of cells was recorded and re-plated at the same density 
in fresh 6 well plates.  The population doublings were calculated and graphed 
cumulatively.  Figure 3.3 shows no significant difference between wild type 
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and Grb2-/- ES cells in GMEM+FCS and significantly (p<0.001 by student’s T-
test) diminished population doublings by Grb2-/- ES cells in N2B27-LB 










 cells were plated per well of a 6 well plate.  After 2 days culture, cells were 
counted and replated to 0.8x10
6
/well.  The number of cumulative population doublings was 
calculated and graphed (n=3 from 3 experiments). 
To support this result using an alternative, quantitative method, an MTT 
assay was performed.  The MTT assay is a colourmetric assay that 
measures cell numbers based on the reduction of 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT), a yellow tetrazole substrate to 
purple formazan by live, metabolically active cells.  8x102 wild type or Grb2-/- 
ES cells were plated per well of a 96 well plate in GMEM+FCS or N2B27-LB.  
Replicate plates were made for each assay timepoint.  Cells were assayed at 
4, 24, 48 and 72 hours.  Data was normalised to the 4-hour timepoint to 
account for potential differences in the number of cells plated in the assay.  
Figure 3.4 shows no significant difference in cell numbers was measured 
between wild type and Grb2-/- ES cells cultured in GMEM+FCS (p=0.12 by 
student’s T-test).  However, in N2B27-LB medium, Grb2-/- cells exhibited 
reduced cell numbers in comparison to wild type (p=0.012 by student’s T-












 cells were plated per well of a 96 well plate.  Replicate plates were created for 
each time point.  At 4, 24, 48 and 72 hours, cells were incubated with 3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) for 1 hour before overnight solublisation.  The 
conversion of yellow MTT to purple formazan was quantified using a spectrophotometric 
plate reader with a 570nm filter.  Data was normalised to the 4-hour time point and a 
student’s T-test performed on the endpoint dataset (n=12 from 2 experiments). 
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3.2.2 Restoration of Grb2 Expression Restores Normal Growth. 
The Grb2-/- cells were generated through the genetic manipulation of an R1 
ES cell line (Cheng et al., 1998).  Through homologous recombination, a 6kb 
deletion of exons 2 and 3 from the Grb2 gene resulted in truncation of the 
Grb2 locus.  The remaining exons 1 and 4 were frameshifted, ensuring no 
expression of Grb2 was possible.  Selection for successful deletion of Grb2 
was based on resistance to G418.  In order to select for cells in which both 
Grb2 alleles have been targeted, Cheng et al. (1998) subjected the cells to 
high levels of G418 and clonal selection. 
To exclude the possibility that the poor growth phenotype exhibited by Grb2-/- 
ES cells was due to clonal variation, Grb2 expression was restored in Grb2-/- 
ES cells.  This was achieved through the construction of a Grb2-expressing 
vector. 
Grb2 cDNA was excised from the plasmid vector by NotI/SalI restriction 
digest and ligated into a NotI/XhoI digested pCAGS-IRES-PUROR vector.  
Both plasmids are derivatives of the pPyCAGIP vector published by 
Chambers et al. (2003) (fig 3.5a).   
The constructed plasmid contains various elements that confer its function 
(fig 3.5b). In order to confirm its functionality, this vector and a 
complementary empty vector acting as a negative control were expressed 
transiently in a cos7 cell line.  This immortalised monkey kidney cell line 
expresses the SV40 large T antigen, which is defective in genomic DNA 
replication (Gluzman, 1981).  As the Grb2 construct contained the SV40 
promoter, it would be substantially amplified if the vector was correctly 
assembled.  This would result in the production of a large amount of protein, 
which would enable easy detection by Western blot.  
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Figure 3.5 b) Schematic of the CAGS-Grb2-IRES-IP expression vector CAG - The CAG 
promoter encompasses the cytomegalovirus (CMV) early enhancer element and chicken !-
actin promoter  (Alexopoulou et al., 2008). This combination results in high levels of gene 
expression and is especially effective in ES cells, which are known to silence the CMV 
promoter alone (Xia et al., 2007). IRES - The internal ribosome entry site (IRES) element 
enables initiation of translation from within a mRNA molecule (Pelletier and Sonenberg, 
1988). Linking a gene of interest to the sequence encoding a selection marker via an IRES 
element improves the likelihood that the level of gene expression is comparable to selection 
marker expression. PURO
R 
- Puromycin N-acetyletransferase (PAC) is an enzyme produced 
by Streptomyces alboniger that acetylates and inactivates puromycin, imparting resistance to 
this antibiotic (Gómez Lahoz et al., 1991). pA - Addition of multiple adenosine nucleotides to 
the tail of an mRNA increases that stability of the transcribed mRNA and enhances 
translation (Guhaniyogi and Brewer, 2001). SV40 - The SV40 promoter interacts with cells 
expressing the SV40 large T antigen, which is defective in genomic DNA replication, 
resulting in increased vector amplification (Gluzman et al., 1981). Bacterial Origin/Amp
R
 - 
These elements enable amplification of the vector upon transformation into bacterial cells. 
c) Transiently transfected Cos7 cells express GRB2 protein.  Four Grb2 expression vectors, 
an empty CAGS-IRES-IP vector and eGFP-expressing vector were lipofected into Cos7 
cells.  Western analysis of protein lysates shows high levels of GRB2 protein expression in 
Grb2-transfected cells.  Cell transfected with the empty vector or eGFP-expressing vector 
exhibit low, endogenous levels of GRB2 protein expression. 
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To test if the Grb2 expression cassette was functional the Grb2 vectors were 
transiently transfected into Cos7 cells and cell lysates were analysed by 
western blotting.  A low level of endogenous GRB2 (25 kDa) was detectable 
in lysates transfected with eGFP-expressing and empty vectors.  Figure 3.5c 
shows cells transfected with any of the four Grb2-containing vectors 
expressed very high levels of GRB2.  This confirms that all four vectors are 
functional. 
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One of the verified constructs was transfected into Grb2-/- ES cells and after 
10 days in puromycin-containing, selective media, stable clones were picked 
and expanded.  The remaining clones were fixed and stained for alkaline 
phosphatase (AP) activity and counterstained with Leishman’s stain to 
visualise the non-AP positive cells.  These stains revealed differences 
between Grb2 and empty vector transfected colonies (Fig3.6).  Empty vector 
(Grb2-/-) transfected colonies appeared highly AP positive whereas Grb2 
transfectants typically exhibited a large area of flat, AP negative cells with 
differentiated morphology, surrounding an AP positive central core. 
 
 
Figure 3.6 Puromycin-resistant colonies stained for alkaline phosphatase activity and 
Leishman’s stain.  Grb2-transfected colonies are surrounded by flat, non-AP positive cells. 
Scale bar = 100µm 
 
 
















To confirm Grb2 was expressed in the ES cell transfectants, lysates from 
expanded clones were analysed by Western blotting (Fig3.7a).  The level of 
GRB2 protein was quantified in comparison to ! actin levels using Image J 
image analysis software (NIH) (Fig 3.7b).  Restoration of GRB2 expression 
was confirmed in four clones.  All restored clones assayed expressed Grb2 
at varying levels.  Grb2-expressing restored clone R24 expressed GRB2 
protein at a lower level than wild type.  However, restored clone R28, R3 and 
R10 expressed GRB2 at a higher level than wild type. 
 
Figure 3.7 a) Levels of GRB2 protein were assessed in various R1-background ES cell 
lines; Grb2
-/-
 and empty vector-transfected (E1) lines, wild type (CK6) and wild type-like 
(Fgf4
+/-
) lines and four Grb2 restored lines (R24, R28, R3 and R10).  1000 cells per sample 
were lysed in SDS buffer and levels of GRB2 and ! actin protein were assayed by Western 
blot.     b)  Levels of GRB2 normalised to ! actin (n=3).  Analysis of Western blot by Image J 
















To assess whether restoration of Grb2 expression was sufficient to permit 
growth of Grb2-/- ES cells in N2B27-LB, wild type, two Grb2 restored lines 
and the parental Grb2-/- line of ES cells were cultured in N2B27-LB for three 
passages.  At passage three, both Grb2 restored clones demonstrated a 
morphology closely resembling wild type, rather than Grb2-/- cells (Fig3.8).  
This suggests that Grb2 may be required for efficient growth in N2B27-LB. 
 
 
Figure 3.8  Restoration of Grb2 expression changes the morphology of Grb2
-/-
 ES cells in 
N2B27-LB.  Wild type, Grb2
-/-
 and two Grb2 restored clones were cultured in N2B27-LB for 3 
passages.  Restored clone adopted a wild type-like ES cell morphology as opposed to the 
tight refractive colony morphology exhibited by the Grb2
-/-
 parental line. Scale bar = 100µm. 
 












 Restored Clone 24                   Restored Clone 28 
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Growth of all four cell lines in GMEM+FCS and N2B27-LB was quantified by 
MTT assay and by CyQuant Direct assay. The MTT assay estimates cell 
numbers based on the level of metabolism in a culture.  This may be 
unsuitable for assaying Grb2-/- ES cell growth as Grb2 may be involved in the 
regulation of metabolism.  The CyQuant Direct assay utilises a fluorescent, 
live cell-permeable nucleic acid dye and a suppression dye, which is 
impermeable to live cells.  The latter dye suppresses fluorescence in all but 
live, intact cells.  Consequently, the CyQuant Direct assay estimates cell 
numbers through the measurement of DNA content of only viable cells.  
Technical advantages of the CyQuant Direct assay over the MTT assay 
include the ability to assay in the presence of phenol red, increased 
sensitivity enabling lower density plating and the omission of media change 
and lysis steps which may affect reproducibility.   
8x102 (MTT) or 4x102 (CyQuant Direct) wild type, Grb2-/- or Grb2 restored ES 
cells were plated per well of a 96 well plate in GMEM+FCS or N2B27-LB.  
Replicate plates were made for each assay time point.  Cells were assayed 
at 4, 24, 48 and 72 hours.  Data was normalised to the 4-hour time point to 
account for potential differences in the number of cells plated at the start of 
the assay.  The MTT assay showed no significant difference in cell numbers 
was measured between wild type, Grb2-/- or Grb2 restored ES cell lines 
cultured in GMEM+FCS at 72 hours (Figure 3.9).  However, after 72 hours 
culture in N2B27-LB medium, Grb2-/- cells exhibited reduced cell numbers in 
comparison to wild type and Grb2 restored ES cell lines.  These data suggest 
that the poor growth exhibited by Grb2-/- ES cells in N2B27-LB is caused by 
the lack of Grb2 expression, rather than clonal variation.  
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Figure 3.9 Restoration of Grb2 expression in Grb2
-/-
 ES increases the rate of growth in 
N2B27-LB medium.  8x10
2
 wild type, Grb2
-/-
 or Grb2 restored ES cells were plated per well 
of a 96 well plate.  Replicate plates were created for each time point.  At 4, 24, 48 and 72 
hours, cells were incubated with MTT substrate for 1 hour before overnight solublisation.  
The conversion of yellow MTT to purple formazan was quantified using a spectrophotometric 







Figure 3.10 Restoration of Grb2 expression in Grb2
-/-
 ES increases the rate of growth in 
N2B27-LB medium.  4x10
2
 wild type, Grb2
-/-
 or Grb2 restored ES cells were plated per well 
of a 96 well plate.  Replicate plates were created for each time point.  At 4, 24, 48 and 72 
hours, cells were incubated with CyQuant Direct dye and suppressor for 1 hour before 
quantification using a fluorometric plate reader with a 488/520nm filter.  Data was normalised 





Both proliferation assays showed a significant (MTT: p<0.01; CyQuant Direct: 
p<0.001 by student’s T-test) growth difference between wild type and Grb2-/- 
ES cells in N2B27-LB medium as demonstrated previously. Grb2-/- cells 
appeared to grow very rapidly in GMEM+FCS but this is contradicted by the 
result of the cell counting and MTT assay, making this result difficult to 
interpret. In comparison to Grb2-/- cells, both Grb2 restored ES cell lines 
showed significantly (MTT: R24 p<0.01; R28 p<0.001; CyQuant Direct: R24 
p<0.05; R28 p<0.001 by student’s T-test) increased cell numbers compared 
when cultured in N2B27-LB medium.  Taken together, the restoration of 
typical ES colony morphology and growth in Grb2 expressing clones 
confirms that Grb2 is required for growth in N2B27-LB medium. 
3.2.3 Investigating the Cause of Poor Growth in Grb2-/- ES Cells.  
The previous experiments show that Grb2-/- ES cells grow poorly in N2B27-
LB medium.  Although a slower growth rate was demonstrated, the cause of 
this defect was not clear.  This could be due to a number of reasons, 
including poor cell survival and slower proliferation.  To elucidate the growth 
deficiency we examined the extent of cell death in the cultures, cell adhesion 
properties and the cell cycle distribution of wild type, Grb2-/- and Grb2 
restored lines. Finding the cause of poor growth may reveal the process 
Grb2 is involved in and will aid in elucidating the molecular mechanism by 
which Grb2 mediates efficient growth of ES cells. 
3.2.3.1 Grb2-/- ES cells Do Not Undergo Increased Apoptosis in N2B27-
LB. 
Apoptosis is a carefully controlled cellular program mediated by a series of 
molecular events resulting in the death of a cell (Kerr et al., 1972).  Loss of 
membrane asymmetry is a very early event in apoptosis.  In viable cells, 
phosphatidyl serine lipid residues are mainly found on the inner, cytosolic 
membrane leaflet (Verkleij et al., 1973).  Some spontaneous switching to the 
outer leaflet occurs, but this is corrected by the enzyme, Flippase (Bretscher, 
1973).  At the onset of apoptosis, phosphatidyl serine residues are not 
translocated back to the inner leaflet (Fadok et al., 1992) and this change 
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can be detected using Annexin V (Vermes et al., 1995).  Annexin V is a 
calcium-dependent phospholipid-binding protein with a high affinity for 
phosphatidyl serines.   Conjugated with a fluorochrome such as FITC, it can 
be used to label cells with exposed phosphatidyl serines residues.  Loss of 
membrane integrity is a later event in apoptosis and necrosis (Kerr et al., 
1972) and can be measured using a live cell-impermeable nucleic acid stain 
such as propidium iodide stain. 
To investigate the levels of apoptosis in Grb2-/- ES cells, the proportion of 
apoptotic (annexin V positive) cells was measured.  Wild type, Grb2-/- and 
two Grb2 restored ES cell lines were cultured in GMEM+FCS or N2B27-LB 
up to passage 3.  Cells were harvested and incubated with FITC-conjugated 
annexin V and propidium iodide before analysis by flow cytometry. Four cell 
populations were defined and gated using unstained, annexin V, PI and dual 
stained wild type control samples. Despite decreased proliferation, Grb2-/- ES 
cells did not exhibit an increase in apoptosis in N2B27-LB medium (Fig 
3.11a/b).  There was no significant difference (p=0.25) in apoptotic cells 
compared to wild type and significantly fewer apoptotic cells in comparison to 





















Figure 3.11 Poor growth of Grb2
-/-
 ES cells is not accompanied by increased apoptosis in 
N2B27-LB.  Wild type, Grb2
-/-
 and two Grb2 restored ES cell lines were cultured in 
GMEM+FCS or N2B27-LB for 3 passages.  Cells were incubated with FITC-conjugated 
annexin V and propidium iodide before analysis by flow cytometry.  a) Typical scatter plots. 
Y-axis: propidium iodide. X-axis: annexin V-FITC. b) Comparison of apoptotic (annexin V 



















3.2.3.2 Grb2-/- ES cells Have No Defect in Initial Cell Adhesion. 
Grb2-/- ES cells grow in tight, refractive colonies in N2B27-LB and some of 
these colonies detach from the tissue culture surface.  Grb2 is associated 
with integrin signalling (Schlaepfer et al., 1998), therefore it was 
hypothesised that the decrease in cell numbers was due to a defect in 
adhesion, which is overcome in the presence of serum.  To address this 
issue, an adhesion assay was performed.  Wild type, Grb2-/- and Grb2 
restored ES cell lines were cultured for two passages in N2B27-LB.  Cells 
were harvested and re-plated in replicate cultures in N2B27-LB.  At 15, 30 
and 60 minutes, wells were gently washed.  The remaining, adherent cells 
were enzymatically dissociated from the culture surface and counted. At the 
1 hour time point, a significantly greater number of Grb2-/- ES cells were 
attached to the culture surface than both wild type (p<0.05) and Grb2 
restored cells (p<0.05) (Fig 3.12).  There was no significant difference 
between wild type and Grb2 restored cells. This suggests Grb2-/- ES cells 
exhibit altered but not defective adhesion properties, at least in the initial 













Figure 3.12  Grb2
-/-
 ES cells show no defect in initial attachment to substrate. Wild type, 
Grb2
-/-
 and a Grb2 restored ES cell lines were cultured for two passages in N2B27-LB.  Cells 
were harvested and re-plated in replicate cultures in N2B27-LB.  At 15, 30 and 60 minutes, 
wells were gently washed.  The remaining, adherent cells were enzymatically dissociated 




3.2.3.3 Adhesion and Spreading of Grb2-/- ES Cell Colonies Is Improved 
with Alternative Substrates 
Although Grb2-/- cells adhere well in the initial stages of plating, the 
morphology of the colonies in N2B27-LB suggests aberrant adhesion occurs 
upon colony formation.  In order to test the adhesive properties of Grb2-/- ES 
cell colonies, cells were plated onto a range of substrates. 
Based on morphology, little improvement in colony spreading was seen when 
cells were plated on collagen-coated, serum-coated and uncoated tissue 
culture plastics (Fig 3.13).  However, Grb2-/- cells demonstrated a more 
typical ES cell-like morphology when plated on fibronectin and laminin.  







Figure 3.13  Grb2
-/-
 colony spreading is improved upon plating on alternative substrates. 
Wild type, Grb2
-/-
 and a Grb2 restored ES cell lines were cultured on various substrates in 
N2B27-LB. Scale bar = 100µm. 
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To quantify the effects of alternative substrates on ES cell growth, a CyQuant 
Direct proliferation assay was performed (Fig 3.14).  
 
Figure 3.14 Plating on alternative substrates does not improve growth rate.  4x10
2
 wild type, 
Grb2
-/-
 or Grb2 restored ES cells were plated per well of a 96 well plate on various 
substrates.  Replicate plates were created for each time point.  At 4, 24, 48 and 72 hours, 
cells were incubated with CyQuant Direct dye and suppressor for 1 hour before 
quantification using a fluorometric plate reader with a 488/520nm filter.  Data was normalised 
to the 4-hour time point (n=12 from 2 experiments) 
 
In comparison to gelatin, only Grb2-/- cells cultured on uncoated plastic 
resulted in a significant (p<0.01 by student’s T-test) reduction in proliferation 
at the 72 hour time point.  All other coatings did not significantly impact on 







3.2.3.4 Grb2-/- ES Cells Exhibit an Abnormal Cell Cycle Distribution in 
N2B27-LB. 
The evidence presented so far suggests Grb2-/- ES cells are not simply lost 
through apoptosis or poor adhesion during culture.  Another explanation 
could be that the cells are simply proliferating more slowly in N2B27-LB 
media.  The rate of cellular growth in all cell types is governed by the speed 
at which cells complete the cell cycle.  Unlike somatic cells, ES cells have a 
particularly short G1 phase, with more cells in S phase cells (Savatier et al., 
1996).   
To investigate the cell cycle distribution of cells in GMEM+FCS and N2B27-
LB media, the flow cytometry profiles of PI-stained cells were compared (Fig 
3.15a/b).  In GMEM+FCS medium, wild type, Grb2-/- and two Grb2 restored 
cell lines exhibited very similar profiles.  This supports data presented 
previously in this chapter, which showed all cell lines proliferate at a similar 
rate in this medium.  Indeed, the cell cycle profiles exhibited a distribution 
typical of mouse embryonic stem cells, with the largest proportion of cells in 
S phase (Stead, et al., 2002).  In N2B27-LB, the proportion of wild type and 
Grb2 restored cells in G1 and S phase was similar.  However, Grb2-/- cells 
exhibited a markedly different profile in the different media, with 
approximately 15% more cells in G1 phase (p<0.01 by student’s T-test), 10% 
fewer cells in S phase (p<0.005) and 5% fewer cells in G2/M phase (p=not 
significant) (Fig 3.15a/b). 
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 ES cell exhibit an abnormal cell cycle distribution.  Wild type, Grb2
-/-
 and 
Grb2 restored ES cells were cultured in N2B27-LB for 3 passages before fixation and PI 
staining followed by flow cytometry analysis a) Typical scatter plots. b) Mean percentage of 







This chapter has established for the first time that Grb2 plays a wider role in 
ES cell biology than might have been anticipated, based on previous reports.  
These results suggest that in addition to its role in differentiation, Grb2 is also 
required for efficient growth in defined culture conditions in N2B27-LB.  This 
was demonstrated by the poor growth phenotype exhibited by Grb2 ES cells 
in N2B27-LB media.  Poor growth is characterised by a decrease in cell 
numbers confirmed by cell counting, metabolic and DNA-based proliferation 
assays. 
Grb2-/- ES cells express high levels of ES cell markers Oct4 and Nanog.  This 
is verified by existing studies in which Grb2-mediated MAPK activation was 
shown to downregulate Nanog (Hamazaki et al., 2006).  This may suggest 
low levels of MAPK activity in Grb2-/- ES cells in N2B27-LB medium. 
Grb2 was confirmed as the essential component missing from the cells as 
restoration of Grb2 expression resulted in improved ES cell morphology and 
growth rate, which closely resembled the wild type phenotype.   
It was determined that Grb2-/- ES cells were not undergoing increased 
apoptosis and initial attachment of the cells to the tissue culture surface was 
not defective.  When plated on laminin or fibronectin, the morphology of 
Grb2-/- cells in N2B27 changed to resemble wild type cells; although 
proliferation data suggested growth had not been rescued.  This suggests 
that morphology and proliferation are not linked under these conditions. 
Grb2-/- ES cell colonies attach poorly to the gelatin-coated tissue culture 
surface, however, the tight, refractive colonies suggest cell-cell adhesion 
may be altered.  This implies the poor growth phenotype may be 
characterised by changes in adhesion properties.  This may indicate integrin 
signalling is disrupted.  Integrins are receptors required for both cell-
extracellular matrix (ECM) and cell-cell interactions.  They consist of different 
isoforms of ! and " subunits enabling a number of combinations that confer 
ligand-binding specificity to the resulting heterodimers.  Insoluble forms of 
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ligands including laminins, fibronectin and collagens can be used as 
substrates to facilitate cell adhesion through the formation of focal contacts 
between integrins and the ECM.  Adhesion to substrates can result in 
profound effects on cell growth (Zhu et al., 1996), death (O'Brien et al., 
1996), shape and migration (Bauer et al., 1984).  
As well as adhesion molecules, integrins are also instigators of cell 
signalling. Ligand-bound integrins have been shown to induce tyrosine 
phosphorylation of proteins, including focal adhesion kinase (FAK), a non-
receptor protein tyrosine kinase co-localised with and activated by integrin 
receptors at sites of cell-ECM interaction.   
The importance of the ECM and integrin signalling is highlighted by the 
embryonic lethality of fibronectin or FAK-/- mice.  Fibronectin null embryos are 
able to implant, gastrulate and form neural folds but the anterior posterior 
axis does not reach full length and the neural tube is deformed (George et 
al., 1993).  Mesoderm-derived tissue suffers severe defects; notochord and 
somites are not formed and the heart is poorly developed.  Defects in the 
yolk sac, extraembryonic vasculature and amnion are also noted. Ilic et al. 
(1995) reported strikingly similar phenotype in FAK-/- embryos, suggesting 
fibronectin-integrin interactions are mediated by FAK at this stage of 
development. 
Grb2 mediates MAPK signalling by various integrin-related mechanisms.  
Alpha1 integrin activates MAPK via Fyn, Shc and Grb2 (Wary et al., 1998).  
Grb2-mediated ! integrin signalling can occur in a FAK-dependent manner 
(Schlaepfer et al., 1998) or by direct association with the cytoplasmic domain 
of ! integrins (Law et al., 1996). 
It is unlikely that the morphology of Grb2-/- ES cells in N2B27-LB is caused by 
insufficient integrin activity in the initial stages of attachment, as Grb2-/- cells 
did not exhibit any defect in adhesion within the first hour of plating.  The !1 
integrin deficient ES cell phenotype supports this (Fässler et al., 1995).  
Although !1 null ES cells exhibit an unusually tight colony morphology, similar 
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to Grb2-/- cells in N2B27-LB, attachment to laminin and fibronectin is 
impaired.  This is the opposite effect to that seen in Grb2-/- ES cells, where 
attachment is improved on these substrates. 
The improvement in adhesion and colony spreading seen on laminin and 
fibronectin substrates may indicate that an alternative mechanism of 
adhesion can be triggered to induce colony spreading in a Grb2-independent 
manner.  One explanation for this could be the involvement of an alternative 
combination of integrin ! and " subunits. 
A series of events occur in the process of cell attachment.  Initially, integrins 
mediate weak binding to RGD protein sequences found in ECM proteins and 
this attachment strengthens as integrin clusters are formed in the cell 
membrane (Gottschalk et al., 2004).  Next, secondary attachment proteins 
such as talin, vinculin and ! actinin accumulate at these clusters and a 
network of interconnected proteins is created within the cluster, which 
interacts with the cytoskeleton (Cluzel et al., 2005). 
The secondary events linking integrins to the cytoskeleton may be affected in 
Grb2-/- ES cells.  Chen et al. (1994) showed cytochalasin D, a potent inhibitor 
of actin polymerization, eradicates MAPK activation by integrins, which is 
likely to be mediated by Grb2. 
Grb2 also interacts with the cytoskeleton via direct interactions with two 
cytoskeletal proteins.  Caldesmon is a calmodulin and actin binding protein 
(Boerner et al., 2003) and Magicin is a Merlin and Grb2 interacting 
cytoskeletal protein (Wiederhold et al., 2004).   
These data implicate Grb2 in the molecular mechanisms of cell attachment, 
which may contribute to the poor growth phenotype exhibited in N2B27-LB.  
This could be investigated further using peptides and antibodies that 
specifically block integrin interactions.  For example, ES cells express !v"5 
integrins (Lee et al., 2009) which bind to vitronectin, a major cell attachment-
promoting ECM protein found in serum (Hayman et al., 1985).  Culturing wild 
type ES cells in N2B27-LB medium or Grb2-/- cells in GMEM+FCS medium in 
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the presence of !v and "5 integrin-specific antibodies may recreate the poor 
growth phenotype described in this chapter, whereas no effect would be 
seen on Grb2-/- cells in N2B27-LB medium.  Multiple combinations of integrin 
subunits can be investigated to identify the integrins responsible.  Comparing 
the integrin expression profiles of Grb2-/- cells in N2B27-LB and GMEM+FCS 
media by FACS analysis may also reveal the underlying cause of abnormal 
adhesion. 
Changes in the cell cycle distribution indicate that growth may be inhibited 
due to slow progression through the G1 checkpoint.  This proposal is 
supported by the current understanding of the role of MAPK in cell cycle 
progression.  MAPK activation has been linked with increased cyclinD1 
expression (Terada et al., 1999) and the assembly of the cyclinD1/Cdk4+6 
complex, which is known to upregulate genes required for G1/S transition 
(Ewen, 2000).  However, cyclinD is not thought to play a role in the ES cell 
cycle due to its low level of expression (Savatier et al., 1996; Jirmanova et 
al., 2002).  This may suggest that trace levels of cyclinD are sufficient for 
efficient progression through G1 under defined conditions.   
Another explanation could be that Grb2 might regulate the cell cycle via a 
direct interaction with p27.  p27 is a cell cycle inhibitor expressed at low 
levels by ES cells (Stead et al., 2002).  Upon binding, GRB2 has been shown 
to facilitate the degradation of p27 (Sugiyama et al., 2001).  In the absence of 
Grb2, levels of p27 may accumulate and inhibit the progression of the cell 
cycle. 
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These data indicate Grb2 does regulate ES cell growth, when compensatory 
mechanisms that are normally provided by serum, are unavailable.  Grb2 is 
required for normal adhesion to a gelatin substrate and plays a distinct role in 






Figure 3.16 Schematic of novel findings described in this chapter.  Grb2 is required for 
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The previous chapter described the novel finding that Grb2 plays an 
important role in the regulation of mouse ES cell growth.  Grb2-/- ES cells 
grow poorly in N2B27-LB.  The data suggest poor growth is caused by a 
defect in proliferation as no increase in apoptosis was measured while there 
was an accumulation of cells in G1 phase.  This chapter will describe an 
investigation into signalling pathways downstream of Grb2 responsible for 
impaired growth of Grb2-/- ES cells in N2B27-LB media.   
 
4.1.1 Signals Immediately Downstream of Grb2  
The GRB2 adapter protein is ubiquitously expressed and interacts with a 
number of downstream effectors, some of which are tissue specific. The N-
terminal SH3 domain of GRB2 predominantly binds to the proline rich domain 
of Son-of-Sevenless (SOS) (Wittekind et al., 1997) whilst the C-terminal SH3 
domain binds to a similar domain in GAB1 (Ong et al., 2001).  Both SOS and 
GAB1 can bind to GRB2 simultaneously, enabling concurrent activation of 
pathways downstream of SOS1 and GAB1.  
 
GRB2 also directly associates with VAV (Ye and Baltimore et al., 1994), a 
proto-oncogenic protein expressed by the haematopoietic lineage.  VAV is a 
guanine exchange factor involved with the activation of RhoGTPase, a key 
regulator of cell proliferation, shape and survival (reviewed in Etienne-
Manneville and Hall, 2002).  GRB2 binding facilitates translocation of VAV to 
the membrane in response to stimulation of the T cell antigen receptor and 
subsequent tyrosine phosphorylation of Linker for Activation of T cells (LAT). 
 
Wiskott-Aldrich syndrome protein (WASp) is a scaffold protein that binds 
strongly with GRB2 N-terminal SH3 domain and more weakly to the C-
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terminal SH3 domain (She et al., 1997).   GRB2 binds to phosphotyrosine 
residues presented by the activated EGF-receptor, translocating WASp from 
the cytoplasm to the membrane where it plays a role in the regulation of the 
actin cytoskeleton of T cells through its interaction with the actin-related 
protein 2/3 (Arp2/3) complex.  No phenotype was reported in WASp-/- ES 
cells (Cotta-de-Almeida, et al. 2007), however, WASp-/- mice were defective 
in T cell development. 
 
4.1.2 MAPK  
The mitogen-activated protein kinase (MAPK) cascade encompasses a 
series of sequentially activated serine/threonine kinases.  In response to 
phosphotyrosine residues presented by active RTKs and docking proteins, 
GRB2 facilitates the translocation of SOS to the membrane.  SOS mediates 
the exchange of GDP for GTP on Ras, a small GTP binding protein.  Active, 
GTP-bound Ras initiates the MAPK cascade of Raf, MEK and ERK activation 
(Fig 4.1a).  Signalling downstream of ERK includes both cytoplasmic targets 
(Sturgill et al., 1988) and nuclear transcription factors (Chen et al., 1992). 
 
There are many signals downstream of ERK.  More than 150 ERK substrates 
have been identified to date and this number is expected to increase (Krishna 
and Narang, 2008).  The best studied downstream target of ERK is E-twenty 
six-like gene 1 (Elk1).  Elk1 is a component of the ternary complex factor 
(TCF) subfamily, forming a ternary complex upon binding the serum 
response factor (SRF) and the serum response element (SRE).  
Phosphorylation by ERK increases the DNA binding capacity of Elk1 












Figure 4.1 The MAP-kinase pathway. Receptor tyrosine kinases or scaffold proteins present 
phosphotyrosine residues upon activation.  The SH2 domain of adaptor protein GRB2 enables binding 
to these phosphotyrosines.  GRB2 also binds to Son of sevenless (SOS) through a SH3 domain.  As 
the GRB2/SOS complex is brought to the membrane via a phosphotyrosine interaction, SOS is 
activated and can carry out its function as a guanine exchange factor of Ras, a small GTP binding 
protein.  SOS exchanges GDP for GTP and Ras is able to activate Raf, a kinase of MEK (MAPK/ERK 
kinase) which in turn is a kinase of ERK (extracellular signal-regulated kinase).  Once activated, an 
ERK dimer regulates cytosolic targets, cytoskeletal proteins and can also enter the nucleus to regulate 
various transcription factors. 
 
 
Burdon et al. (1999) demonstrated that suppression of MAPK signalling, 
specifically MEK signalling, inhibited differentiation in ES cells.  This work 
was later developed into the model wherein ERK activation shifts pluripotent 
ES cells into a reversible state where cells are receptive to differentiation 
signals (Kunath et al., 2007).  ES cells under MEK inhibition are described as 
‘Ground State’ ES cells, indicating their status as a homogeneous, pluripotent 
population of ES cells (Ying et al., 2008). 
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4.1.3 PI3K  
The PI3K pathway can be activated through direct receptor interactions or by 
an indirect mechanism.  For example, PI3K/AKT is activated by PDGF via the 
direct recruitment of PI3K to the activated PDGF receptor (Kazlauskas et al., 
1992).  However, this is not the case for many RTKs.  FGF signalling 
employs an intermediate docking molecule to achieve PI3K activation via 
GRB2 and Grb2-associated binding protein 1 (Gab1).  The FGF-Receptor 
Substrate (FRS) contains numerous tyrosine residues, which are 
phosphorylated in response to the autophosphorylation of ligand-bound FGF-
receptor (Fig 4.1B).  GRB2 is recruited via its SH2 domain and serves as an 
adapter molecule between the receptor substrate and Gab1, which is bound 
to GRB2 at its C-terminal SH3 domain.  Activation of Gab1 in this manner 
generates phosphotyrosines which recruit PI3K regulatory subunit p85 to the 

























Figure 4.2 FRS-facilitated activation of PI3 kinase.   A) Ligand is presented to receptor and the 
receptor’s intracellular domain autophosphorylates, presenting a phosphotyrosine residue.  FRS is then 
recruited to the receptor.  B) Activated FRS presents many phosphotyrosine residues and the GRB2-
Gab1 complex is recruited via the GRB2 SH2 domain.  Gab1 recruits the regulatory subunit (here p85) 
of PI3K.  C) The catalytic subunit (e.g. p110) is recruited to the membrane by the regulatory subunit.  








PI3K has been shown to apply to many functions within the cell including 
proliferation, differentiation and survival.  In ES cells, PI3K has been implied 
to play a role in both self-renewal (Paling et al., 2004; Watanabe et al., 2006) 
and proliferation (Jirmanova et al., 2002). 
 
Many studies indicate PI3K/AKT signalling regulates the control of ES cell 
growth.  ES cells under inhibition of PI3K activity through the activity of 
inhibitor LY294002 exhibit decreased proliferation, with cells accumulating in 
the G1 phase of the cell cycle.  Also, deletion of Eras, an ES cell-specific 
form of Ras responsible for constitutive activation of PI3K results in poor 
proliferation and reduced tumourigenicity (Takahashi et al., 2003).  
Conversely, Phosphatase and Tensin Homolog (PTEN) is a negative 
regulator of PI3K through its function as a PIP3 phosphatase (Maehama and 
Dixon, 1998).  Knockdown of this protein results in high levels of PIP3, 
essentially a hyperactivation of the PI3K signal.  PTEN-/- ES cells 
demonstrate increased proliferation and enhanced tumourigenicity (Sun et 
al., 1999).  Normal growth is restored upon deletion of AKT from PTEN-/- ES 
cells (Stiles et al., 2002), suggesting AKT is the key downstream effector of 
the PI3K signal in ES cells.  However, no proliferative defect was reported in 
PDK1-/- ES cells (Williams, 2000).  As PDK1 is responsible for the 
phosphorylation of AKT, it was suggested ES cells do not require AKT.  This 
work was carried out in serum-based media, therefore it is possible that 
PDK1-/- cells survive due to an undefined factor present in the media, 
perhaps in a similar manner to Grb2-/- ES cells. 
 
GSK3! is a major downstream effector of PI3K signalling in ES cells.  This is 
supported by Storm et al. (2007) who showed inhibition of GSK3! reverses 
the differentiative effect of PI3K inhibition via inhibitor LY294002. However, 
McManus et al. (2005) generated ES cells expressing a form of GSK3! 
containing a serine-alanine substitution at residue 9.  This mutation disabled 
GSK3! inhibition via AKT phosphorlyation without affecting self-renewal, 
suggesting GSK3! phosphorylation via AKT may not be required by ES cells.  
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GSK3! inhibition via Wnt3a remained intact in these cells, which may 
indicate Wnt signalling is solely responsible for GSK3! inhibition in ES cells 
or perhaps both pathways encompass a convergent function to keep this 
integral pathway under tight control. 
 
This chapter describes experiments with the aim of defining and 
characterising the pathways regulated by Grb2 that are required for efficient 
growth.   
 
 
4.2.  Results 
 
4.2.1.  AKT Signalling is Not Disrupted in Grb2-/- ES Cells 
PI3K/AKT is a major signalling pathway associated with cell growth and 
survival (Yao and Cooper, 1995).  Activation of AKT has been shown to 
inhibit apoptosis (Kulik et al., 1997) and increase protein synthesis (Gingras 
et al., 1998).  Forced expression of activated AKT has been shown to support 
ES cell self-renewal in the absence of LIF (Watanabe et al., 2006).  
Disruption of this pathway can cause poor growth in many cell types (Fruman 
et al., 1999; Gao et al., 2000; Coutant et al., 2002). 
 
Evidence suggests the PI3K/AKT pathway is important for cell proliferation 
and survival and Grb2 can regulate PI3K/AKT signalling through its role in 
recruitment of Gab1 to the membrane.  To investigate the status of the ES 
cell PI3K/AKT pathway in the absence of Grb2, ES cells were stimulated with 
FGF or IGF growth factor and the activity of the PI3K/AKT pathway was 
assayed biochemically.  A wild type, Grb2-/- and two Grb2 restored ES cell 
lines were plated overnight, washed and starved of serum for 3 hours to 
reduce background signalling.  After this time, cells were then exposed to 
either 25ng/ml FGF2 and 1µg/ml heparin or 100ng/ml IGF1 for 10 minutes 
before being promptly lysed for protein.  AKT activation was assayed through 

























Figure 4.3 a) Wild type, Grb2
-/-
 and two Grb2 restored cell lines were starved of LIF and 
serum for 3 hours and induced with 25ng/ml FGF2 and 1µg/ml heparin for 10 minutes before 
lysis and Western analysis. FGF2 did not significantly induce activation of AKT in ES cells.  
Some upregulation of GSK3! was observed.  ERK1/2 activation was clear in all Grb2 
expressing lines. b) Quantification of pGSK3!. The integrated density of pGSK3! signal 
was measured using Image J image analysis software and normalised to the integrated 
density of the corresponding GSK3! signal in the blot presented above.  
 
 
Unexpectedly no increase in phosphorylation of AKT was detected in 

































GSK3! is phosphorylated at serine residue 9 by active AKT (Cross et al., 
1995).  There is some evidence of a small increase in GSK3! 
phosphorylation in response to FGF2 at this time point (Fig4.3b). This 
indicates that there is an increase in AKT activity in response to FGF2 which 




Figure 4.4 Wild type, Grb2
-/-
 and restored cell lines were starved of LIF and serum for 3 
hours and induced with 100ng IGF1 for 10 minutes before lysis and Western analysis. IGF1 
induced phosphorylation of AKT in ES cells.  ERK1/2 activation is clear in all Grb2 
expressing lines.  
 
 
IGF1 induction confirmed activation of AKT was possible in all four ES cell 
lines (Fig 4.4).  Grb2-/- ES cells did not exhibit any significant difference in 
AKT activation compared to the wild type or Grb2 restored lines.  These 
results indicate AKT signalling is intact in Grb2-/- ES cells.  
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In order to establish that the growth factors were active and FGF-mediated 
phosphorylation of AKT can be detected, 3T3 fibroblast cells were plated 
overnight, washed and starved of serum for 3 hours to reduce background 
signalling.  After this time, cells were exposed to either 25ng/ml FGF2 and 
1µg/ml heparin or 100ng/ml IGF1 for 10 minutes before being lysed for 
protein.  AKT activation was assayed through probing for phosphorylation at 
serine residue 473 on a Western blot. Fig 4.5 shows clear activation of AKT 




Figure 4.5 NIH 3T3 fibroblast cells were starved of serum for 3 hours and induced with 
either 25ng/ml FGF2 and 1µg/ml heparin or 100ng/ml IGF1 for 10 minutes before lysis and 








4.2.2.  ERK Signalling is Disrupted in Grb2-/- ES Cells 
The MAPK pathway is a major pathway that connects extracellular growth 
factor signals to their intracellular targets.  Many extracellular signals have 
been shown to activate this pathway such as integrins (Schlaepfer et al., 
1994), G protein coupled receptors (Buist et al., 1998) and growth factors 
(Lenormand et al., 1998) including those signalling through receptor tyrosine 
kinases (RTKs) (Reviewed in McKay and Morrison, 2007).  Activation of the 
MAPK pathway is known to regulate many essential cellular processes for 
example apoptosis, growth and differentiation. 
 
Grb2 is a key molecule in the MAPK pathway.  Its major role links 
extracellular phosphorylation signals to Son-of-Sevenless (SOS), which in 
turn activates Ras GTPase.  Cheng et al. (1998) described a fusion protein 
consisting of the N terminal domain of SOS fused to a Grb2 SH2 domain. 
Expression of this protein bypassed the requirement for Grb2 in ES cells and 
restored wild type function, indicating pathways downstream of SOS are key 
functions of Grb2 in ES cells. 
 
To investigate MAPK signalling in Grb2-/- ES cells, the levels of 
phosphorylated ERK were estimated in response to FGF2 and IGF1 by 
reprobing the Western blots constructed in the experiments described in 
section 4.2.1.   
 
Figures 4.3 and 4.4 show Grb2-/- ES cells exhibit no activation of ERK in 
response to FGF2 or IGF1.  The basal level of ERK activation was also 
undetectable in these cells.  Wild type and restored lines showed increased 







4.2.3 ERK Phosphorylation is Not Detected in Grb2-/- ES Cells Cultured 
in N2B27-LB 
Induction experiments described previously in section 4.2.2 highlighted 
disruption of the MAPK signalling pathway in Grb2-/- ES cells in response to 
two specific stimuli; FGF2 and IGF1 (Fig 4.3 and 4.4).  To investigate the 
activity of MAPK signalling, ES cells growing in GMEM Complete ES Cell 
Media or serum-free N2B27 Complete ES Cell Media (N2B27-LB) were lysed 
for protein and levels of activated ERK deduced by Western blot.  Higher 
levels of activated ERK were present in serum-based media in all four cell 
lines.  Levels of phosphorylated ERK were lower in N2B27-LB in wild type 




Figure 4.6  Grb2
-/-
 ES cells exhibited no activation of ERK1/2 in N2B27.  Wild type, Grb2
-/-
, 
an empty vector-transfected Grb2
-/-
 and a Grb2 restored cell line were cultured in 
GMEM+FCS or N2B27-LB overnight.  Protein lysates were Western analysed to show pERK 
signalling status.  
 
 
This result indicates Grb2-/- ES cells had a deficit in ERK signalling in N2B27-
LB.  The level of phosphorylated ERK observed in Grb2-/- cells cultured in 
serum-based media appeared similar to wild type, suggesting activated ERK 




4.2.4 Restoration of ERK signalling   
ERK phosphorylation is not detected in Grb2-/- ES cells in N2B27-LB, a 
condition in which Grb2-/- ES cells grow poorly.  Accordingly, attempts were 
made to restore this signal to ascertain whether ERK is the downstream 
effector of Grb2 required for efficient growth in N2B27-LB.  
 
4.2.4.1 Activation of ERK by PMA  
To investigate whether MAPK/ERK activation is required for efficient growth 
in N2B27-LB, ERK was activated using phorbol 12-myristate 13-acetate 
(PMA).  PMA is a phorbol diester known to mimic diacylglycerol, a ligand and 
activator of protein kinase C (PKC) (Verin et al., 2000).  In order to ascertain 
the effect of PMA on ERK signalling in ES cells, an induction experiment 
replicating previous inductions was set up utilising 1000u/ml LIF or 100µM 













Figure 4.7 PMA induces ERK1/2 activation in Grb2
-/- 
ES cells. Wild type, Grb2
-/-
 and a Grb2 
restored cell lines were starved of LIF and serum for 3 hours and induced with 1000uLIF or 
100nM PMA for 10 minutes before lysis and Western analysis.  
 
10 minutes after addition of the stimulant, an increase in ERK 
phosphorylation in response to LIF was observed in all Grb2 expressing lines 
(Fig 4.7).  Grb2-/- ES cells showed no ERK phosphorylation.  However, in 
response to PMA, all ES cell lines exhibited strong activation of ERK.  At 10 
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minutes induction, PMA induced higher levels of ERK activation than LIF in 
all lines. 
 
PMA activates ERK via upregulation of the GTP-bound, active form of Ras 
(Verin et al., 2000), although this has not been demonstrated in ES cells.  To 
investigate the mechanism by which PMA activates ERK, cells were induced 
as in previous experiments with the exception of an additional 1 hour 
incubation in the presence or absence of PD0325901, a specific inhibitor of 




Figure 4.8 PMA activation of ERK1/2 is via MEK. Wild type and Grb2
-/-
 ES cells were 
starved of LIF and serum for 3 hours, exposed to MEK inhibitor PD0325901 for 1 hour then 
PMA induced for 10 minutes. 
 
 
These experiments show that PMA is a highly potent activator of ERK in ES 
cells.  This activation is independent of Grb2 but activation is MEK-
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dependent, suggesting PMA activates the MAPK pathway downstream of 
Grb2.  In order to investigate whether restoration of ERK signalling would 
improve the growth of Grb2-/- ES cells in N2B27-LB, cells were cultured in the 
presence of PMA or the equivalent volume of DMSO vehicle.   
 
After 3 days, wild type and Grb2 restored ES cells showed no change in 
morphology in the presence or absence of PMA and Grb2-/- ES cells retained 
their poor growth phenotype (Fig 4.9). A CyQuant Direct assay was used to 
assess the proliferation of the cells.  Wild type, Grb2-/- and two Grb2 restored 
ES cell lines were cultured in replicate plates for 3 days in the presence or 
absence of PMA.  Cell numbers were recorded at 4, 24, 48 and 72 hours and 
data normalised to the 4 hour measurement.  This assay confirmed that there 
was no increase in the rate of proliferation of the four cell lines in response to 
PMA (Fig 4.10).  Furthermore, wild type and Grb2 restored clone 28 exhibited 
a significant (WT p<0.005; R28 p<0.001) decrease in cell numbers in at the 






















 ES cell morphology does not change after 3 days in N2B27-LB in the 




Figure 4.10 Addition of PMA did not increase the rate of growth of ES cells in N2B27-LB 
medium.  4x10
2
 wild type, Grb2
-/-
 and two Grb2 restored ES cell lines were plated per well of 
a 96 well plate in N2B27-LB alone and in the presence of 100nM PMA or the equivalent 
amount of ethanol carrier.  Replicate plates were created for each time point.  At 4, 24, 48 
and 72 hours, cells were incubated with CyQuant Direct dye and suppressor for 1 hour 
before quantification using a fluorometric plate reader with a 488/520nm filter.  Data was 
normalised to the 4-hour time point (n=12 from 2 experiments). 
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Although ERK activation via PMA was observed in Grb2-/- ES cells, this 
biochemical assay was too short-term to conclude ERK signalling was 
significantly restored.  To investigate the duration of the ERK signal 
stimulated by PMA, cells were induced as in previous experiments and 
harvested at various time points.  Wild type cells showed a peak of ERK 
activation at 30 minutes, which was undetectable by 8 hours (Fig 4.11).  
Grb2
-/- cells exhibited a shorter period of ERK activation which also peaked 

































Figure 4.11 PMA induced ERK1/2 activation for over 1 hour in Grb2
-/- 
ES cells.  WT and 
Grb2
-/-  
ES cells were starved of LIF and serum for 3 hours before induction with 100nM 
PMA.  Cells were lysed at 10 minutes, 30 minutes, 1 hour, 4 hours and 8 hours and analysed 




PMA has been verified as a Grb2-independent activator of ERK.  When 
applied to N2B27-LB culture, PMA did not restore efficient growth to Grb2-/- 
ES cells.  One explanation for this may be the brevity of the ERK signal 
provided by PMA, as the longevity of the ERK signal can have profound 
effects on the behaviour of cells.  This is demonstrated clearly by PC12 cells, 
which respond in a different manner depending on whether ERK signalling is 
transient or sustained (Reviewed by Marshall, 1995). Exposure to epidermal 
growth factor (EGF) produces a short-lived burst of ERK activation and 
promotes cell proliferation, while neural growth factor (NGF) induces a more 
sustained activation of ERK and cells undergo differentiation. 
 
 
4.2.4.2 Activation of ERK via Raf-ER 
To investigate the effect of sustained ERK activation on Grb2-/- ES cells, a 
genetic approach was used.  A plasmid containing a conditionally active 
kinase domain of Raf1 was used (Samuels et al., 1993).  Amino acids 305-
648 of Raf1 were shown to efficiently transform NIH 3T3 cells (Stanton, 
1989) due to the truncation of the 5’ regulatory domain.  This constitutively 
active Raf1 kinase domain was fused to the HE14 oestrogen receptor 
sequence to enable Raf1 activation upon the addition of a 4-hydroxy-
tamoxifen (4OHT) ligand.  The HE14 oestrogen receptor domain contains a 
glycine-valine substitution at residue 400, which reduces oestrogen binding 
and consequently reduces unwanted activation by the oestrogen hormone 
(Tora et al., 1989). 
 
The Raf-ER plasmid and an empty vector containing matching drug 
resistance were lipofected into Grb2-/- ES cells and cultured under 
hygromycin selection for 10 days.  Hygromycin-resistant clones were 
expanded and tested for stable expression of a functional Raf-ER.  Lines 
were starved of LIF and serum for three hours, exposed to 4OHT or the 
equivalent volume of ethanol vehicle for 2 hours or 3 days, lysed and 
analysed by Western blot.  Detection of phosphorylated ERK in response to 
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4OHT rather than the ethanol vehicle was interpreted to mean Raf-ER was 
successfully integrated into cells and functional.  
 
 
Figure 4.12 Three Raf-ER expressing, Grb2
-/- 
clones showed an induction of ERK activation 
(pERK) in response to tamoxifen ligand (4OHT) and no response to the ethanol (etOH) 
vehicle.  Empty vector transfected clones showed no ERK response to ethanol or 4OHT. 
 
 
Fig 4.12 shows three Raf-ER transfected, Grb2-/- cell lines exhibiting 
activated ERK upon exposure to 4OHT for 2 hours.  Ethanol-treated cells or 
cells containing an empty control vector failed to activate ERK, indicating 
ERK upregulation is a direct consequence of 4OHT treatment of Raf-ER 
expressing cells. At 3 days only one Raf-ER expressing clone exhibited 
detectable levels of phosphorylated ERK (Fig 4.13). 
 
 
Figure 4.13 Western blot showing levels of activated ERK (pERK) after three days culture in 




In order to assess the effect of sustained Raf-ER activation on the signalling, 
morphology and identity of Grb2-/- ES cells, two Grb2-/-, Raf-ER expressing 
ES cell lines and an empty vector-transfected control line were plated in 
replicate cultures in N2B27-LB with the addition of 4OHT or an equal amount 
of ethanol carrier.  After 3 days, cells were paraformaldehyde fixed for 
immunohistochemical analysis. 
 
Both Raf-ER-expressing clones performed comparably regarding morphology 
and Nanog intensity.  Figure 4.14 shows a change in colony morphology was 
observed upon activation of Raf-ER.  Colonies covered a greater area and 
lost their refractive appearance.  An increase in the number of cells was also 
observed upon Raf-ER activation.  Cells remained Nanog positive ES cells 




Figure 4.14 Morphology and immunohistological detection of Nanog in Raf-ER cells after 





To quantify the effects of conditional Raf-ER activation on Grb2-/- ES cell 
growth, a CyQuant Direct proliferation assay was performed (Fig 4.15). Two 
Grb2
-/-, Raf-ER expressing lines and an empty vector transfected control line 
were cultured in replicate plates for 3 days in the presence or absence of 
4OHT or the equivalent volume of ethanol carrier.  Cell numbers were 
recorded at 4, 24, 48 and 72 hours and data normalised to the 4 hour 
measurement.  Proliferation of all cell lines did not increase in response to 
4OHT.  Furthermore, all three cell lines exhibited significantly (Empty vector 
p<0.001; Clone 4 p<0.005; Clone 8 p<0.01) reduced cell numbers at the 72 





Figure 4.15 Raf-ER did not increase the rate of growth of Grb2
-/-





 empty vector control and Grb2
-/-
 Raf-ER expressing cells were plated 
per well of a 96 well plate in the presence of 0.1µM 4OHT or the equivalent amount of 
ethanol carrier.  Replicate plates were created for each time point.  At 4, 24, 48 and 72 
hours, cells were incubated with CyQuant Direct dye and suppressor for 1 hour before 
quantification using a fluorometric plate reader with a 488/520nm filter.  Data was normalised 
to the 4-hour time point (n=12 from 2 experiments). 
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4.2.5 Addition of Small Chemical Inhibitors 
So far only modulation of the MAPK pathway has been considered to 
improve growth of Grb2-/- ES cells in N2B27-LB.  Two inhibitor compounds 
were considered as candidates for restoring efficient growth.  Both 
compounds act upon specific molecular targets, which may reveal which 
signals are important in Grb2-independent growth. 
 
4.2.5.1 ROCK inhibition does not improve growth  
Rho Kinase (ROCK) is a serine-threonine kinase activated by Ras homolog 
gene family A (RhoA).  RhoA is a ubiquitously expressed small GTPase 
known to regulate many pathways including actin cytoskeleton remodelling 
(Amano et al., 1997), microtubule dynamics (Kosako et al., 1999) and 
transcription factor activity (Carnac et al., 1998).  ROCK is a downstream 
effector of RhoA activity.  It activates LIM Kinase, which in turn 
phosphorylates and deactivates Cofilin, an actin-depolymerising factor.  
Thus, the consequence of ROCK activation is increased actin cytoskeleton 
stability. 
 
Inhibition of ROCK has been associated with the inhibition of apoptosis 
(Koyanagi et al., 2008) although other studies disagree with this assertion.  
Sebbagh et al. (2001) showed ROCK inhibition by Y27632 prevented 
apoptotic blebbing but this did not stop the apoptotic program.  This is 
supported by Coleman et al. (2001) who also demonstrated that, though 
ROCK is required for apoptotic body formation and the localization of DNA 
into these bodies, ROCK inhibition does not prevent apoptosis.  This is 
relevant to the Grb2-/- poor growth phenotype as no increase in apoptosis 
was measured. 
 
ROCK inhibition aids the passage of human embryonic stem cells (hES 
cells).  Specifically, inhibition of ROCK enables cells to survive single cell 
dissociation, previously a limiting step in hES cell culture and expansion 
(Watanabe et al., 2007). 
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In order to assess whether ROCK inhibition improved growth of Grb2-/- ES 
cells in N2B27-LB, cells were cultured in N2B27-LB in the presence or 









 ES cell morphology does not change after 3 days culture in N2B27-LB in 
the presence of Y27632 ROCK inhibitor.   
 
 





























ROCK inhibited cells adopted a spherical morphology without any cell-cell 
contact, whilst remaining attached to the coated issue plastic (Fig 4.16). A 
CyQuant Direct assay was used to assess the proliferation of the cells. Wild 
type, Grb2-/- and 2 Grb2 restored ES cell lines were cultured in replicate 
plates for 3 days in the presence or absence of Y27632.  Cell numbers were 
recorded at 4, 24, 48 and 72 hours and data normalised to the 4 hour 
measurement.  This assay confirmed proliferation of all cell lines did not 
increase in response to ROCK inhibition (Fig 4.17). 
 
 
Figure 4.17 Addition of Y27632 ROCK inhibitor did not increase the rate of growth of ES 
cells in N2B27-LB medium.  4x10
2
 wild type, Grb2
-/-
 and two Grb2 restored ES cell lines 
were plated per well of a 96 well plate in N2B27-LB alone and in the presence or absence of 
10µM ROCK inhibitor Y27632.  Replicate plates were created for each time point.  At 4, 24, 
48 and 72 hours, cells were incubated with CyQuant Direct dye and suppressor for 1 hour 
before quantification using a fluorometric plate reader with a 488/520nm filter.  Data was 




4.2.5.2 GSK3! Inhibition Does Not Restore Growth of Grb2-/- ES Cells 
GSK3! is a serine-threonine kinase originally associated with the 
downregulation of glycogen synthesis (Embi et al., 1980) and has since been 
attributed to numerous cellular functions.  GSK3! is constitutively active, thus 
it is negatively regulated by signalling pathways such as PI3K/AKT and the 
canonical Wnt pathway.   
 
Sato et al. (2004), applied indirubin BIO (6-bromoindirubin-3'-oxime), a 
GSK3! inhibitor, to human and mouse ES cultures.  Addition of BIO 
maintained undifferentiated morphological and molecular phenotypes for 
cells of both species in the absence of self-renewal factors.  It was suggested 
that Wnt signalling was responsible for factor independent self-renewal 
although the involvement of the Wnt signalling pathway in hESCs has been 
strongly contested (Dravid et al., 2005).  
 
Inhibition of GSK3! has been implicated in the promotion of growth and 
survival of murine ES cells under MAPK inhibition.  ES cells under combined 
inhibition of MEK and FGFR grow poorly, undergo cell cycle arrest and 
apoptose (Ying et al., 2008), although this is circumvented by the addition of 
CHR99021 (CHR), a GSK3! inhibitor with higher specificity than BIO (Bain et 
al., 2007).  The exact mechanism by which GSK3! inhibition acts to improve 




-/- ES cells exhibit undetectable levels of phosphorylated ERK in N2B27-
LB media (Fig 4.6).  It was hypothesised that Grb2-/- cells were a genetic, 
rather than chemical, representation of cells under MEK inhibition.  In this 
regard, the effect of CHR on Grb2-/- cells in N2B27-LB was investigated.  In 
order to assess whether GSK3! inhibition improved growth of Grb2-/- ES cells 
in N2B27-LB, cells were cultured in N2B27-LB in the presence or absence of 













 ES cell morphology did not change after 3 days culture in N2B27-LB in 
the presence of CHR99201 GSK3! inhibitor.   
 
After 3 days culture, the morphology of the cells did not improve (Fig 4.18).  
Furthermore, colonies became smaller and highly refractive, demonstrating 
an exaggeration of the poor growth phenotype of Grb2-/- ES cells in N2B27-
LB alone. 
 
The pluripotency of the cells was confirmed through immunohistochemical 
staining for ES cell marker Nanog. Grb2-/- ES cells under GSK3! inhibition 
stained very highly for Nanog (Fig 4.19).  The levels of Nanog were 
quantified via image analysis.  The mean fluorescence intensity of 6 images 
of Nanog-stained and corresponding DAPI-stained ES cells were measured 
using Image J image analysis software by normalising the signal to DAPI.  
Calculation of the intensity of Nanog signal suggested CHR-treated Grb2-/- 




Figure 4.19 Wild type and Grb2
-/-
 ES cells were cultured in GMEM+FCS, N2B27-LB or 
N2B27-LB +CHR99201 GSK3! inhibitor for 3 days. Grb2
-/-
 ES cells stained very highly for 










Figure 4.20 Analysis of fluorescence intensity normalised to DAPI nuclear stain.  Images of 
6 random fields were analysed by Image J image analysis software. 
 
 
    GMEM+FCS     N2B27-LB    N2B27-LB+CHR 
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To quantify the effect CHR exerted on ES cell growth, a CyQuant Direct 
assay was performed.  Wild type, Grb2-/- and 2 Grb2 restored ES cell lines 
were cultured in replicate plates for 3 days in N2B27-LB alone or in the 
presence of PD03, CHR or PD03 and CHR combined.  Cell numbers were 
recorded at 4, 24, 48 and 72 hours and data normalised to the 4 hour 
measurement.  This assay showed CHR significantly (P<0.001 by student’s 
T-test) reduced proliferation of Grb2-/- ES cells at the 72 hour time point (Fig 
4.21). CHR also significantly (p<0.01) reduced the proliferation of wild type 
ES cells. However, both Grb2 restored clones showed a significant (R24 
p<0.001; R28 p<0.001) increase in cells numbers, making these data difficult 






Figure 4.21 Addition of 
CHR99201 GSK3! 
inhibitor did not increase 
the rate of growth of 
Grb2
-/-
 ES cells in 
N2B27-LB medium.  
4x10
2
 wild type, Grb2
-/-
 
and two Grb2 restored 
ES cell lines were plated 
per well of a 96 well 
plate in N2B27-LB alone 
and in the presence of 
3µM CHR99201, 1µM 
PD0325901 or both 
CHR990201 and 
PD0325901 together 
(2i).  Replicate plates 
were created for each 
time point.  At 4, 24, 48 
and 72 hours, cells were 
incubated with CyQuant 
Direct dye and 
suppressor for 1 hour 
before quantification 
using a fluorometric 
plate reader with a 
488/520nm filter.  Data 
was normalised to the 4-
hour time point (n=12 





This chapter focuses on the biochemical events that contribute to efficient 
growth in N2B27-LB.  Grb2-/- ES cells grow poorly in this media and attempts 
were made to understand the signals required to improve growth. 
 
AKT signalling is intact in Grb2-/- ES cells.  FGF and IGF signalling were 
investigated, two key factors responsible for upregulation of AKT. 
Phosphorylation at serine 473 of AKT in all ES cell lines was demonstrated in 
response to stimulation by IGF1.  However, phosphorylation of AKT did not 
increase upon FGF2 induction in all four ES cell lines despite successful 
activation of the MAPK pathway in the same experiment and confirmation of 
the activity of the growth factors through induction of 3T3 fibroblasts.  In this 
cell type, phosphorylation of AKT in response to FGF was demonstrated.  
Reprobing for phosphorylated GSK3! revealed a potential increase in activity 
downstream of AKT.  This is supported by evidence suggesting FGF receptor 
and/or MEK inhibition has no effect on steady state AKT phosphorylation 
(Ying et al., 2008).  
 
After investigating AKT signalling, the FGF and IGF induction Western blots 
were stripped using Restore stripping buffer and reprobed for ERK 
phosphorylation using pERK1/2 and then ERK2-specific antibodies. This 
showed FGF and IGF-induced MAPK activity in wild type and Grb2 restored 
cell lines, confirming FGF induction was successful in these cell lines.  Both 
FGF and IGF induction failed to activate ERK in Grb2-/- ES cells.  
Investigation of the signalling status of cells in culture revealed Grb2-/- ES 
cells have a deficit in ERK activation in N2B27-LB.  This is supported by the 
reported restoration of Grb2 dependent differentiation upon expression of a 
SOS-SH2 domain fusion protein (Cheng et al., 1998).  This fusion protein is 
thought to restore MAPK signalling. 
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FGF and IGF-induced MAPK activation is disrupted in Grb2—ES cells. ERK 
activation was restored in Grb2-/- ES cells using two approaches: chemical 
induction via PMA and expression of conditionally active Raf1 (Fig4.22).  
Both methods were successful in providing cells with an ERK signal.  
Addition of PMA to N2B27-LB had little effect on growth and morphology of 
Grb2-/- ES cells whereas Raf-ER activation changed the appearance of the 













Figure 4.22 Summary of signalling events discussed in this chapter. ERK activation by IGF 
and FGF signalling is Grb2 dependent. Grb2-independent ERK activation was achieved by 
two approaches. Addition of PMA induces a burst of ERK activation and induction of Raf-ER 
by 4OHT provides a more sustained activation of ERK. 
 
4 hours of ERK activation via PMA induction was not sufficient to change the 
growth rate or morphology of Grb2-/- ES cells.  This may suggest PMA 
induction of ERK is not equivalent to conventional GRB2-MEK-ERK 
signalling. PMA is regarded as a pleiotropic activator of PKC (von Lindern et 
al, 2000) due to its varying effects on the array of PKC isoforms.  It is 
possible that ERK activation via PMA bypasses an upstream feedback loop 
required to spatially and temporally regulate a pathway responsible for 
amplifying or sustaining the ERK signal.  Furthermore, chronic induction by 
PMA can result in down-modulation of PKC (Hofmann, 1997) which may 







    RAF  ERK 
IGF1 FGF2 
    RAF-ER 
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Sustained ERK activation was achieved via the expression of a tamoxifen-
inducible Raf.  Activation of Raf-ER was shown to induce phosphorylation of 
ERK and after 3 days Grb2-/- ES cells exhibited morphology more similar to 
wild type. 
 
Immunohistochemical staining revealed all cells remained Nanog positive.  
However, upon 4OHT exposure Raf-ER cells stained less intensely.  This 
result is in agreement with published data showing MAPK activation 
represses Nanog expression (Hamazaki et al., 2006). 
 
Prolonged activation of MAPK may augment differentiation of ES cells 
(Kunath et al., 2007).  However, after three days of sustained Raf-ER 
activation cells remained Nanog positive.  This may suggest Raf-ER 
activation is not equivalent to FGF-MEK-ERK signalling, but it is more likely 
that LIF and BMP4 counteract the effect of ERK activation downstream of the 
Raf-ER-ERK signal (Ying et al. 2003). 
 
4OHT-mediated Raf-ER activation can be effective at sustained ERK 
activation.  Activation of Raf-ER in Grb2-/- ES cells changes the adhesive 
properties of the colony but does not enhance growth.  Interestingly, this 
conclusion was also made regarding the use of fibronectin or laminin as an 
alternative substrate in the previous chapter.  In order to confirm that 
adhesion is mediated by MAPK signalling, the Raf-ER cells must be cultured 
in the presence of a MEK inhibitor such as PD03 to see if the effect of Raf-
ER activation is reversed. 
 
Despite a 10-fold reduction in comparison to the standard amount of 4OHT, 
this drug appeared to have a toxic effect on the cells. This is demonstrated 
by the reduced proliferation exhibited by empty vector-transfected cells 
cultured in the presence of 4OHT.  This may suggest that the Raf-ER system 
is not suitable for use under serum-free conditions.  One alternative system 
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that may be impart less toxicity is the FKBP-derived destabilising domain, 
which can be fused to a protein of interest, such as the activated Raf used in 
the Raf-ER system (Chu et al., 2008).  This protein is then ubiquitously 
expressed and instantly destabilised by the FKBP domain, until a Shield-1 
ligand is present.  There is growing evidence that this system has a low level 
of toxicity (Pruett-Miller et al., 2009). 
 
The Grb2-/- poor growth phenotype is characterised by both slow proliferation 
and altered colony adhesion.  Poor colony adhesion may be regulated 
separately from poor proliferation (Fig4.23) as results indicate pathways 
downstream of Raf support colony adhesion but not growth. 
 
ROCK inhibition augments enzymatic passage of hES cells.  However, 
ROCK inhibition did not aid efficient growth of Grb2-/- ES cells in N2B27-LB.  
Evidence has been put forward suggesting the increase in survival of ROCK 
inhibited hES cell cultures is due to changes in the adhesive properties of the 
cells.  Addition of EGTA to cultures abrogates the effect of ROCK inhibition.  
This is explained by the chelation of Ca2+, which disrupts the binding of 
calcium-dependent cell-cell adhesion molecules such as N cadherin and E 
cadherin (Chitaev et al., 1998).  ROCK inhibition increases the cell adhesion 
properties of cells (Amano et al., 1997) and this facilitates the formation of 
aggregates in suspension.  These small aggregates of hES cells are able to 
survive and expand into colonies, which were previously assumed to grow 
from a single cell. 
 
Murine ES cells have the ability to grow from a single cell in standard ES cell 
media (Smith, 2001), accordingly ROCK inhibition is not required to enhance 
this property.  Grb2-/- ES cells do not grow efficiently in N2B27-LB medium, 
but ROCK-mediated signalling is not responsible for the growth defect. 
 
GSK3! inhibition mimics the effect of PI3K/AKT hyperactivation.  Inhibition or 
deletion of components of this cell survival pathway has varying results on 
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ES cells.  Inhibition of PI3K by LY294002 results in ES cell differentiation 
(Storm et al. 2007), therefore it is unclear what role PI3K has in ES cell 
growth. 
 
Cells under MEK inhibition fail to thrive in N2B27 media (Ying et al., 2008) 
and this is rescued upon inhibition of GSK3!.  It was hypothesised that Grb2-
/- ES cells are equivalent to cells under MEK inhibition and GSK3! inhibition 
would restore efficient growth in N2B27.  However, addition of GSK3! 
inhibitor (CHR) resulted in further reduction of growth. 
 
There is some evidence that Grb2-/- ES cells exhibit high basal levels of 
GSK3! phosphorylation, although this needs to be verified by further 
Western blotting of more appropriate lysates, such as those presented in 
figure 4.6. Assaying levels of pGSK3! in wild type, Grb2-/- and Grb2 restored 




-/- ES cells under GSK3! inhibition also stained very highly for self-
renewal marker Nanog. This may infer that GSK3! inhibition promotes self-











Figure 4.23 Schematic of novel findings described in this chapter. In N2B27-LB medium, 
Grb2-mediated growth and adhesion are distinct processes. Grb2-mediated attachment 














Activation of the MAPK pathway is one of the earliest steps of ES cell 
differentiation (Kunath et al., 2007; Stavridis et al., 2007).  Upon 
phosphorylation of ERK, naïve ES cells enter a reversible state in which they 
are receptive to differentiative signals. 
 
Grb2-/- ES cells have been reported to have a limited capacity to differentiate 
due to abrogated GRB2-SOS-Ras-MAPK signalling (Cheng et al., 1998).  
The previous chapter demonstrated Grb2-/- ES cells cultured in N2B27-LB 
exhibit undetectable levels of ERK phosphorylation.  However, in the 
presence of serum, ERK phosphorylation was detected (fig 4.6).  This 
suggests that one or more components of serum activate the MAPK pathway 
independent of Grn2. 
 
These data raise a question:  If the MAPK pathway is activated in Grb2-/- 
cells, what potential do they have to differentiate? 
 
5.2 Grb2-Independent Differentiation 
 
5.2.1 Grb2-/- ES cells Produce Alkaline Phosphatase Negative Cells 
upon Withdrawal of LIF. 
Initially, to investigate the differentiation capacity of Grb2-/- ES cells, wild type 
and Grb2-/- ES cells were cultured in the presence or absence of LIF.  After 5 
days, cells were fixed and assayed for alkaline phosphatase (AP) activity.  
Alkaline phosphatase is a marker of pluripotent ES cells and a reduction in 
alkaline phosphatase activity is an indicator of ES cell differentiation.  Figure 
5.1 shows pink, AP positive cells were maintained in the presence of LIF for 
both wild type and Grb2-/- lines.  The intensity of AP staining is not as strong 
as other AP staining presented in earlier experiments (e.g. Fig3.6) and this 
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was attributed to the length of time the cells were dried and stored before 
images were taken.  As expected, LIF withdrawal resulted in spontaneous 
differentiation of wild type cells, demonstrated by the presence of unstained, 
AP negative cells.  Grb2-/- ES cell also produced AP negative cells, indicating 
differentiation had occurred.  Both cell lines differentiated to produce flat cells 



















 ES cells spontaneously differentiate upon withdrawal of LIF in a 
monolayer culture. Wild type and Grb2
-/-
 ES cells were plated at low density and cultured for 
5 days in the presence or absence of LIF.  After 5 days cells were fixed and stained for 
alkaline phosphatase activity. 
 
 
5.2.2 Grb2-/- ES Cells Undergo Differentiation upon Embryoid Body 
Formation. 
EC and ES cells form aggregates, termed embryoid bodies (EBs), when 
cultured in suspension.  These aggregates can differentiate into all three 
germ layer lineages; endoderm, ectoderm and mesoderm.  It was thought 
this differentiation happened in a disorganised manner (Martin et al., 1977), 
however, ten Berge et al. (2008) showed EBs produced by ES cell 
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aggregation can establish anteroposterior polarity and primitive streak-like 
structures that mimic early embryonic patterning.   
 
This patterning was dependent on localised Wnt signalling, demonstrating 
the role of morphogen gradients in imparting positional information to the 
developing embryo.  Wnt3a, BMP4 and nodal signals were implicated in the 
initiation of pattern formation in embryoid bodies.  Addition of Wnt3 ligand to 
EB cultures causes most cells to differentiate into the mesodermal lineage, 
whereas inhibition of this pathway results in largely ectodermal differentiation.   
 
In vivo, the primitive streak and anteroposterior polarity are regulated by the 
visceral endoderm and extraembryonic ectoderm (reviewed in Tam and 
Loebel, 2007).  Visceral endoderm produces Nodal and Wnt agonists, 
promoting anterior patterning and ectodermal differentiation (Glinka et al., 
1996; Yamamoto et al., 2004). 
 
5.2.2.1  Grb2-/- ES Cells have a Capacity to Form Advanced Cell Types, 
with Some Limitation. 
In order to generate EBs, wild type, Grb2-/- and two Grb2 restored ES cell 
lines were cultured in suspension in the absence of LIF for 4 or 7 days.  
Grb2-/- ES cells readily formed EBs which may have been smaller than those 
formed by wild type or Grb2 restored ES cells but this was not quantified.  
After 4 or 7 days culture in suspension, approximately 20 aggregates per cell 
line were plated in all 6 wells of a gelatin-coated 6-well-plate.   Seven days 
after plating the number of beating areas of tissue were counted.  One well of 
Grb2-/- plated EBs was fixed and immunostained for the neural markers 





Figure 5.2 a) Grb2
-/-
 EBs produce !-III-tubulin positive neurons. Grb2
-/-
 ES cells were 
cultured in suspension for 7 days and the resulting EBs plated on gelatin for 7 days.  After 
this time, cells were fixed and immunostained for neural markers Nestin (Red) and !-III-
tubulin (Green).  b) The average number of beating bodies counted after 4 or 7 day EBs 
plated on gelatin for 7 days.  Wild type, Grb2
-/-
 and two Grb2 restored ES cell lines were 
cultured in suspension for 4 and 7 days.  Approximately 20 of the resulting EBs were plated 




Figure 5.2a shows Nestin positive and !-III-tubulin positive cells. !-III-tubulin 
positive cells form a complex network of processes amongst other cells.  This 




Figure 5.2b shows the average number of beating cardiomyocyte colonies 
observed upon plating of EBs on gelatin for 7 days following 4 and 7 days 
culture in suspension.  Wild type and both Grb2 restored ES cell lines 
produced a greater number of beating bodies after 7 days culture in 
suspension compared to 4 days.  Grb2-/- ES cells failed to produce beating 
colonies in all experiments. 
 
5.2.2.2 Grb2-/- EBs Express Markers of all Lineages Excluding 
Endoderm. 
To investigate which germ layer lineages Grb2-/- ES cells are able to 
generate, wild type, Grb2-/- and two Grb2 restored ES cell lines were cultured 
in suspension.  EBs were harvested at 2, 4, 6, 8 and 10 days culture in 
suspension.  RNA was extracted and DNase treated to eliminate genomic 
DNA.  cDNA was synthesised using the Invitrogen ‘Superscript First-Strand 
cDNA Synthesis’ kit for PCR analysis of gene expression.  
 
cDNA samples were assayed for numerous markers by PCR.  Figure 5.2c 
shows markers expressed by ES cells and EBs differentiating for up to 10 
days.  As a loading control, housekeeping gene ! actin was amplified.  All 
samples produced a single band at an equivalent intensity. 
 
Primers were designed to amplify the full sequence of Grb2.  In wild type 
cells a band of approximately 700bp is detected.  Grb2-/- ES cells express a 
truncated, frameshifted form of the Grb2 mRNA (Cheng et al., 1998) and this 
was detected as a band of approximately 400bp by RT-PCR.  Grb2 restored 
lines express both the functional and non-functional Grb2 mRNAs.  This 
enables the identification of each sample as wild type, Grb2-/- or Grb2 








ES cell markers Oct4 and Nanog are highly expressed in all ES cell cultures.  
Both markers are detected in EB cultures and, as a general trend, appear to 
be downregulated over time in all cell lines.  Expression in Grb2-/- EBs may 
be slightly more persistent, while Restored clone 24 (R24) appeared to 
downregulate these markers earlier. 
 
Fgf5 is a marker of the late epiblast and early ES cell differentiation.  Figure 
5.2c shows weak detection of Fgf5 in all ES cell cultures.  Fgf5 is detected in 
differentiated EBs, indicating all ES cell lines undergo differentiation through 
a late epiblast-like state. 
 
Caudal-type homeodomain protein Cdx2 is a transcription factor expressed 
by the trophectoderm lineage.  Trophoblast cells form the peripheral wall of 
the developing blastocyst at embryonic stage E3.5 and become the placenta 
and membranes required for implantation and nourishment of the developing 
embryo.  Figure 5.2c shows detection of Cdx2 in all differentiating EB 
cultures, indicating all cell lines have the capacity to form trophoblast. 
 
Ectoderm is the outermost germ layer that forms the skin, nerves and brain of 
the developing organism.  Nestin, Sox1 and Pax6 are markers of ectodermal 
differentiation.  Nestin is a type VI intermediate filament protein (Liem, 1993) 
considered to be a marker of multi-lineage progenitor cells (Wiese et al., 
2004).  Sex determining region Y-box 1 (Sox1) is the earliest known, 
neuroectodermal-specific marker gene.  Sox1 expression is initially detected 
upon formation of the neuroectoderm.  Pax6 is part of the paired box family 
of transcription factors and is initially expressed in radial glial cells, which 
give rise to the majority of the neurons in the cerebral cortex. 
 
Figure 5.2c shows expression of Nestin, Sox1 and Pax6 in all cell lines upon 
EB formation.  These markers are detected later in Grb2-/- differentiating EBs 
compared to wild type and Grb2 restored lines. 
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Cells of the mesodermal lineage form the tissues of many organs including 
the heart, muscles and skeleton of the developing organism.  Mesoderm 
forms during gastrulation from epithelial cells in a process termed the 
epithelial to mesenchyme transition (EMT).  In this process epithelial cells 
undergo cytoskeletal remodelling, lose polarity and cell-cell contact to adopt 
a migratory cell type (reviewed in Thiery, 2002).  Brachyury, Twist and Snail 
are considered markers of mesodermal differentiation. 
 
Brachyury is a T-box transcription factor, which was first described after the 
discovery of a mouse with a mutation in the Brachyury gene (Dobrovolskaïa-
Zavadskaïa, 1927). Twist1 and Snail are highly conserved zinc-finger 
transcription factors implicated in the EMT and mesodermal differentiation. 
Snail is initially expressed in the primitive streak at embryonic stage E7.5 and 
is required for the formation and maintenance of mesoderm tissues (Smith et 
al., 1992).  Twist1 mRNA is first expressed in mesoderm outside of the 
primitive streak at embryonic stage E7 (Gitelman, 1997), although protein is 
not detectable until E8.25.   Figure 5.2c shows upregulation of Brachyury, 
Snail and Twist as EB differentiation progresses in all cell lines.  As expected 
(Rivera-Perez and Magnuson, 2005), Brachyury expression appeared to be 
downregulated by day 10 in Grb2-/- and Grb2 restored EBs. However, wild 
type EBs did not appear to downregulate Brachyury expression.  This may be 
explained by heterogeneous progression through the stages of differentiation 
or defective differentiation through the mesodermal lineage. This should be 
investigated further using a more quantitative method such as qPCR. 
 
Endoderm differentiation occurs at two points in development.  
Extraembryonic endoderm forms at embryonic stage E3.5 in the ICM and 
contributes to the lining of the yolk sac.  The definitive endoderm lineage 
forms at the primitive streak at embryonic stage E6-6.5 and goes on to 
produce the gastrointestinal tract, respiratory tract and urinary system of the 
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developing organism.  Gata4, Gata 6 and Sox17 are markers of the 
endodermal lineage. 
 
The GATA transcription factors are named after the (A/T) GATA (A/G) 
consensus sequence they bind.  There are six members of this zinc finger 
binding protein family in mammals named GATA1-6.  Sex determining region 
Y-box 17 (Sox17) is a member of a family of transcription factors involved in 
the regulation of embryonic development and in the determination of cell fate. 
Expression is first detected in the extraembryonic endoderm at embryonic 
stage E6.0 and in the definitive endoderm developing at the primitive streak 
at stage E7.0.  Figure 5.2c shows expression of Gata4, Gata6 and Sox17 
endodermal markers in wild type and Grb2 restored EBs.  Grb2-/- EBs do not 
express any of these markers, indicating a limited capacity for endodermal 
differentiation. 
 
5.2.2.3 Grb2 is Not Required for Differentiation Under Defined 
Conditions. 
In order to investigate the potency of Grb2-/- ES cells in a defined culture 
system, wild type, Grb2-/- and two Grb2 restored ES cell lines were plated at 
low density in N2B27 media for 14 days.  Cells were passaged at day 7.  
Chapters 3 and 4 describe the poor attachment of Grb2-/- ES cell colonies to 
gelatin in N2B27 media.  To overcome this, cells were plated on laminin as 
well as gelatin as described in Ying et al. (2003).  After 14 days, cells were 

































































 ES cells differentiate in a defined culture system.  Wild type, Grb2
-/-
 and 
two Grb2 restored ES cell lines were plated in N2B27 on gelatin or laminin coated plates at 
low density for 14 days.  Cells were passaged at day 7.  After 14 days, cells were fixed and 
immunostained for ES cell marker Oct4 (Red) and neural marker !-III-tubulin (Green). Scale 




Figure 5.3a shows !-III-tubulin positive neural processes were observed in all 
cell lines.  There was no observable difference in neural differentiation in wild 
type or Grb2 restored cells when plated on gelatin or laminin.  However, 
Grb2-/- ES cells produced a greater number and longer neural processes 
upon plating in laminin, suggesting laminin aids neural differentiation in the 
absence of Grb2.  After 14 days, wild type and Grb2 restored cell lines 
exhibited no Oct4 positive cells.  However, some Oct4 positive ES cell 
colonies persisted in Grb2-/- cultures. 
 
5.2.2.4 Neural Differentiation Occurs in the Presence of PD0325901 
Chapter 4 shows undetectable levels of phosphorylated ERK in Grb2-/- ES 
cells in N2B27-LB.  Despite this, Grb2-/- ES cells generated advanced cell 
types when cultured for 14 days in N2B27 alone.  This suggests Grb2-/- ES 
cells have a capacity to differentiate independent of the MAPK pathway.  To 
investigate this, attempts were made to inhibit ERK signalling in cells 
undergoing neural differentiation. 
 
To demonstrate the efficacy of MEK inhibitor PD0325901 (PD03), wild type, 
Grb2-/- and two Grb2 restored ES cell lines were cultured for 24 hours in 
three different media: GMEM with FCS, N2B27-LB and N2B27 with 1µM 
PD03.  After 24 hours cells were lysed and assayed for ERK phosphorylation 
by Western blot. 
 
 
Figure 5.4 ERK signalling is inhibited by PD0325901.  Wild type, Grb2
-/-
 and two Grb2 
restored ES cell lines were cultured for 24 hours in GMEM +FCS, N2B27-LB or N2B27-LB + 






Figure 5.4 shows all cell types exhibit ERK phosphorylation in the presence 
of serum.  Plating in N2B27-LB reduces ERK phosphorylation in all cell lines.  
However, no phosphorylated ERK is detected in Grb2-/- ES cells. In the 
presence of 1µM PD03, ERK phosphorylation was not detected in wild type, 
Grb2-/- or Grb2 restored cell lines. 
 
In order to investigate the role of ERK signalling in neural differentiation, wild 
type, Grb2-/- and two Grb2 restored ES cell lines were plated at low density in 
N2B27 media in the presence of 1 and 2 µM PD03 MEK inhibitor for 14 days.  
Cells were passaged on day 7.  In addition to gelatin, a laminin substrate was 
utilised to aid colony attachment of Grb2-/- cells.  After 14 days culture, cells 












 ES cells differentiate in a defined culture system.  Wild type, Grb2
-/-
 and 
two Grb2 restored ES cell lines were plated in N2B27 + 1µM PD0325901 on gelatin and 
laminin coated plates at low density for 14 days.  Cells were passaged at day 7.  After 14 
days, cells were fixed and immunostained for ES cell marker Oct4 (Red) and neural marker 





Figure 5.5 shows neural differentiation was observed in all cell lines when 
cultured in the presence of 1µM PD03.  On gelatin and laminin substrates, 
wild type and Grb2 restored lines retained Oct4 expressing colonies.  On 
laminin, Oct4 positive cells covered a larger area and fewer neural processes 
were observed compared to gelatin.  Grb2-/- ES cells failed to expand 
efficiently on gelatin but some neural processes were observed.  When 
plated on laminin, Grb2-/- ES cells exhibited an increased number of Oct4 
positive cells under PD03 MEK inhibition compared to inhibitor-free culture.  










 ES cells differentiate in a defined culture system.  Wild type, Grb2
-/-
 and 
two Grb2 restored ES cell lines were plated in N2B27 +2µM PD0325901 on gelatin or 
laminin coated plates at low density for 14 days.  Cells were passaged at day 7.  After 14 
days, cells were fixed and immunostained for ES cell marker Oct4 (Red) and neural marker 





Figure 5.6 shows neural differentiation was almost eradicated in wild type 
and Grb2 restored cell lines when cultured in the presence of 2µM PD03.  On 
gelatin, wild type and Grb2 restored lines remained Oct4 positive after 14 
days.  Both Grb2 restored lines produced neurons, but this was a rare 
occurrence.   On laminin, wild type cells did not produce !-III-tubulin positive 
neurons.  However, both Grb2 restored lines produced a small number of 
cells bearing neural processes.  These cell lines also exhibited poor adhesion 
to the laminin substrate, demonstrated by the holes in the cell monolayer. 
 
Grb2-/- ES cells failed to expand efficiently on gelatin and laminin but neural 
differentiation was observed.  A number of small Oct4 positive colonies were 
observed and an increased number of !-III-tubulin neural processes were 
produced when plated on laminin. 
 
5.2.2.5 Grb2-/- ES Cells Produce Fewer Nestin Positive Neuronal 
Precursors.  
Proliferation of neural stem cells is dependent on FGF signalling (Kosaka et 
al., 2006).  As Grb2 is a mediator of FGF signalling, the number of neural 
precursors was estimated through staining for neural precursor marker 
Nestin. 
 
Wild type, Grb2-/- and two Grb2 restored ES cell lines were plated on laminin 
at low density in N2B27 media in the presence of 1µM PD03 for 14 days.  
Cells were passaged on day 7.  These conditions were considered optimal 
for capturing the maximum number of neural precursors in all cell lines.  After 
14 days cells were fixed and immunostained for Oct4 and !-III-tubulin or 









































 ES cells produce fewer Nestin positive cells.  Wild type, Grb2
-/-
 ES cells 
and two Grb2 restored ES cell lines were plated in N2B27+ 1µM PD0325901 on laminin 
coated plates at low density for 14 days.  Cells were passaged at day 7.  After 14 days, cells 
were fixed and immunostained.  a) Oct4 (Red), !-III-tubulin (Green), DAPI (Blue).  b) Nestin 
(Red), !-III-tubulin (Green), DAPI (Blue).  Scale bar – 50µm. c) Analysis of Nestin 
fluorescence intensity normalised to DAPI nuclear stain.  Images of 3 random fields were 
analysed by Image J image analysis software. d) RT-PCR analysis of neural cultures. e) 
Western blot analysis of ERK phosphorylation at days 0, 1, 9 and 14 of neural differentiation.  
A wild type ES cell line cultured in N2B27-LB was utilised as a positive control.  
 
 
After 14 days, all cell lines produced !-III-tubulin positive neuronal cells.  
Oct4 positive cells were also observed (Figure 5.7a).  Fewer Grb2-/- Nestin-
positive cells were observed (Figure 5.7b) despite comparable numbers of 




analysis.  The fluorescence intensity of 3 fields of Nestin-stained and 
equivalent DAPI-stained neural cultures were measured using Image J image 
analysis software by normalising the signal to DAPI.  Calculation of the 
intensity of Nestin signal suggested fewer Nestin positive cells were present 
in Grb2-/- cultures (Fig 5.7c). 
 
In order to substantiate the claim that neural differentiation can occur in a 
Grb2-independent manner, RNA samples were collected from cells cultured 
on laminin in the presence of PD03 for 14 days.  RNA samples were DNase 
treated and cDNA synthesised using the Invitrogen ‘Superscript First-Strand 
cDNA Synthesis’ kit for PCR analysis of gene expression.  cDNA samples 
were assayed for neural markers Nestin, Sox1, Pax6 and MAP2 by PCR. 
 
!-III-tubulin is expressed by most cell types and cannot be utilised as a 
neural marker using this technique.  Its application in immunohistochemistry 
is widespread as a combination of strong "-III-tubulin expression and long 
cellular processes is unique to neurons.  Microtubule-associated protein 2 
(MAP2) is a structural protein responsible for the stabilisation of microtubules 
through cross-linking with intermediate filaments.  MAP2 contains SH3 
domains and has been identified as a direct binding partner of Grb2 (Lim et 
al., 2000).  This may indicate a Grb2-mediated interaction between 
extracellular signals and regulation of the cytoskeleton.  Expression of MAP2 
is specific to neurons, making it a suitable marker for advanced neuronal 
differentiation using a PCR technique.  
 
All cell lines expressed neural markers Nestin, Sox1, Pax6 and MAP2 (Figure 
5.7d), indicating a range of neural precursors and differentiated neurons were 
present in the cultures. 
 
Mesodermal marker Brachyury was expressed by all cell lines, suggesting 
differentiation was not restricted to the ectodermal lineage.  Endodermal 
markers Gata6 and Sox17 were absent, indicating some restriction in 
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differentiation.  ES cell marker Oct4 was expressed in all cell lines, 
supporting the immunohistochemical data.  Nanog expression was largely 
absent from wild type and Grb2 restored cell lines but expressed in Grb2-/- 
cells.   
 
5.2.2.6 Trace levels of ERK activation can be Detected in the Presence 
of PD0325901 
To confirm that ERK signalling is abrogated in Grb2-/- cells in the presence of 
PD03, protein samples were taken on day 1, 9 and 14 of the laminin-based 
neural assay to be probed for ERK phosphorylation by Western blot. The 
photographic film was exposed to the chemiluminescent signal overnight to 
ensure capture of all signal.  A positive control of wild type cells cultured in 
N2B27-LB was included.  Figure 5.7e shows phosphorylated ERK can be 
detected, albeit at very low levels in comparison to wild type cells growing in 
N2B27-LB.  These data suggest very low levels of ERK activation are 
sufficient to allow cells to undergo differentiation.   
 
A study by Stavridis et al. (2007) showed only one hour of ERK activity is 
required for ES cells to become committed to differentiation.  It was 
hypothesised that plating on laminin may cause a brief surge in ERK activity 
and this activity permits cells to commit to differentiation.  
 
Wild type, Grb2-/- and two Grb2 restored ES cell lines were plated on laminin-
coated plastics in N2B27 containing 1µM PD03.  Protein samples were 
collected at 4, 6, 8, 10 and 12 hours to be assayed for ERK phosphorylation 
by Western blot.  The photographic film was exposed to the 
chemiluminescent signal overnight to ensure capture of all signal.  Figure 





Figure 5.8 Western blot analysis of ERK phosphorylation upon plating on a laminin substrate 
in the presence of PD0325901.  Wild type, Grb2
-/-
 and two Grb2 restored ES cell lines were 
plated on a laminin substrate in N2B27 + 1µM PD0325901.  Protein samples were harvested 
at 4, 6, 8, 10 and 12 hours and assayed for ERK phosphorylation by Western blot using 
chemiluminescent detection.  Signal emitted by the chemiluminescent reaction was collected 









This chapter demonstrates that Grb2-/- ES cells have a capacity to 
differentiate.  Differentiation was detected in a LIF withdrawal monolayer 
assay, embryoid body culture assay and in a defined, monolayer 
differentiation assay.  
 
5.3.1 Grb2-/- ES Cells Differentiate upon LIF Withdrawal 
In the absence of LIF, wild type and Grb2-/- ES cells differentiated into large, 
flat alkaline phosphatase negative cells.  Cells of a similar morphology are 
produced by ES cells plated in N2B27 containing BMP4 (Ying et al., 2003; 
Kunath et al., 2007).  There is some evidence that these cells are early 
epidermal precursors (Harvey et al., 2010). 
 
5.3.2 Grb2 is Required for Endodermal Differentiation 
Experiments in this chapter show no expression of endoderm markers Gata6, 
Gata4 and Sox17 was detected in Grb2-/- EBs by RT-PCR, supporting 
previously published data. Cheng et al. (1998) reported a lack of endoderm 
after 2 days of EB differentiation by Grb2-/- ES cells.  However, this was 
demonstrated using immunological staining for laminin and cytokeratin.  
These markers are non-specific, for example trophoblast cells also express 
cytokeratin (Sasagawa et al., 1986) and this can be detected using the 
TROMA-1 antibody used in the aforementioned study.  Laminin is also 
expressed at the 8 cell morula stage and in extraembryonic matricies.  These 
findings were developed by Chazaud et al. (2006) when Grb2-/- embryos 
were shown to lack Gata6 expression via immunostaining, indicating 
defective primitive endoderm development at the blastocyst stage.   
 
It was suggested that FGF-Grb2-MAPK signalling was responsible for this 
phenotype as both Fgfr2-/- and FgfGF4-/- embryos exhibit a similar restriction 
in endodermal differentiation (Arman et al., 1998; Feldman et al., 1995).  This 
is supported by a recent study showing PD0325901 MEK inhibition prevents 
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primitive endoderm development in the ICM of developing blastocysts 
(Yamanaka et al., 2010). 
 
Differentiation of the definitive endoderm is distinct from primitive endoderm 
differentiation as it occurs later in the development of the embryo.  Gata4, 
Gata6 and Sox17 also mark the definitive endoderm lineage.  These markers 
were not detected in differentiating Grb2-/- EBs, indicating Grb2 is required for 
both primitive and definitive endoderm differentiation.  Like primitive 
endoderm, FGF signalling has been implicated in the regulation of definitive 
endoderm differentiation (Morrison et al., 2008).  However, the downstream 
effector of FGF signalling has not been confirmed.  These data could suggest 
Grb2 plays a similar role in both primitive and definitive endoderm 
differentiation. 
 
5.3.3 Grb2 is Required for the Formation of Beating Cardiomyocytes 
Grb2-/- EBs failed to produce beating cardiomyocytes when plated on gelatin.  
Mesoderm markers Brachyury, Snail and Twist were detected upon EB 
formation, suggesting mesodermal differentiation is possible.  However, while 
Brachyury is a marker of cells fated to make mesoderm, it may also mark 
cells with neural potential.  Also, Snail and Twist have been detected in 
differentiating trophoblast cells that undergo an EMT immediately before 
implantation (Abell et al., 2009).  Indeed, trophoblast marker Cdx2 was 
expressed in the absence of Grb2.  This suggests a larger panel of 
mesodermal markers should be studied in order to confirm mesoderm 
differentiation is Grb2-independent. 
 
Another explanation for the lack of beating cardiomyocyte differentiation is 
the lack of GATA factor expression.  Overexpression of Gata4 promotes the 
cardiac gene program in ES cells, resulting in a 10-fold increase in beating 
cardiomyocytes cells (Grepin et al., 1997).  Conversely, inhibition of Gata4 by 
RNAi inhibits cardiomyocyte development.  It was reported that Gata4 
deficient ES cells differentiated to the cardioblast stage before arresting and 
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undergoing apoptosis.  A later study reported Gata4 deficient ES cells can 
form beating cardiomyocytes (Narita et al., 1997) and it is thought that Gata6 
can compensate for the loss of Gata4.  This supports the observation that 
Grb2-/- EBs do not express Gata4 or 6 and fail to develop into beating 
cardiomyocytes. 
 
5.3.4 Grb2-/- ES Cells Exhibit a Delay in Differentiation 
Markers of differentiation were detected later in Grb2-/- differentiating EBs 
than in wild type or Grb2 restored lines, while ES cell markers were more 
persistent.  One explanation for this may be the abrogation of RTK-Grb2-
MAPK signalling.  Grb2-independent ERK activation is detected in the 
presence of serum.  However, subtraction of Grb2-mediated RTK signalling 
such as FGF, IGF and LIF may result in a weaker ERK signal.  A reduction in 
ERK activation may reduce the propensity for cells to undergo differentiation.  
This would result in a delay in leaving the naïve ES cell state without a defect 
in following the instruction to differentiate. 
 
5.3.5 Grb2 is Dispensable for Neural Differentiation. 
Grb2-/- ES cells differentiate into terminally differentiated neurons in a defined 
monolayer culture system.  Plating on a laminin substrate aided the formation 
of Grb2-/- neurons, however this effect was not observed in wild type or Grb2 
restored cells.  This may be due to the poor attachment Grb2-/- colonies 
exhibit on a gelatin substrate as previously observed in Grb2-/- ES cells.   
 
Neural differentiation occurs in the presence of a strong MEK inhibitor.  In the 
presence of 1µM PD03, some Oct4 positive cells persisted in the cultures 
indicating PD03 inhibits some differentiation.  This is in agreement with 
published data (Burdon et al., 1999; Ying et al., 2008).  However, all cell lines 
produced neurons after 14 days.   
 
There was some evidence that Grb2-/- cells produced fewer Nestin 
precursors.  This is in agreement with data presented by Kosaka et al. (2006) 
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wherein FGF signalling regulates the proliferation of neural stem cells.  This 
reduced proliferation would result in a restricted number of precursors but 
would not inhibit the process of differentiation. 
 
Increasing the level of PD03 to 2µM eradicated the appearance of all 
neurons in wild type cultures but a small number of these cells were 
produced by Grb2 restored ES cell lines.  This may indicate ERK signalling, 
and therefore differentiation has been shut down in these cells.  However, at 
a concentration of 2µM, PD03 may confer non-specific inhibition of other 
kinases (Bain et al., 2007). 
 
Surprisingly, Grb2-/- ES cells formed neurons in the presence of PD03.  It 
was assumed that abrogation of Grb2 signalling combined with inhibition of 
MEK would extinguish all activation of ERK and differentiation would not 
occur.  However, a highly exposed film showed weak ERK phosphorylation 
was detectable in Grb2-/- ES cells in the presence of MEK inhibition by 
Western blot.  There are a number of potential explanations for this result. 
 
The technical issue of antibody cross-reactivity with the non-phosphorylated 
form of ERK is unlikely to be responsible as levels of phosphorylated ERK 
oscillate between samples while levels of unphosphorylated ERK do not. 
 
Another explanation may be incomplete inhibition by MEK inhibitor PD03. 
PD03 is a non-competitive inhibitor reported to be the most specific and 
potent inhibitor of MEK currently available (Bain et al., 2007).  The small 
molecule inhibitor has an affinity for a unique binding pocket adjacent to the 
ATP binding site of MEK (Ohren et al., 2004).  Inhibitor binding causes 
several conformational changes in the MEK molecule, resulting in a 
catalytically inactive protein.  For these reasons it is unlikely that MEK 
signalling is possible in the presence of PD03. 
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Two studies implicate alternative signalling pathways in MEK-independent 
activation of ERK.  Prolonged stimulation of NIH and Swiss 3T3 fibroblasts by 
PDGF results in PI3K and PKC-mediated ERK phosphorylation (Grammer 
and Blenis, 1997).  Aksamitiene et al. (2010) also showed trace levels of 
ERK phosphorylation are detectable by Western blot in an EGF-stimulated 
breast cancer cell line in the presence of MEK inhibitor U0126.  This 
phosphorylation was eradicated when MEK inhibition was combined with 
PI3K inhibitor Wortmannin or siRNA-mediated silencing of PI3K or AKT 
genes.  It was suggested that PDZ-Binding Kinase/T-LAK cell-Originated 
Protein mediates this form of MEK independent ERK phosphorylation.  
However, inhibition of PI3K has been shown to enhance LIF-induced 
phosphorylation of ERK in ES cells (Paling et al., 2004) so MEK-independent 
activation of ERK is unlikely to be mediated by this pathway.  This leaves 
PKC as a potential candidate for weak ERK activation independent of MEK. 
 
In an attempt to expand on these data, the neural assay was applied to Erk2-
/- ES cells (Kunath et al., 2007).  These cells failed to produce !-III-tubulin 
positive neurons (see appendix), suggesting ERK is essential for 
differentiation.  However, it was later discovered that the genetic approach 
used to delete Erk2 from ES cells disrupted expression of a micro RNA 
cluster known to regulate neural differentiation.  These complications render 
these data difficult to interpret. 
 
This chapter demonstrates the novel finding that Grb2 is not required for the 
differentiation of ES cells into some lineages.  However, as no endodermal 






Embryonic stem cells are immortal and pluripotent.  Advances in the 
understanding of ES cell biology have implications in our comprehension of 
early developmental processes and in the field of regenerative medicine.  
Experiments described in this thesis expand on current knowledge of signals 
regulating ES cell growth and differentiation in the context of the adapter 
protein Grb2. 
Grb2-/- ES cells grow normally in serum-based media.  However, under 
defined conditions, Grb2-/- ES cells grow in tight, poorly attached colonies 
and exhibit a decrease in proliferation compared to wild type cells.  No 
increase in apoptosis was observed but it was demonstrated that Grb2-/- cells 
exhibit an abnormal cell cycle distribution under defined conditions.  A large 
proportion of cells were seen in the G1 phase of the cell cycle.  This is 
normal in somatic cells but not in ES cells.  However, as Grb2-/- cells express 
ES cell marker Nanog, it is unlikely that this change in distribution was due to 
the onset of differentiation.  One explanation for this change in distribution 
could be that the cell cycle is inhibited at the G1/S transition. 
It was hypothesised that MAPK signalling was responsible for the abnormal 
cell cycle distribution.  Indeed, no phosphorylation of ERK was detected in 
Grb2-/- ES cells in N2B27-LB.  However, MAPK is not likely to be the missing 
signal that causes slow growth, as reinstating MAPK signalling via the 
addition of PMA or expression and activation of Raf-ER failed to increase the 
rate of proliferation.  Cell cycle analysis of Grb2-/- ES cells under these 
conditions is required to confirm this idea. 
Another possible explanation for the abnormal cell cycle distribution is that 
Grb2 may mediate the degradation of cell cycle inhibitor p27.  ES cells 
express low levels of this protein compared to somatic cells but the 
mechanism governing this level of expression is not known.  Western blot 
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analysis of protein lysates will show whether the absence of Grb2 results in 
high levels of this cell cycle regulator. 
Serum contains a complex mixture of growth factors, fatty acids and 
adhesion molecules.  This study suggests one or more of these factors are 
insufficient in N2B27-LB medium, and Grb2-mediated signalling enables 
efficient growth in their absence. 
As both FGF and IGF signalling did not activate the MAPK pathway, it is 
unlikely that growth factor signalling causes the differences in behaviour 
between Grb2-/- ES cells in serum-based and serum-free media. This is 
supported by the failure of both PMA and Raf-ER to restore efficient growth 
of Grb2-/- ES cells in serum-free medium, despite successful activation of 
MAPK signalling.  However, it appears activation of Raf-ER in Grb2-/- ES 
cells changes their adhesive properties, which may suggest a role for Grb2-
mediated MAPK signalling in ES cell adhesion. 
Grb2
-/- ES cell colonies adhere poorly to a gelatin substrate.  Interestingly, 
there was no defect in the initial adhesion of Grb2-/- cells.  This suggests that 
a secondary adhesion event mediated by Grb2 may be responsible for 
colony attachment to this substrate.  Grb2 is involved with linking integrins 
and the cytoskeleton to intracellular signals and may be required for the 
assembly of the complexes that form at focal adhesions. 
Plating on laminin and fibronectin substrates restored colony adhesion to 
Grb2
-/- ES cells.  These substrates interact with an alternative complement of 
integrin subunit heterodimers and this may account for the differences in 
colony adhesion observed.   This can be investigated using antibodies or 
blocking peptides specific to integrins to recapitulate the changes in 
attachment exhibited by Grb2-/- ES cells in N2B27-LB medium. 
It is likely that one or more cell attachment molecules (CAMs) that are 
present in serum are responsible for augmenting ES cell growth and 
adhesion in the absence of Grb2. The specific molecule(s) could be 
elucidated experimentally by incubating the cells with CAM-specific 
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antibodies or blocking peptides. Blocking the function of these CAMs may 
recreate the colony morphology presented by Grb2-/- ES cells in N2B27-LB 
medium. 
Expression and activation of Raf-ER also rescued colony adhesion on a 
gelatin substrate.  This indicates Grb2-Raf-mediated signalling is required for 
efficient colony adherence.  It is likely that MAPK is the downstream effector 
of this signal.  Application of MEK inhibitor PD032901 to the Raf-ER system 
will test this idea.  If MAPK signalling is critical for effective colony 
adherence, inhibition of MEK will reverse the Raf-ER-augmented 
improvement in adhesion. 
Interestingly, despite the changes in morphology, plating on laminin or 
fibronectin substrates or activation of Raf-ER did not improve the proliferation 
rate of Grb2-/- ES cells in N2B27-LB.  This suggests that these processes of 
colony adhesion and proliferation are not linked. 
Grb2-/- ES cells exhibited an increase in phosphorylation of AKT at serine 
residue 471 in response to IGF1, in a manner similar to wild type cells.  This 
suggests IGF-PI3K signalling is not mediated by Grb2. 
No induction of phosphorylation of AKT was observed in response to FGF2 
in Grb2 or wild type ES cells.  Therefore, no conclusion can be made about 
the role Grb2 plays in FGF-mediated PI3K signalling.  Expanding this study 
to include a time course of FGF induction may reveal AKT phosphorylation at 
a later time point. 
Phosphorylation of ERK1/2 at residues thr202/tyr204 respectively was not 
detected in Grb2-/- ES cells in response to IGF or FGF induction.  
Furthermore, no phosphorylation of ERK was detected in cells cultured in 
N2B27-LB.  This lead to the hypothesis that MAPK signalling was required 
for efficient growth in this medium.  However, no improvement in proliferation 
rate was observed upon activation of ERK signal through addition of PMA or 
expression and activation of Raf-ER.  This suggests MAPK signalling does 
not augment efficient growth in N2B27-LB.  
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Experiments in chapter 5 showed a very low level of ERK phosphorylation 
was present in Grb2-/- ES cells in N2B27 medium, even in the presence of 
MEK inhibitor PD03.  This suggests that MAPK signalling is not eliminated in 
Grb2-/- cells and may support the data suggesting MAPK is not the 
downstream factor regulating growth.  
Inhibition of GSK3! improves growth of cells under FGFR and MEK inhibition 
(Ying et al., 2008).  As no ERK phosphorylation was detected in Grb2-/- ES 
cells in N2B27-LB, it was hypothesised that growth would be restored upon 
addition of GSK3! inhibitor CHR99021.  GSK3! inhibition did not improve 
growth of Grb2-/- cells.  This indicates Grb2-/- ES cells are not equivalent to 
cells under FGFR and MEK inhibition.   
To investigate how GSK3! inhibition failed to improve growth, analysis of 
GSK3! signalling should be carried out, including ascertaining the level of 
phosphorylated GSK3! in wild type and Grb2-/- ES cells in N2B27-LB and 
whether any effect can be detected on downstream components of the 
GSK3! signal.  This may include assaying the level of phosphorylated and 
unphosphorylated !-catenin and the location of this molecule in the cell.  
High levels of phosphorylated GSK3! should result in high levels of 
unphosphorylated !-catenin in the nucleus and may indicate that this 
pathway is misregulated in Grb2-/- ES cells. 
Grb2 may be a useful target for therapeutic intervention of cancer. Giubellino 
et al. (2007) stated Grb2 plays a role in metastasis.  This thesis supports 
these findings; demonstrating deletion of Grb2 changes the adhesive 
properties of ES cells, although this is only evident under serum-free 
conditions.  Of particular interest is the combination of Grb2 and GSK3! 
inhibition. Data presented in this thesis may suggest that application of this 
dual inhibition to the in vivo models described by Giubellino et al. (2007) may 
impact significantly on the proliferation and migration of cancerous cells.   
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Grb2-/- ES cells were subjected to a number of different differentiation 
protocols and demonstrated a capacity to differentiate, with some 
restrictions. 
Grb2-/- ES cells demonstrated the ability to differentiate into advanced cell 
types of the ectoderm lineage.  Additional MAPK inhibition via PD0325901 
did not prevent differentiation in N2B27.  Very low levels of ERK 
phosphorylation were detected in Grb2-/- cells under MEK inhibition, 
indicating differentiation was not MAPK-independent.  This does suggest that 
very low levels of ERK activation are permissive for exiting self-renewal and 
differentiating into neurons.  Differentiation is asynchronous and many cells 
remain undifferentiated in these cultures.  This suggests a stochastic element 
in the mechanism of Grb2-independent, low MAPK differentiation.  This may 
also infer Grb2-deficient cultures under MEK inhibition exhibit a low level of 
heterogeneity.  This may be a result of a novel autocrine signal or an effect of 
cell density that is inherent in in vitro culture. 
Mesoderm markers Brachyury, Snail and Twist were expressed in Grb2-/- EB 
cultures.  However, these markers may not be sufficient to confirm the 
presence of mesoderm in these cultures.  Investigating the expression of an 
additional marker, such as Msh homeobox 1 (Msx1) may help elucidate 
whether mesodermal differentiation is possible.  Indeed, beating 
cardiomyocytes were not produced by differentiating Grb2-/- ES cells, 
suggesting Grb2 is required for differentiation into some lineages of the 
mesoderm.  A lack of beating cardiomyocytes may be due to the abrogated 
expression of Gata factors 4 and 6 in Grb2-/- EBs.  Careful analysis of the 
markers of cardiomyocyte differentiation could identify the stage at which 
Grb2 is required for these cells to form. 
Grb2-mediated signalling is required for differentiation into the endoderm 
lineage.  This expands upon published data which describes short-term in 
vitro assays and a limited set of markers (Cheng et al., 1998; Chazaud et al., 
2006).  Grb2-/- embryoid bodies do not express endoderm marker Gata6 after 
10 days in culture.  Markers Gata4 and Sox17 were also absent.  The 
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limitation of Grb2-/- ES cells to produce cells of the endoderm lineage 
suggests they lack true pluripotency. 
As Grb2-/- ES cells exhibit restricted differentiation, this limitation could be 
used as an advantage in controlling the generation of ES cell-derived tissue.  
Selective inhibition of Grb2 can be achieved through the application of 
peptide analogs (Lung et al., 2002) or small molecules such as CGP85793 
(Gay et al., 1999).  Utilisation of these compounds may increase the 
homogeneity of differentiation cultures by eliminating cell fates such as the 
endoderm and cardiac lineages, but at the cost of efficient growth. 
The ground state hypothesis describes a state in which an ES cell is 
unaffected by any process of differentiation.  It essentially concerns the 
status of ES cells in relation to their pluripotency.  Grb2-/- ES cells are often 
used to support this hypothesis as they are considered to have limited 
differentiation potential due to their lack of MAPK signalling (Cheng et al., 
1998), the key signal that causes an ES cell to leave the naïve ground state 
(Kunath et al., 2007; Ying et al., 2008).  This thesis shows Grb2-/- ES cells 
can readily leave the ground state under MEK inhibition, which severely 
reduces, but does not eradicate MAPK signalling.  This suggests that MAPK 
suppression by this method is not sufficient to preserve ES cells in a naïve 
ground state.  
Furthermore, the ground state hypothesis does not yet take into 
consideration other cellular processes such as cell proliferation and 
adhesion, which are critical for the survival of any cell in vivo and in vitro. 
The experiments presented in thesis describe a novel contribution of Grb2 in 
growth and adhesion and expands upon current knowledge of its role in 
differentiation.  Further investigation into the processes mediated by Grb2 in 
ES cells will provide a valuable insight into the mechanisms governing ES 







ERK2-/- ES cells do not produce neurons.  ERK2-/- ES cells (Kunath et al., 
2007) were plated in N2B27 on a) gelatin or b) laminin coated plates at low 
density for 14 days.  Cells were passaged at day 7.  After 14 days, cells were 
fixed and immunostained for ES cell marker Oct4 (Red) and neural marker beta-
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